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ABSTRACT
It is important to obtain reliable measures of vital sign parameters, e.g. heart rate, respiratory rate
(RR), and the oxygen saturation of the blood (SpO2). In current clinical practice the RR is assessed
by manual count of the chest movements and pulse oximetry probes have been limited to the fingertip
or the earlobe. These methods are documented to be time consuming or inaccurate when monitoring
patients with low blood flow or decreased perfusion at the extremities (e.g. patients with obstructive
lung diseases, diabetes, or heart failure). Furthermore, they are obtrusive for long-term recordings.
The main focus of this project is to investigate the clinical applicability of photoplethysmography
(PPG) measured at the chest bone (sternum). PPG is an optical method from which the RR and the
SpO2 level can be obtained.
For this purpose we have developed a prototype of a wearable PPG sensor and conducted three
clinical studies both on healthy participants and on patients with obstructive lung diseases. The
first clinical study was a controlled desaturation study. All 14 subjects were exposed to hypoxia
by breathing an air mixture of reduced oxygen concentration in a closed system. We obtained an
average root mean squared error (Arms) of 1.75 % compared to invasive measures of the oxygen
saturation in the radial artery (SaO2) which is within the clinically and commercially accepted range.
Furthermore, this study served as a calibration of the PPG sensor in a clinical relevant range (100 %
- 70 %).
In the second study, sternal PPG recording was conducted from 30 admitted patients with either
asthma or Chronic Obstructive Pulmonary Disease (COPD). We compared the SpO2 levels simul-
taneously obtained from the sternal PPG recording and a conventional finger pulse oximeter. The
Pearson correlation between the SpO2 levels estimated from the two body locations was found to be
0.89 (p < 0.05) and the mean system bias was only 0.052 % with upper and lower limits of agree-
ment of 2.5 % and -2.4 %, respectively. The RR was also obtained from sternal PPG and compared
to conventional capnography. In a range of 11 to 36 breaths/min the Pearson correlation was 0.93
v
(p < 0.001) and the system mean bias was 0.6 breaths/min. The upper and lower limits of agreement
was found to be -2.8 to 4 breaths/min.
In the last clinical study, the focus was to investigate the clinical reliability of long-term PPG record-
ings from the sternum. Fifteen admitted patients were included in the study and were monitored
with the sternal PPG sensor for approximately 20 hours. On average it was found that clinically
reliable SpO2 and RR estimates could be calculated for 58 % of the recording time. Furthermore,
the average longest period of time with unreliable data in terms of the SpO2 level and the RR was
only 23.6 minutes and 20 minutes, respectively.
The results of this project show that it is possible to obtain reliable quasi-continuous recording of
the SpO2 level and the RR from sternal PPG in many different clinical applications in the future.
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DANSK RESUME
For kritisk syge patienter er det af stor vigtighed at opna˚ pa˚lidelige ma˚linger af de vitale parametre
som for eksempel puls, respirationsfrekvens og iltmætningen af blodet. Med den nuværende klinisk
praksis ma˚les respirationsfrekvensen ved manuel optælling af brystkassens bevægelser over et minut.
Ma˚lingen af iltmætningsniveauet udføres med et pulsoximeter, i form af en fingerklips, som placeres
pa˚ patientens finger eller øreflip. Disse ma˚lemetoder er dokumenteret tidsskrævende og unøjagtige
for patienter med lav blodgennemstrømning eller nedsat perfusion i ydreekstremiteterne, hvilket
eksempelvis ses hos patienter med obstruktiv lungesygdom, diabetes eller hjertesvigt.
Dette ErhvervsPhD-projekt omhandler ma˚ling af respirationsfrekvensen og iltmætningen i kroppen
ved hjælp af en pulsoximetersensor placeret pa˚ brystbenet (sternum). Ma˚lemetoden kaldes for foto-
plethysmografi (PPG) og er baseret pa˚, at lys med en bestemt bølgelængde sendes ind i huden. Lyset,
PPG-signalet, der sendes ind i huden bliver reflekteret i vævet, hvorved blodets iltmætning og pulsen
kan bestemmes ud fra karakteristikaene af det reflekterede PPG-signal. Det reflekterede PPG-signal,
som kan registreres pa˚ sternum, er endvidere overlejret med et signal indeholdende information om
vejrtrækningen. Fysiologiske undersøgelser har vist, at denne information om vejrtrækningen er re-
lateret til ændringen i det intrathorakale tryk under vejrtrækning der giver anledning til ændringer i
den venøse blodvolumen, samt strækning og udvidelse af huden pa˚ sternum.
Hovedfokus i dette projekt er at undersøge den kliniske anvendelighed af PPG ma˚lt pa˚ sternum. Til
dette forma˚l har vi udviklet en prototype af en kropsba˚ren PPG-sensor. Endvidere er der gennemført
tre kliniske studier i samarbejde med Bispebjerg Hospital pa˚ ba˚de raske forsøgsdeltagere og pa˚
patienter med obstruktive lungesygdomme.
Det første kliniske studie omhandlede kontrolleret nedsænkning af iltmætningen i blodet og ma˚ling
heraf med den udviklede PPG-sensor. I alt 14 raske forsøgspersoner undergik hypoksi ved at trække
vejret i et lukket gena˚ndingssystem med atmosfærisk luft, hvor iltindholdet gradvist blev reduc-
eret. Der blev opna˚et en gennemsnitlig nøjagtighed (average RMS accuracy) pa˚ 1,75 % for den
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udviklede PPG-sensor sammenlignet med invasive referencema˚linger af blodets iltmætning fra ar-
terielle blodprøver. Data fra dette studie er anvendt til kalibreringen af den udviklede PPG-sensor.
I det andet kliniske studie blev sternumbaseret PPG ma˚lt pa˚ 30 indlagte patienter med enten astma
eller kronisk obstruktiv lungesygdom (KOL). Den pa˚ sternum ma˚lte iltmætning blev sammenlignet
med konventionel pulsoximetri ma˚lt pa˚ fingeren. Pearson-korrelationen mellem iltmætningen es-
timeret fra de to placeringer, blev givet til at være 0,89 (p < 0,05). Bland-Altman analysen viste
en lav systematisk forskel pa˚ kun 0,052 %. Respirationsfrekvensen blev ogsa˚ fundet ved hjælp af
sternumbaseret PPG og blev sammenlignet med respirationsfrekvensen fra den kapnografibaserede
reference. I et interval mellem 11 til 36 a˚ndedrag/minut, var Pearson-korrelationen 0,93 (p < 0,001)
og den gennemsnitlige afvigelse var pa˚ 0,6 a˚ndedrag/minut.
I det tredje kliniske studie var fokus at undersøge den kliniske troværdighed af langtidsma˚linger
med sternumbaseret PPG. 15 indlagte patienter var inkluderet i dette studie og blev overva˚get med
sternumbaseret PPG i tilnærmelsesvis 20 timer. Det blev vist at den klinisk troværdige iltmætning
og respirationsfrekens kunne blive udregnet for 58 % af ma˚lingsperioden. Ydermere, de længste
respektive perioder med ikke-troværdig data, anga˚ende iltmætning og respirationsfrekvens, var hen-
holdsvis 23,6 minutter og 20 minutter.
Resultatet af dette projekt indikerer et højt potentiale for implementeringen af kvasikontinuerte
ma˚linger af iltmætningsniveauer og respirationsfrekens fra sternumbaseret PPG i mange forskellige
applikationer i fremtiden. Resultatet a˚bner samtidigt op for fremtidige muligheder for proaktiv pa-
tientmonitorering, hvor patientforværring kan blive identificeret tidligere og behandling kan startes
tidligere end muligt i dag.
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AC Alternate current
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ANS Autonomic nervous system
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R Optical ratio
RIIV Respiratory induced variation
RMSE Root Mean Squared Error
RR Respiratory rate
SPO2 Oxygen saturation in the blood
TIA Trans-impedance amplifier
USB Universal serial bus
x
CONTENTS
Preface i
Acknowledgements iii
Abstract v
Dansk Resume´ vii
Abbreviations ix
1 Introduction 1
1.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Thesis Outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3 List of Papers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2 Preliminaries 7
2.1 Electrocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.2 Photoplethysmography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.2.1 Principles of Pulse Oximetry . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.3 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
3 Proof of Principle: Sternal Photoplethysmography 17
3.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
3.2 PPG at the Sternum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
3.3 Methods and Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
3.3.1 PPG Probe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
3.3.2 Study Design and Data Acquisition . . . . . . . . . . . . . . . . . . . . . 21
3.3.3 Respiratory Rate Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 22
xv
3.3.4 Pulse Rate Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.4.1 Respiratory and Cardiac Variations . . . . . . . . . . . . . . . . . . . . . . 26
3.4.2 Pulse Rate Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.6 Conclusive Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
4 Development of a Vital Sign Patch 35
4.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
4.2 Sensor Design Specifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4.3 Opto-Mechanical Construction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.4 PPG-patch Front-end Architecture . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.4.1 Signal Conditioning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.4.2 LED Intensity Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.4.3 Data Acquisition and Processing . . . . . . . . . . . . . . . . . . . . . . . 46
4.5 PPG-patch for Long-term Monitoring . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
5 Clinical Study I: Invasive Controlled Desaturation Study 55
5.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
5.2 Method and Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
5.2.1 Study Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
5.2.2 Normalization and Filtering . . . . . . . . . . . . . . . . . . . . . . . . . 59
5.2.3 Estimation of the Optical Ratio R . . . . . . . . . . . . . . . . . . . . . . 60
5.2.4 Calibration Curve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
5.5 Conclusive Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
6 Clinical Study II: Short-Term PPG Measurement on COPD and Asthma Patients 69
6.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
6.2 Method and Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
6.2.1 Study Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
6.2.2 Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
6.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
6.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
6.5 Conclusive Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
7 Clinical Study III: Long-Term PPG Measurement on COPD and Asthma Patients 83
xvi
7.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
7.2 Method and Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
7.2.1 Study Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
7.2.2 Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
7.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
7.3.1 Long-term Monitoring of the SpO2 Level . . . . . . . . . . . . . . . . . . 93
7.3.2 Long-term Monitoring of the RR . . . . . . . . . . . . . . . . . . . . . . . 98
7.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
7.5 Conclusive Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
8 Conclusion 105
8.0.1 Future Perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
Bibliography 109
A Appendix: Data of Study III 117
A.1 Long-Term SpO2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
B Appendix: Datasheets 119
Paper I 123
Paper II 129
Paper III 135
Paper IV 153
Paper V 161
xvii
xviii
CHAPTER
ONE
INTRODUCTION
1.1 Motivation
”Would you like to borrow my finger pulse oximeter device? No thanks, the patient’s hands are cold
so I can’t trust the readings anyways. I will try again later.”
For the last decade there has been an emergence of wireless healthcare technologies and ad-
vancements in on-body embedded sensor technology. These technology developments may enable
the opportunity of changing the conventional healthcare systems with wearable devices that focuses
on personalized healthcare. For instance, being able to measure the vital signs continuously
(long-term) will not only enhance the quality of life for chronic disease patients, but it will also
decrease the economical burden on the hospital facilities. Moreover, there is no doubt that the
application of long-term measurement of the vital signs is pivotal in terms of early intervention.
A state-of-the-art example of an on-body embedded health monitoring technology is the ePatch R©
platform manufactured by DELTA. The ePatch R© platform is a continuous electrocardiographic
(ECG) recorder that is developed on the ”wear and forget” principle which enables continuous ECG
monitoring without interrupting any normal life activity of a patient in contrast to regular Holter or
telemetry equipment. The ePatch R© is worn on the chest bone (sternum). A detailed overview about
the ePatch R© technology is given in [1].
The vital signs are essential parameters to assess a patient’s health condition. The vital signs are:
body temperature, heart rate, respiratory rate (RR), blood pressure and the oxygen saturation in the
blood. The focus in this research project will be on the RR and the oxygen saturation in the blood.
The standard procedure for monitoring the vital signs in the hospital environment (outside the inten-
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sive care unit) currently relies on manual techniques and relatively intermittent manual observation
of the patients. Fig. 1.1 shows an example of a vital signs monitoring during a normal day at Bis-
pebjerg Hospital in Copenhagen, Denmark. Furthermore, the vital signs are currently being used to
calculate an early warning score (EWS) which is used to determine the degree of illness of an admit-
ted patient. The oxygen saturation and the heart rate are measured by a pulse oximeter attached to the
finger or the earlobe and the RR is measured by a manual count of the rib cage (thorax) movement.
This procedure is done at least once every 12 hours, which is not only time consuming, but also
uncomfortable in relation to the patients. Moreover, the oxygen saturation measurement through
the conventional finger probe is in many case difficult or even impossible [2–4]. Conditions such as
hypothermia, hypotension, or peripheral vasoconstriction may influence the blood flow and thereby
the pulse oximeter reading at the extremities. These conditions may lead to centralization, which
is a reduction of the perfusion to the extremities to maintain blood circulation at the central organs.
It is for example known that in Chronic Obstructive Pulmonary Disease (COPD) patients may have
low perfusion in the peripheral circulations [5], that may affect the pulse oximeter readings.
The RR is known to be an early indicator for detecting exacerbations and changes in the severity
of COPD [6]. According to the World Health Organization, COPD is currently the third leading
cause of death globally. Exacerbation of COPD is not only one of the major causes of morbidity
and mortality, but it also puts a high economic burden on the healthcare facilities [7]. In a small
country like Denmark, with around 6 million citizens, it is estimated that approximately 23,000
acute COPD-related patients are admitted to the hospital every year and the readmission rate is as
high as 24 % [8]. The mortality rate during admission is furthermore 8 %, which is in line with
the mortality in acute myocardial infarction [7]. In spite of this, recent studies have found that the
RR and the oxygen saturation of the blood are often not recorded even in cases where the patient’s
primary problem is a respiratory challenge [9]. The lack of consistent routine vital signs monitoring
may be a consequence of shortcomings in today’s measuring techniques.
The sternum provides an alternative measurement site due to the local anatomy and the proximal
position to the heart. It was recently discovered that the oxygen saturation of the blood and the RR
can be estimated from photoplethysmography (PPG) recorded at the sternum [10]. However, the
research group was not sure about how reliable the technique is and if it can be used on patients with
obstructive lung diseases. Thus, the goal of this project is to explore the potentials of monitoring
the oxygen saturation in the blood and the RR using PPG at the sternum, not only for short-term
measurement, but also for continuous long-term measurement on patients with obstructive lung
diseases.
2 Chapter 1. Introduction
Figure 1.1: Conventional monitoring procedure of the vital signs. GE Carescape V100 on a roll
stand is one of many vital signs monitors used at the hospital. However, the respiratory rate is
measured by a manual count of thorax movements over 60 seconds.
Four scientific hypotheses form the basis for this dissertation:
1. It is possible to make reliable short-term monitoring of reflective pulse oximetry at the sternum.
2. It is possible to make reliable short-term monitoring of the respiratory rate derived from ster-
nal PPG.
3. It is possible to make reliable long-term monitoring of reflective pulse oximetry at the sternum.
4. It is possible to make reliable long-term monitoring of the respiratory rate derived from sternal
PPG.
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Figure 1.2: Illustration of the progress of the conducted research. First a PPG probe has been
developed, then a proof of principle study has been conducted. Afterwards, another version of a
prototype PPG sensor was developed and used to investigate the clinical applicability of sternal
PPG through three clinical studies.
The process of the conducted research is illustrated in Fig. 1.2. The first step of this project was to
develop a prototype PPG probe in order to investigate the feasibility of estimating the RR and the
oxygen saturation level in the blood from sternal PPG, which was conducted through a pre-clinical
experiment. Then, another improved prototype PPG sensor was developed and used in three clinical
studies. The general aim of all three studies is to investigate the clinical applicability of sternal PPG.
1.2 Thesis Outline
The structure of the this thesis is based on the progress of the conducted research. The preliminary
chapter introduces the used modalities and the measurement techniques, followed by a chapter de-
scribing a proof of principle based on a preliminary study. Then, a description of the design and
development of the prototype PPG sensor, three chapters describing the conducted clinical experi-
ments and last a conclusion and future perspective of the research project. The background, method-
ologies and results described in the papers are reproduced in this dissertation. Some sections may
however contain more details and extended work related to what is reported. The following is a brief
description of each chapter:
Chapter 1 provides an introduction of the thesis by describing its motivation and major research
objectives.
Chapter 2 provides a description of the background information required for the understanding of
this project.
Chapter 3 presents the results of a pre-clinical experiment that was conducted to investigate the fea-
sibility of using the sternum as a measurement site for monitoring the RR and the oxygen saturation
of the blood. The aim of this study was also to investigate the morphology of the sternal PPG. The
findings of this chapter has been published in paper I and II.
Chapter 4 presents the conception and the development of a prototype sternal PPG sensor that can
be integrated with current state-of-the-art ePatch R© platform. The hardware, the software and the
opto-mechanical design is described and evaluated.
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Chapter 5 presents the description and the results of a hypoxia/desaturation study conducted on
healthy participants. The study is used to calibrate the sternal PPG sensor. This content is also
addressed in paper IV.
Chapter 6 demonstrates the description and the results of a clinical study of short-term measure-
ments conducted on COPD and asthma patients. This study is also addressed in paper III and IV.
Chapter 7 demonstrates the description and the results of a clinical study of long-term measurements
conducted on healthy participants and on a group of COPD and asthma patients. Parts of this study
is addressed in paper V.
Chapter 8 summarizes the main conclusions of the research described in the other chapters.
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CHAPTER
TWO
PRELIMINARIES
Objective This chapter will provide a short description of the primary modalities used in this project
and the fundamental theory behind photoplethysmography will be described in terms of the pulse
oximetry.
2.1 Electrocardiography
The electrocardiogram (ECG) reflects the electrical activity of the heart. The ECG is an extremely
important diagnostic tool in current clinical practice, which is primely used to track any myocardial
infarction, cardiac rhythm disturbances or changes in the electrical conduction system of the heart.
Moreover, the ECG is considered to be the gold-standard in terms of heart rate monitoring [11]. In
short, when the cardiac cells depolarize (increasing potential) and repolize (decreasing potential),
the electrical current is spread throughout the body and can be measured at the skin for example
silver/silver chloride electrodes placed at a specific body positions. The time delay between the
depolarization and the repolarization of the atria and the ventricles of the heart produces the ECG
waveform [12]. For each heartbeat the ECG constitutes of a P-wave, QRS-complex, and a T-wave
as seen in Fig. 2.1. The heart rate is defined as the time delay between two consecutive heartbeats
(i.e. QRS complexes). In the context of this project the ECG signal is measured to compare the
timing/pulse with sternal PPG and in the signal processing of the PPG signal (more about that in
chapter 5). The R-peak in the QRS-complex is the most important wave in regarding to this project.
The QRS-complex represents the depolarization of the ventricles. To record the ECG signal with the
highest R-peak a lead-II electrode configuration is used. As seen in Fig. 2.2, the positive electrode is
on the left side on the upper thigh and the negative electrode is on the right side of the upper chest.
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Figure 2.1: An electrocardiogram from a healthy subject. It is a typical ECG that can be acquired
through lead-II configuration. The P-wave is related to the contraction of the atria, the QRS-
complex to the contraction of the ventricles, and the T-wave is related to the repolarization of the
ventricles. Adapted from [12].
-
+
GND
Figure 2.2: Lead-II electrode configuration. This configuration gives the largest R-peak in the
ECG recording.
On the right thigh a grounding electrode for recording purposes is attached.
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Figure 2.3: When the hand is illuminated by the light, the entire hand glows where the skin color
becomes red due to the dominated concentration of the blood.
2.2 Photoplethysmography
From an optical point of view the human skin is considered strongly scattering (opaque). However,
most soft tissue will behave as translucent and therefore transmit and absorb both visible and infrared
light [13]. For example when illuminating a hand using a lamp in a dark room, it can be seen that
some of the light is transmitted through the whole hand. The transmitted light is red because of the
dominating concentration of the blood in the hand as seen in Fig. 2.3. In other words, light is emitted
into the skin where it undergoes absorption and scattering, which results in reduced transmitted light
intensity at the photo detector. This is what the photoplethysmography (PPG) is based on and can be
utilized using two different modes; transmission mode and reflectance mode. In transmission mode
the tissue is illuminated on one side and the light transmitted through it and detected on the other
side. This mode is of course confound to the extremities like fingers or toes but also earlobe. Where
in reflectance mode, the light source and the photo detector is placed on the same side. It can be
used on body locations like the forehead or at the sternum. The two different PPG modes are shown
in Fig. 2.4.
The PPG signal contains two components, a pulsatile (AC component), which fluctuates due
to the arterial blood and is superimposed on a ”DC” component that varies with the respiration
[15]. Non-pulsatile absorbers such as the venous blood and the bones also contribute to the DC
component. The pulsatile AC component oscillates in sync with the cardiac cycle. For every
heartbeat, the ventricles of the heart is contracted and blood is ejected (the QRS-complex in the
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Figure 2.4: Illustration of the transmission and reflectance mode PPG. The region of application
for the transmission mode is in the extremities, while the reflectance mode can be used in the
proximal regions of the body. Adapted from [14].
ECG) to the cardiovascular bed, which gives a larger blood volume, which means a larger absorption
and a lower light intensity is received at the photo detector. Giving the rising edge of the PPG
waveform, during the ventricular relaxation and filling (diastole) of the heart is shown in the falling
edge of the PPG waveform. So as a result of this volume change during the cardiac cycle, the
path length of the light will also periodically change. In compliance to the Beer-Lambert’s law,
the absorption is proportional to the optical path length and therefore the volume change will be
reflected at the photo detector.
The AC component of the PPG waveform is two to three orders of magnitude smaller than
the DC component. However, the ratio between the AC and DC components depend on the
measuring site, the perfusion and the skin temperature [13, 15]. A typical AC component of the
PPG waveform is seen in Fig. 2.5a and b, where Fig. 2.5a is recorded at the sternum and Fig. 2.5b
is recorded on the finger. Both signals are synchronized with the ECG signal seen in Fig. 2.5c.
The PPG waveforms are inverted, meaning that the rising edge corresponds to higher absorption
due to the systolic phase, while the falling edge corresponds to the diastolic phase. Moreover, it
is seen that the sternal PPG waveform appears before the finger PPG waveform because of the
proximal position of the sternum compared to the finger. These morphological differences are
further discussed in chapter 3.
The wavelength of the light source is crucial in the interaction of light and tissue. As mentioned
before the tissue is a turbid media and the heterogeneity of the tissue exhibit different absorbers with
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Figure 2.5: Typical AC component of the PPG waveforms recorded on the sternum (a) and on
the index finger (b). Both signals are synchronized with the ECG signal (c). Interesting but not
surprisingly the rising edge of the sternal PPG signal comes before the one at the finger PPG. The
same case with the diacrotic notch. This is due to the proximal location to the heart compared to
the finger. The PPG signals are inverted, meaning that the rising edge corresponds to the systole
(highest absorption) while the falling edge corresponds to the diastole (lowest absorption).
different absorption coefficients. The main contributors to the absorption in the tissue is Hemoglobin
(Hb) which is the main constituent of blood. The absorption coefficient ofHb change with its chemi-
cal binding and the wavelength of the emitted light. Oxyhemoglobin (HbO2) and Deoxyhemoglobin
Hb, have different absorption coefficients as a function of wavelength, this is what the pulse oxime-
try takes advantage of (explained in the next section). Another main contributors to the absorption
of light is water (H2O), Melanin and Collagen as seen in see Fig. 2.6. However in terms of pulse
oximetry the ”optical tissue window” is the most used wavelength range. In this range (650 nm
- 950 nm) the absorption of water is smaller than the absorption of HbO2 and Hb, cf. Fig. 2.6.
Furthermore, the tissue is optically most transparent in this region [13].
PPG has been used to estimate various physiological parameters besides pulse oximetry, such as the
estimation of the RR, blood pressure, cardiac output, tissue perfusion, vascular assessment and pulse
rate variability. A comprehensive review of the clinical application of the PPG is given by Allen [15]
and recently by [17]. In the next section the theory behind pulse oximetry is given.
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Figure 2.6: Absorption coefficient of main biological tissue content (H2O, HbO2, Hb, Collagen
and Melanin). Adapted from [16].
2.2.1 Principles of Pulse Oximetry
The blood of an human adult consists of four different types of hemoglobin:
Oxyhemoglobin (HbO2): Hemoglobin that is fully saturated with oxygen.
Deoxyhemoglobin (Hb): Hemoglobin that is not fully saturated with oxygen.
Methemoglobin (MetHb): Oxidized hemoglobin.
Carboxyhemoglobin (COHb): Hemoglobin combined with carbon monoxide (CO).
The last two types of hemoglobin is present in small concentrations (proportion of 0-2 % of the total
Hb) in the blood of an healthy adult. The fractional oxygen saturation is therefore defined as:
Fractional SaO2(%) =
cHbO2
cHbO2 + cHb+ cCOHb+ cMetHb
(2.1)
However because of the small concentrations of MetHb and COHb they are excluded in the defi-
nition of functional oxygen saturation that is expressed as:
Functional SaO2(%) =
cHbO2
cHbO2 + cHb
(2.2)
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Figure 2.7: Molar extinction coefficients of HbO2 and Hb. The oxygen saturation is a ratio be-
tween the two types of hemoglobins. At least two wavelengths 660 nm and 940 nm with two
different Molar extinction coefficients are required to estimate the SpO2 level. The largest dif-
ference in absorption between HbO2 and Hb is seen at 660 nm and the smallest and most stable
region is in the infrared region (i.e 940 nm which is commonly used). Adapted from [10].
In the application of pulse oximetry, the functional oxygen saturation definition is commonly used
and the two wavelengths that are used is red (λ = 660nm) and infrared (λ = 940nm). The abbre-
viation used for this definition when estimated by pulse oximetry is SpO2. The SpO2 is determined
by taking the ratio of two PPG signals recorded using light emitting diode (LED) with red and in-
frared wavelength. The reason behind the choice of 660 nm and 940 nm is illustrated in Fig. 2.7.
The largest difference of extinction coefficient between HbO2 and Hb is seen at 660 nm, this is a
key factor because with this large difference in absorption, small changes in oxygenation will be
detected [13]. The choice of 940 nm is not only because the difference is small, but also because
the absorption spectra of the HbO2 and the Hb at this region is stable and a slight variation of peak
wavelength will not affect the accuracy of the pulse oximeter [13].
The estimation of pulse oximetry has been applied in a theoretical model based on Beer-Lambert law,
that described the absorption of light when it passes through a homogeneous medium containing
a variety of light absorbing molecules. The model is based on the assumption that there are no
scattering effect and the optical modulation depends only to an increased path length during the
systolic phase. The model is fully described in [13] and expressed as:
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SpO2 =
Hb(λRed)− Hb(λIR)R
Hb(λRed)− HbO2(λRed) + (HbO2(λIR)− Hb(λIR))R (2.3)
where R is the optical ratio of ratios and the molar extinction coefficients λ for HbO2 and Hb are
0.08 and 0.81 mmol−1cm−1 for 660 nm and 0.29 and 0.18 mmol−1cm−1 for 940 nm [13]. Fig.
2.8 illustrates the optical ratio as a function of SpO2 based on Beer-Lambert model.
Figure 2.8: Calibration curve for pulse oximeter in compliance with Beer-Lambert model from
equation 2.3.
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Figure 2.9: Three factors that can affect the PPG; Sensing factors (blue), biological factors (or-
ange) and cardiovascular factors (red). After [14].
In practice the value of R is not calculated as stated in equation 2.3. Instead the amplitude of the
PPG signal (AC) and its average level (DC) are commonly used to calculate the ratio of ratios as
[13, 18]:
R =
ACRed
DCRed
ACIR
DCIR
(2.4)
Unfortunately, the assumptions made in the Beer-Lambert model makes it incomplete in terms of
reality, not only the light interaction is complex in the tissue, but also the orientation of the ery-
throcytes in the blood also affects the optical modulation in addition to the path length [18]. Other
limitations are shown in Fig. 2.9, for example the DC component of the PPG signal is not constant,
but influenced by the respiration (this influence is discussed in chapter 3). Moreover, the sensor-skin
coupling of the corresponding PPG device also affects the PPG signal [14, 17]. As illustrated in Fig.
2.9 three main factors may influence the PPG signal; Biological factors, cardiovascular factors, and
sensing factors.
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To overcome these factors all commercial pulse oximeters use an empirically generated calibration
curve. As in compliance with [13] the calibration curve can be used as a linear approximation in the
clinically important range of SpO2 level (100 % to 70 %) with a negative slope:
SpO2 = −aR+ b (2.5)
where a and b are constants. This procedure is performed in this project and is further described in
chapter 5.
2.3 Summary
Two primary modalities are used in this project: the ECG and the PPG. The former reflects the elec-
trical activity of the heart whereas the latter contains information about the cardiac activity (AC com-
ponent) and respiratory activity (DC component). By using two PPGs with different wavelengths,
it is possible to estimate the oxygen saturation in the blood. However, due to the limitation of
Beer-Lambert model and the inhomogeneity of the tissue a calibration scheme is needed in order to
estimate the oxygen saturation level. The calibration is usually performed using a linear regression
from data recorded on healthy subject during a hypoxia experiment. In the next chapter a proof of
principle regarding sternal PPG and its feasibility of extracting the RR, cardiac pulse and the oxygen
saturation level is discussed.
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CHAPTER
THREE
PROOF OF PRINCIPLE: STERNAL
PHOTOPLETHYSMOGRAPHY
Objectives In the beginning of this project, the knowledge about the sternal PPG was very limited,
and it was therefore not well understood whether the sternal PPG could provide satisfactory clinical
information in terms of the respiratory rate (RR) and the oxygen saturation level in the blood (SpO2).
In the previous chapter some fundamental background theory was given to ease the understanding
of the scientific work of this project. The following chapter will describe the proof of principle of
this project aiming of investigation of the feasibility of RR monitoring at the sternum. The pulse rate
is also investigated in terms of pulse rate variability (PRV). This chapter is composed upon the two
papers (I and II).
3.1 Background
The whole idea of this project is to investigate the possibility of measuring the RR and the SpO2
level at the sternum. As mentioned previously PPG is primarily performed peripherally in the
application of pulse oximetry. The most common measuring sites are the fingertip, earlobe, and
forehead. However, a number of other sites have been investigated such as the sternum [19–21]
and the shoulder [22]. Monitoring the RR from PPG has previously been studied through analysis
of peripheral PPG. Leonard et al. [23] and Clifton et al. [24] have described the derivation of
RR from finger PPG and Lindberg et al. [25] have shown the possibility of RR monitoring from
reflective PPG signals measured on the forearm. Whereas Shelley et al. [22] have found that the
respiratory component is significant in the regions of the head (the ear and the forehead) compared
to the component derived from the finger. This indicates that the measuring site has a significant
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importance for the magnitude of the respiratory component in the PPG signal. Furthermore, it
may also indicate that the smaller the distance to the chest, the less attenuation of the respiratory
component by the vasculature. This assessment is supported by Nilsson et al. [26] who found that
the respiratory and cardiac induced variations in the PPG were different at different measuring sites
(finger, forearm, wrist, forehead, and shoulder). Additionally, they found that the forearm had the
most pronounced respiratory component variation and the finger the least. In the literature, it is thus
a consensus that the magnitude of the RR component is attenuated in the arms and fingers. The RR
obtained from sternal PPG has been claimed in a patent by Kronberg and Leist [27]. However, no
studies have been conducted on investigating the clinical applicability of RR obtained from sternal
PPG.
In terms of SpO2 measurement, it was reported by Nogawa et al. [19] that the relative AC
amplitude of sternal PPG was 10 % compared to the finger PPG, whereas the AC amplitude of
the PPG from the forehead was 30 % relative to the finger PPG. Konig et al. [28] reported that
the signal quality on the sternum is comparable to the arterial blood samples. This is also in line
with Mendelson et al. [29]. Additionally, Mendelson and McGinn [30] reported that the error on
estimating the SpO2 from the forearm and calf is slightly larger compared to the forehead and the
sternum. Recently, it was reported by Vetter et al. [20] that the SpO2 level can be estimated within
an absolute error of 3 %.
From the literature it can be concluded that sternal PPG can be used for the estimation of the SpO2
level. However, the quality of the signal is lower than those obtained from the forehead and fin-
gertips. Moreover, nothing of the above cited papers reported any results from clinically relevant
patients. All the reported experiments have been conducted on healthy subjects.
3.2 PPG at the Sternum
The sternum is expected to be a robust location for acquiring PPG signals, because of the central
body location and the proximity to the heart and lungs. The anatomy of the thoracic cage and the
blood supply to the subcutaneous vessels at the sternum are very relevant components when measur-
ing the PPG signal at that region. As seen in Fig. 3.1a, the blood flow is ejected from the ventricles
of the heart, then into the ascending aorta, where it continues to the left and the right brachio-
cephalic trunks. The blood is subsequently supplied to the internal thoracic arteries on both sides
of the sternum, on the posterior side which then supplies the perforating branches that goes into the
micro-musculature of the subcutaneous tissue of the sternum, cf. Fig. 3.1b.
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Figure 3.1: The local anatomy of the thoracic cage. (a) The route of arterial blood supply to the
sternal region (indicated by the green arrows). Both at the arterial and the venous site the blood
is pumped out from the ventricles of the heart and ends at the internal thoracic arteries and veins
which supply the sternal tissue through the perforating branches seen in (b).
The respiratory-induced intensity variation (RIIV) in the PPG is well documented in the literature
[31–35]. It is the intra-thoracic pressure variations that happens during the exchange of blood be-
tween the pulmonary and the systemic circulation that is reflected in the venous and the artery system
and causes the baseline variations. However this is the only mechanism that reflects the respiration
in the extremities. Where as, at the sternum the local variation is believed to contribute to larger
pressure variations during respiration. The pressure variations in the thoracic cavity change and
affect the blood volume in the internal thoracic arteries and the anterior perforating branches of in-
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tercostal vessels. The PPG signal measured at the sternum would basically be measuring the blood
flow through the sternal micro-musculature of the subcutaneous tissue supplied from the perforating
branches seen in Fig. 3.1b. To investigate the PPG signal measured at the sternum a PPG probe has
been developed and a pre-clinical experiment was conducted. A more comprehensive description of
a more advanced version of the PPG probe and the rational behind the proposed design is given in
chapter 4.
3.3 Methods and Materials
3.3.1 PPG Probe
For the purpose of this pre-clinical experiment a PPG probe has been designed and developed, shown
in Fig. 3.2. Four photo detectors (PD1-PD4) were placed radially around a dual LED, where the
LED can manually be switched ”on” and ”off” and emit red (660 nm) or infrared (940 nm) light.
The overall sensitivity area for each photo detector is 4.4 mm2 and the output from the four photo
detectors was treated as four independent PPG channels. The reason for choosing four photo detec-
tors is to acquire light intensity from different sternal positions, since the perfusion at the chest is
known to be lower than at the periphery [20]. Another configuration could be to parallel connect all
four photo detectors and thereby get a summation of the generated current.
The light and photo detector distance was chosen to 7 mm as proposed for less perfused skin areas
by [36]. The bottom of the probe is covered with optically transparent polycarbonate. Each of the
four photo detectors measure the light intensity and produce a small current, which is amplified and
converted to a voltage signal by a high gain-low noise trans-impedance amplifier. The voltage signal
is afterwards high-pass filtered to eliminate any offset from the trans-impedance amplifiers. The
signal is then amplified and low-pass filtered. The cut-off frequencies for the two filters are 0.05 Hz
and 20 Hz respectively to preserve the respiratory information in the PPG signal (6-30 breaths/min)
and to maintain the cardiac component (30-240 beats/min). The 20 Hz was chosen to minimize 50
Hz power line interference.
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Figure 3.2: An illustration of the developed PPG probe. The photo detectors (PD1-PD4) are
radially arranged around the dual LED and separated by an optical shield to prevent direct light
from the LED.
3.3.2 Study Design and Data Acquisition
A group of 10 healthy volunteers (9 males, 1 female) with mean age of 39.2±12.6 years and a mean
Body Mass Index (BMI) of 24.5±3.2 kg/m2 were recruited for this pre-clinical study.
The reflective PPG probe was positioned on the skin over the sternum using adhesive tape, a trans-
mission mode PPG was obtained using a conventional finger probe (Datex-Ohmeda AS/3, GE
Healthcare, USA) and lead-II ECG was also acquired and used as a cardiac reference signal. As
a reference signal to the RR derived from sternal PPG, the inspiratory and expiratory fraction of
carbon dioxide (fCO2) was acquired via a nasal catheter. The reference signals and the sternal
PPG signals were collected simultaneously and digitized with a sampling rate of 1000 Hz (Powerlab
8/35, 16 bit ADC, ADInstruments, USA) and stored on a laptop computer using Lab Chart 7 Pro
(Lab Chart Version 7.3.7, ADInstruments, USA) data acquisition software. Fig. 3.3 outlines the
experimental setup. For each subject being in a supine position data were collected in two stages:
1. Spontaneous respiration: The subjects were instructed to relax and breathe with natural RR
for 10 min.
2. Paced respiration: The subjects were instructed to breathe in time with a visual scale. The
pace was set to 6, 17, 24, 12, and 27 breaths/min for three minutes each.
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Figure 3.3: A picture of the measurement setup. For each subject, the four channels sternal
PPG sensor (PD1-PD4), lead-II ECG, conventional finger PPG, and nasal (fCO2) were acquired
simultaneously. All the equipment is connected to the data acquisition system through BNC cables,
and the test subjects were positioned in a supine position.
The subjects were instructed not to make any unnecessarily body movements to avoid motion arti-
facts. The room temperature was 20− 22 ◦C.
3.3.3 Respiratory Rate Analysis
In order to quantify the respiratory and cardiac contents of the sternal PPG signals and compare
them with the reference signals, we used three methods: (1) Power spectrum analysis, (2) Magni-
tude squared coherence analysis, and (3) time-domain RR estimation. All three methods have been
applied on data acquired during the first stage of the experiments, where, only the last method has
been used for the second stage of the experiment.
Power Spectrum Analysis
The power spectral density (PSD via Welch’s averaged, modified periodogram- method, 50% over-
lap, 160-s Hamming window) for the sternal PPG signal was calculated and the power (%) within
the range of 0.1 to 0.45 Hz (6 to 27 breaths/min) was used as a measure of the respiratory component.
The same procedure was used to estimate the cardiac content within the range of 0.5 to 2 Hz (30 to
120 beats/min) for the sternal PPG. The same PSD for the reference signals has also been calculated
for comparison. Eight minutes recording periods were used in the analysis.
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Magnitude Squared Coherence Analysis
The similarity between the fCO2 reference signal and the sternal PPG signal as well as between
the ECG reference signal and the sternal PPG signals is calculated using the magnitude squared
coherence analysis [26]. The magnitude squared coherence Cxy(f) is given in (3.1)
Cxy(f) =
|Pxy(f)|2
Px(f)Py(f)
(3.1)
The result is a normalized measure between 0 and 1 of the correlation between the frequency content
of two signals x and y at the frequency f , where Pxy(f) is the cross-spectral density between x
and y, and Px(f) and Py(f) are the power spectra densities of x and y respectively. Cxy(f) was
calculated at the frequency of the reference RR and heart rate, respectively.
Calculation of the Sternal PPG based RR
The sternal PPG signal was filtered using a zero-phase 3rd order Butterworth band-pass filter with
cut-off frequencies at 0.1-0.5 Hz (6 to 30 breaths/min) [37]. These cut-off values are chosen to
suppress the cardiac-related variations and the frequencies below the respiratory frequency in the
PPG signals. After the filtering process MATLAB’s peak detection algorithm has been applied. The
same procedure was applied to the capnographic reference fCO2 signal. The RR was calculated
using one-minute, non-overlapping segments.
3.3.4 Pulse Rate Analysis
The hemodynamic and the morphology of the sternal PPG is investigated using the approach of heart
rate variability (HRV).
HRV obtained from ECG recordings is a commonly used method that reflects the balance between
sympathetic and parasympathetic modulation of the heart rate [38]. HRV parameters are derived
by analysis of the temporal relationship between successive heartbeats (R-R intervals) in the ECG
signal. From these intervals we can compute time and frequency domain, and nonlinear dynamics
analysis to extract features to assess the autonomic nervous system (ANS) modulation of the
heart rate. The morphology of the PPG signal is useful for the study of autonomic control of the
peripheral vascular tone [15]. The physiological information derived from the R-R intervals can
also be derived from the pulse-to-pulse (P-P) intervals of the PPG signal. Studies on pulse rate
variability (PRV) have been conducted on the peripheral location of the body, mainly at the fingertip
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and the earlobe using a conventional pulse oximetry probes [39]. Prior to the extraction of R-R
and P-P intervals, the ECG signals were band-pass filtered using a second order Butterworth filter
with cut-off frequencies of 0.05 Hz and 40 Hz. As for the PPG signals the cut-off frequencies were
0.05 Hz and 15 Hz. The R-peak detection was performed using Pan and Tompkins QRS detection
algorithm [40]. The R-R intervals were extracted from the located R-peaks. As for the PPG signals,
the foot of the sternal PPG were located (using MatLab’s peak detection function) and used to
produce the P-P intervals. The peak can also be used, but for sternal PPG the foot is more distinct.
To compare the HRV and PRV methods, a commonly used time and frequency domain pa-
rameters were computed according to the standard definitions of HRV parameters [38]. As for the
time domain parameters, the mean value of the R-R and P-P intervals (mean NN), the standard
deviation of N-N intervals (SDNN), the square root of the mean of the squares of differences
between successive N-N intervals (RMSSD), and the pNN50, which is the proportion of differences
of successive intervals differing more than 50 ms was calculated. Prior to the frequency domain
calculations the R-R and P-P intervals were resampled at 4 Hz and cubic spline interpolated [38].
From the power spectrum density the normalized low frequency (LF) power (0.04-0.15 Hz), the
normalized high frequency (HF) power (0.15-0.4 Hz), and the LF/HF ratio has been computed.
The time domain parameters are related mostly with the overall variability of the heart rate. The
LF components represents the sympathetic and parasympathetic tones, while the HF components is
more related to parasympathetic modulation.
The Pearson correlation coefficient was used to correlate the calculated parameters derived
from the ECG and PPG respectively. In addition, the lower and the upper limits of agreement and
the mean system bias between the two methods is compared using the Bland-Altman analysis.
Furthermore, the mean squared error is computed between the values of the HRV parameters
derived from the R-R and P-P intervals.
3.4 Results
Fig. 3.4 shows a 30 second segment of a typical recording, it is a recording during spontaneous
respiration. From (a) to (d) the sternal PPG (PD1-PD4) acquired by the four photo detectors of the
PPG probe, the rest are the signals recorded by the patient monitoring system; Finger PPG (e), ECG
(f) and in- and exhaled carbon dioxide fraction (g). It is clearly seen that all the sternal PPG contains
the cardiac pulses which are beat-by-beat synchronous with the heartbeats in the ECG signal and
the pulses in the finger PPG. At the same time, it is seen how the cardiac pulses are superimposed
on the respiratory baseline. These variation are in all four sternal PPG signals in sync with the nasal
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Figure 3.4: All the recorded modalities from the experiments. From (a) to (d) sternal PPG from the
corresponding photo detectors (PD1-PD4). The rest of the signals are recorded through the patient
monitoring system; (e) Finger PPG, (f) ECG and (g) in- and exhaled carbon dioxide fraction. All
the signals in the figure are unfiltered data.
(fCO2) signal. Fig. 3.5 shows a typical result of the power spectral analysis for all three acquired
signals. The figure shows that the sternal PPG signal contains both a respiratory and a cardiac
component. However, the power spectral content of the respiratory variations in the sternal PPG is
larger than the power spectral content of the cardiac variations, which is the case for all the recorded
signals.
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Figure 3.5: Power spectrum analysis of one of the recordings. (a) The ECG signal, (b) The
respiratory reference signal, and (c) The sternal PPG signal. Generally, the sternal PPG signal
contains both a respiratory and a cardiac component.
3.4.1 Respiratory and Cardiac Variations
During spontaneous respiration the median and interquartile range of the RR was calculated to 10.99
(3.68) breaths/min and 11.41 (3.32) breaths/min from sternal PPG and the reference signal respec-
tively. As seen in Fig. 3.5 the sternal PPG signal contains both a respiratory and a cardiac compo-
nent. The power spectral content of the respiratory variations in the sternal PPG is larger than the
power spectral content of the cardiac variations. The median and interquartile range of the respira-
tory power spectral content in the PPG signal acquired for each photo detector (PD1-PD4) is 73.43
(25.37) %, 79.67 (23.91) %, 79.12 (29.55) %, and 70.1 (26.82) %. The pulse spectral power at the
sternum is 23.76 (18.79) %, 18.19 (21.13) %, 18.81 (15.53) %, and 26.76 (19.11) % for all four ster-
nal PPG signals respectively. The distribution of the spectral power content for all the participants
from the recorded PPG signals is shown in Fig. 3.6. The result from the squared coherence calcula-
tion is shown in Table 3.1. The values are calculated for the respiration and for the pulse. As seen
in the table the sternal PPG signal shows strong coherence with both the respiratory reference signal
and the ECG reference signal, respectively. The results for the paced respirations are summarized in
Table 3.2. RRs derived from sternal PPG are significantly correlated with reference RRs.
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Heart rate
Respiratory rate
Figure 3.6: The respiration and cardiac spectral power content derived from each of the four
sternal PPGs for each subject.
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Table 3.1: Result of the squared coherence values when comparing sternal PPG from each photo
detector with the respiration (resp) reference signal and pulse rate reference (pulse) ECG signal,
respectively. IQR is the interquartile range.
Subject # PD1 PD2 PD3 PD4
Resp Pulse Resp Pulse Resp Pulse Resp Pulse
1 0.98 0.98 0.98 0.99 0.97 0.99 0.94 0.99
2 0.94 0.99 0.96 0.99 0.96 0.99 0.94 0.99
3 0.96 0.99 0.96 0.99 0.95 0.99 0.94 0.99
4 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99
5 0.96 0.95 0.96 0.96 0.95 0.96 0.96 0.99
6 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99
7 0.98 0.99 0.98 0.99 0.98 0.99 0.98 0.99
8 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99
9 0.92 0.99 0.95 0.99 0.96 0.99 0.97 0.99
10 0.98 0.99 0.98 0.99 0.98 0.99 0.98 0.99
Median
(IQR)
0.98
(0.03)
0.99
(0.01)
0.98
(0.03)
0.99
(0.00)
0.98
(0.03)
0.99
(0.00)
0.97
(0.05)
0.99
(0.00)
Table 3.2: Summary of the RRs during paced respiration. The results are expressed in median
(interquartile range).
Visual scale fCO2 Sternal PPG
RR RR RR
(breaths/min) (breaths/min) (breaths/min)
6 6.10 (0.14) 6.03 (0.15)
12 12 (0.14) 11.95 (0.12)
17 17.01 (0.55) 16.97 (0.12)
24 23.99 (0.15) 23.86 (0.24)
27 26.98 (0.01) 26.98 (0.13)
Correlation Coefficient 0.99 (p <0.001)
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Figure 3.7: (a) A band-pass filtered PPG signal (PD2) with the detected foot (red markers) that are
used to form the P-P interval. (b) A filtered ECG signal and the detected R peaks (red markers) are
used to form the R-R intervals from which the HRV analysis is performed.
3.4.2 Pulse Rate Analysis
A band-pass filtered signal of sternal PPG is shown in Fig. 3.7 together with the corresponding
detected foot. From the detected indicies the P-P interval time series is derived and shown in Fig.
3.8a. The same procedure is done with the ECG signal and the R-R interval time series is derived
as shown in Fig. 3.8b. All detected peaks were visually inspected and manually corrected. For all
the subjects the derived parameters obtained from PRV and HRV are presented in Table 3.3. All
the computed parameters derived from the PRV had correlation coefficients of > 0.95 (p <0.001)
when compared to HRV. The error analysis showed insignificant differences between the parameters
derived from the two methods (p <0.05). The Bland-Altmann analysis showed close agreement
between the parameters derived from ECG and PPG. During spontaneous respiration the average
system bias for the mean NN interval was -0.03 ms and the lower and upper limits of agreement
was -0.561 ms and 0.501 ms respectively, cf. Fig. 3.9a. As for the LF/HF ratio, the average system
bias was -0.0064 ms and the lower and upper LOA was -0.27 ms and 0.25 ms respectively as seen
in Fig. 3.9b. Similarly, high degree of agreement was found for the rest of the parameters under
spontaneous respiration. During paced respiration the average system bias increased in the same
direction for all parameters. It is also seen in Table 3.3, that the LF/HF ratio increased from 1.045 to
2.99 for HRV and from 1.05 to 2.76 for PRV.
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Figure 3.8: Comparison of the (a) P-P interval derived from the sternal PPG signal and (b) R-R
interval derived from the ECG signal.
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Figure 3.9: (a) Bland-Altman plot of the Mean NN derived from the sternal PPG signal and the
Mean NN derived from the ECG signal.(b) Bland-Altman plot of the LF/HF ratio derived from the
sternal PPG signal and the LF/HF ratio derived from the ECG signal.
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Table 3.3: The time and frequency domain parameters, correlation coefficients and Bland-Altmann
analysis derived from P-P and R-R intervals respectively. LOA corresponds to the limits of agree-
ment lines.
Parameters HRV PRV Bias Lower Upper Correlation Abs.
(Mean±SD) (Mean±SD) LOA LOA coef. error
Sp
on
te
no
us
re
sp
. Time domain:
Mean NN (ms) 1012±134 1012±134 -0.03 -0.56 0.5 0.99 0
SDNN (ms) 63±34 63±34.6 -0.2 -2.5 2.15 0.99 0
RMSSD (ms) 50.5±41.2 50.64±41.6 -0.1 -5.8 5.53 0.99 0
pNN50 (%) 21.01±23.7 20.9±23.3 0.04 -5.9 5.9 0.99 0
Freq. domain:
LF/HF 1.045±0.6 1.05±0.7 0 -0.3 0.3 0.98 0
Pa
ce
d
re
sp
. Time domain:
Mean NN (ms) 953±112 954±112 -0.1 -1.3 1.1 0.99 0
SDNN (ms) 52±24 55±23 -3.1 -9.1 3 0.99 0.1
RMSSD (ms) 45.1±32.9 53.8±35.7 -8.7 -23.2 6 0.98 0.2
pNN50 (%) 22.5±21.7 29.5±24.6 -6.9 8.8 -22.7 0.95 0.2
Freq. domain:
LF/HF 2.9±1.9 2.8±1.7 0.2 -0.9 1.4 0.95 0.1
3.5 Discussion
The key findings of this pre-clinical study are that sternal PPG shows very strong coherence
with the respiratory fCO2 reference signal and the ECG signal, respectively. Furthermore, the
power spectral analysis showed that the sternal PPG contains larger power spectral content of the
respiratory variations than the cardiac variations. This is a key result, which illustrates that the RR
can be derived at the sternum with high accuracy within a clinical relevant range (6-27 breaths/min).
Additionally, the results showed a high correlation 0.99 (p > 0.001) between the capnography
based RR and the PPG based RR. The power spectral density and magnitude squared coherence
analysis are widely used in the literature in order to quantify the respiratory content in the PPG
signal. In this study we used similar approach as reported by Nilsson et al. [26]. These authors
reported that the best site for measuring the RR is at the forearm, but they did not investigate the
PPG at the sternum. In this study the sternal PPG had a relatively large respiratory component
compared to what is reported in [26]. A direct comparison to peripheral PPG is described in
chapter 6. Furthermore, the magnitude squared coherence analysis showed a strong similarity
(0.98) between the sternal PPG signal and the ECG reference signal. In terms of the pulse rate
variations, the study showed a close agreement between the HRV parameters derived from the PPG
signals and the ECG signals on a healthy group of subjects at rest and under paced respiration.
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Although, the average system bias increased between the parameters derived from PRV and HRV,
the absolute values changed in the same direction as seen in Table 3.3. The LF/HF ratio derived
from PRV increased during paced respiration, confirming that the change in the autonomic tone
was also reflected in the PRV as it did in the HRV. The sternal PPG sensor is reliable for recording
a PPG signal from, which HRV parameters can be derived, at least in healthy subjects at rest. The
morphology of the PPG signal acquired at the sternum has also a clear systolic and end-diastolic
peak, as seen in Fig. 3.7. This might be useful for different types of pulse wave analysis since
other clinically relevant features may be extracted. Recent studies have reported that the use of
PPG recordings might be a more convenient method for the measurement of HRV in clinical
environments and for ambulatory recordings than ECG. However, there has been a difference in
the accuracy between the PRV derived from finger PPG and HRV both at rest and during physi-
cal and mental tasks [41]. Furthermore, there is a clear uncertainty regarding the measuring site [41].
The vascular properties of the skin differ between various locations on the body. The tissue
at the sternum is less perfused when compared with the peripheral locations such as the fingertip
[20]. Nevertheless, acquiring the RR from sternal PPG has several advantages that makes the
sternum an appropriate sensor position. First of all, a probe placed at the sternum is less obtrusive
than earlobe or finger probes. Secondly, the sternum can be used to monitor other clinically relevant
parameter such as pulse oximetry [20]. Respiratory pressure variations in the thoracic cavity affects
the blood volume on the venous side and on the arterial side. We propose that the center location at
the sternum and the anatomical structure of the thoracic cage is the main contributor to a pronounced
respiratory effect. The perforating veins and arteries that surround the chest bone affect the PPG
signal at the sternum. In addition to this mechanism, we propose that the mechanical tension over
the sternum during inhalation/exhalation causes the skin to stretch. This affects the underlying
vasculature of the skin and due to the thin wall of the veins, this mechanical effect is believed
to be more prominent in the veins than in the arteries and therefore contributes to the respiratory
component in the sternal PPG signal.
3.6 Conclusive Remarks
This proof of principle study has shown through different kind of signal analysis that the RR and the
pulse rate can be calculated from the sternal PPG. We propose that the local anatomy of the skin at
the sternum and the physiology of the thoracic cage create three mechanisms that dynamically affect
the blood volume and makes sternum superior in terms of monitoring the RR from PPG compared
to other measurement sites mentioned in the literature. For the thoracic cage, the three mechanisms
that affect the sternal PPG are:
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The mechanical stretching over the sternum in relation to expansion of the thoracic cage and
stretch of the skin produces a compression pressure to the underlying blood vessels. This
is most noticeable for the veins because their thinner vessel walls make them more pressure
sensitive when compared to the arteries.
Respiratory induced variations arises from the venous return to the heart, caused by the alter-
ations in intrathoracic pressure. This mechanism is well documented [31–35].
The arterial effect is seen as cardiac pulsations with similar frequency as in the ECG. The cardiac
pulse is from the pulsating nature of the arterial blood volume, which is taken advantage of in
ordinary pulse-oximetry using the relation between PPG signals at two different wavelengths
(mainly 660 nm and 940 nm). The cardiac pulse variations was seen in the raw PPG signal
of the sternum, although roughly 75 % of the total blood volume is present in the venous
compartment (Fig. 3.4a-d).
Another important finding is that there was no significant difference between the four PPG signals
acquired from each photo detector. This finding is important for the future design of a PPG sensor.
Based on this, four photo detectors is found to be redundant in the developed PPG probe. However,
connecting the photo detectors in parallel and thereby sum the total currents might be a useful ap-
proach. It is a trade-of between signal quality and sensor design constraints. During the experiment
it was observed that the signal quality got enhanced when a pressure is applied on the skin where the
sensor is placed. The effect of probe pressure and coupling media is discussed in the next chapter.
Additionally, a description of a developed PPG sensor is given.
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DEVELOPMENT OF A VITAL SIGN
PATCH
Objectives Central to the PPG sensor design is the ability of long-term monitoring and reliable sen-
sor attachment to the sternum. In the previous chapter the PPG probe with four photo detectors
was briefly introduced and used in a proof-of-principle study. This chapter will focus on the concep-
tion, development and evaluation of a fully functional prototype pulse oximeter sensor (PPG-patch).
Prior to this, a short review of previous reflective pulse oximeter designs is given. Some information
regarding the design and the fabrication of the PPG-patch is not included in this dissertation due to
confidentiality reasons.
4.1 Background
Sternum as a measurement site challenges the design of the device and demands a new paradigm in
designing the reflectance sensor. As mentioned in chapter 3, the sternal PPG contains both a cardiac
and a respiratory component and with a proper sensor-skin coupling it was possible to obtain a
reliable PPG signal at the sternum as shown in the proof of principle study, cf. Chapter 3.
The work of designing reflection mode pulse oximeter sensors is well documented in the sci-
entific literature and in the patents. Interestingly was the beginning of Nellcors progression in
the medical device market using their first reflection mode probes [42]. Moreover, other attempts
in developing reflection mode pulse oximeter sensors was done in the late 80’s and in the 90’s
[19, 36, 43–45]. The focus was on developing sensors with multiple wavelength or photo detectors,
sensors with improved handling of motion artifacts and better accuracy during low saturations
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levels. An early design made by Dassel et al. [46] shows a sensor design with an array of three
photo detectors and one single light source as seen in Fig. 4.1a. A similar design approach has been
used by Mendelson et al. [47, 48]. Their aim was to lower the pulse oximeter’s power consumption
using low LED drive current but large photo detector area. Another design approach by Takani
et al. [49] used 16 LEDs radially placed around one single photo detector as seen in Fig. 4.1b.
A combination of this sensor design and the sensor designed by Mendelson’s group was recently
adapted by Sola et al. [50] and is shown in Fig. 4.1c. This PPG probe has eight photo detectors
and 16 dual LEDs. The sensor is designed to be placed at the sternal area using an elastic band
that surrounds the whole upper thorax [20]. The elastic band is used to obtain a contact pressure
between the skin and the PPG probe. Similar principle is used by [51] on the forehead using a
commercially available headband (OxiMax MAX-FAST headband; Nellcor Healthcare, Pleasanton
CA). However, the headband is not only used to enhance the contact interface, but to compress the
superficial veins so the blood oxygen saturation readings are not affected by the venous pooling.
In the attempt of making a sensor design with large photo detector area radially oriented
around a light source embedded in a an electronic patch has recently been designed by Duun et al.
[10]. All these designs have two functionalities in common; firstly large photo detector area (one
large or multiple photo detectors) and secondly many LEDs. The first case gives a large detecting
area with low power consumption and the latter gives a better PPG signal quality, but larger power
consumption.
Another important design aspect that needs to be taken into account is the separation distance
between the photo detector and the light source. The light backscattered from the tissue contains
the same information in all scattering directions. This gives the reason to design the sensor so that
the photo detectors are distributed from an area concentric with the light source. It is well known
that this distance is significant for the quality of the recorded PPG signal [15]. If the distance is
very small the AC/DC ratio of the PPG signal will be low and therefore it will contain very small
pulsatile information. If the distance is very large the light penetration depth will increase and the
overall signal-to-noise level will be low. Moreover, it will affect the power consumption of the
device because more light is needed when the light and photo detectors are distant. The intensity
of the backscattered light decreases in direct proportion to the square of the separation distance
between the photo detector and the light source [36, 52]. Hicky and Kyriacou [53] found that the
optimal separation distance was in the range of 3-6 mm when testing on the finger, while Takatani et
al. [49] and Mendelson et al. [47] are suggesting between 4 mm and 10 mm based on experiments
conducted on the forearm. Furthermore, it was suggested that the separation distance of 7 mm is
the most optimal. In a later study conducted by Mendelson and Pujary [54] separation distances
between 6 mm and 10 mm were used. Thus, the ideal separation distance between the photo detector
and the light source involves a trade-of between signal quality and power consumption.
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(a) Sensor design by Dassel et al. [46]. The
sensor design constitute of one dual wave-
length LED and an array of three photo de-
tectors.
(b) Sensor design by Takatani et al. [49]
The sensor has 16 LEDs radially oriented
around one photo detector.
(c) Sensor design by Sola et
al. [50]. The sensor contains
eight photo detectors and 16
dual LEDs.
(d) Sensor design by Duun et al. [10]. This
sensor has an annular photo detector that
surrounds one dual wavelength LED.
Figure 4.1: Four different reflection mode pulse oximeter designs.
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Thus, in the context of this work it is important to lower the power consumption by choos-
ing only one light source and separation distance between the optical elements in the range of 4 mm
to 10 mm. In regarding the photo detector area it was shown in the proof-of-principle study, that
the use of four separately connected photo detectors (each having 4 mm2 sensitivity area) gave no
significant difference. Therefore, it is assessed that four photo detectors may be redundant and the
amount of photo detectors can easily be reduced.
Another important aspect is the contact force between the sensor and the skin. When a pressure
is exerted on the skin by the sensor, the geometry of the superficial layers of the skin changes and
the arterial and venous vessel diameters is affected. The quality of the PPG signal is significantly
affected when pressure is applied. This claim is reported by numerous research groups [55–58].
There is a consensus in the literature that the optimal pressure varies and depends on the measure-
ment site. However, no optimum or accepted standardization have been implemented for clinical or
experimental PPG measurements.
In the context of this work a contact force between the sensor and the skin was applied by designing
the optical window such that it is higher than the rest of the sensor body.
4.2 Sensor Design Specifications
It is important that the PPG-patch can operate in two modes; A mode for short-term measurement
and a mode for long-term measurement. The technical setup for the first mode is sketched in Fig.
4.2a. The output pins from the PPG-patch are connected through BNC cables to a data acquisition
system. The PPG-patch can be configured and controlled through a microcontroller that is con-
nected to a computer via USB. With this setup, it is possible to connect other hospital devices (i.e.
capnography, conventional pulse oximeters and ECG recorder) to the same data acquisition system
and thereby simultaneously acquire all the connected signals. In the second operation mode the
PPG-patch electronics is connected to the ePatch R© electric front-end. All the data acquisition is
done through the ePatch R© electronics and modified firmware. This configuration mode does not
require any external wires. However, it limits the design of the PPG-patch because of the geometry
and the limited space inside the ePatch R© mechanical body, cf. Fig. 4.2b. On the other hand, it
will be possible to acquire PPG, ECG and accelerometer signals synchronously from the same de-
vice. Moreover, it can be attached to the body through DELTA’s ePatch R© electrode. A sketch of the
ePatch R© electrode is seen in Fig. 4.2b.
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Figure 4.2: (a) The technical setup where PPG-patch can function independently of the ePatch R©
framework. The faded blocks can be any device from the hospital that has a digital or analog
output. (b) The PPG-patch sensor configuration. It was necessary to modify both the ePatch R© and
the corresponding electrode.
The primary design constraint of the PPG-patch was that it must fit in the ePatch R©electrode socket
manufactured by DELTA. Therefore, the front-end architecture and the opto-mechanics should fit
into the mechanical body of the ePatch R©. The secondary constrain was that the PPG-patch can
work independent of the ePatch R©platform. Meaning that by connecting it to a data acquisition
system while it is attached to the skin one should be able to record the PPG signal.
Therefore it was decided that the PPG-patch must have the following properties:
• The printed circuit board (PCB) of the PPG-patch must fit in the area where the ePatch battery
is located, hence the PCB must only have a dimension of 32 x 20 mm.
• The PPG-patch must have two photo detectors and one dual LED; red and infrared (λ = 940
nm and λ = 660 nm). The photo detectors must have relatively high spectral sensitivity in the
red and infrared region.
• The LED and photo detector separation distance must be between 4 mm and 10 mm.
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• The LED and photo detectors must be separated such that no direct light can be registered by
the photo detectors.
• The PPG-patch electronics can be connected with the ePatch R© electric front-end. So in addi-
tion to the PPG signals, one channel ECG and three accelerometer channels (X, Y, Z) can be
acquired in the internal flash memory of the ePatch R© .
All the electronics components must be surface-mount devices (SMDs) and operate with 3.7 V power
supply.
4.3 Opto-Mechanical Construction
As mentioned previously the mechanical body of the ePatch R© was used to integrate the whole
PPG-patch solution. It was chosen to use silicone photo detectors (VBP104SR, Vishay Semi-
conductors) with an active sensing area of 4.4 mm2, cf. Appendix B. A dual LED component
(SML12R3KIR941T-TR, Ledtronics, INC.) with peak emission wavelength of 660 nm and 940 nm
was chosen as a light source. The seperation distance between the optical elements was chosen to be
7 mm. To minimize the amount of light transmission and reflection between the LEDs and the photo
detectors an optical opaque shield of black polyoxymethylen was placed such that it surrounds the
optical element. The LEDs and photo detectors was encapsulated with an optically transparent and
biocompatible epoxy (EPO-TEK 302-3M, Epoxy Technology, Inc.), cf. Appendix B. The chosen
epoxy has a refractive index of 1.56 which is close to the refractive index of the epidermal layer of
the human skin, which is approximately 1.43 at 660 nm and 1.42 at 940 nm [59]. The final result
after this coating process can be seen in Fig. 4.3.
4.4 PPG-patch Front-end Architecture
The electronics of the PPG-patch has been made to support the purpose of embedding the solution
into the ePatch R© platform utilizing the recording of two PPG channels in addition to ECG and
triaxial accelerometer at the sternum. Moreover, the PPG-patch front-end was also designed to work
independently of the ePatch R© platform utilizing the ability of short-term measurement. In this
section a description of the PPG-patch electronics together with its functionality independently of
the ePatch R© platform will be given. In the next section it is described how the PPG-patch sensor
has been embedded with the existing state of the art ePatch R© platform. A diagram of the front-
end architecture of the PPG-patch is shown in Fig. 4.4 and the corresponding circuit schematic is
shown in Fig. 4.5. Going from the optical domain to the electrical and then to the digital requires
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three fundamental blocks; a signal conditioning block, a LED intensity regulation block, and a data
acquisition and processing block. The three blocks are marked with red dashed squares in Fig. 4.4.
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Figure 4.3: The final result of the PPG-patch. It is seen how optically transparent the optical
window is.
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Figure 4.4: Diagram of the PPG-patch electronic front-end architecture. It contains three main
blocks (surrounded by red dashed lines); Signal conditioning, LED intensity regulation Data ac-
quisition and processing.
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4.4.1 Signal Conditioning
The photo current detected by the photo detectors (PD) is passed through a trans-impedance amplifier
(TIA) each. The signal conditioning is the same for both photo detectors so only the signal from one
photo detector is described. Going from the TIA the signal is subsequently passed through different
stages carrying out the following functions:
• Filtering.
• Dividing the signal into AC and DC components.
• Providing further amplification for the AC component of the signal, and adjusting the DC level
to better take advantage of the input dynamic range of the A/D converter.
Current-to-voltage Conversion
The photo detector detects the light signals coming from the tissue and produces a current propor-
tional to the intensity of the received light. By earlier experimental tests, the current reaching the
photo detector was found to be < 1µA. To convert the current signal to a useful voltage signal the
TIA was used. The schematic diagram of the TIA is shown in Fig. 4.6.
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Figure 4.6: Electric diagram of the trans-impedance amplifier (TIA) that converts the photo detec-
tor current Iin into the voltage output Vout. The gain is given by the feedback resistor Rf and the
bandwidth limitation is employed by the feedback capacitor Cf across Rf .
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Figure 4.5: Schematic of the PPG-patch electronic front-end architecture.
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The current through the feedback resistor Rf creates a voltage at the output that is proportional to
the current coming from the photo detector Iin. The output voltage can be calculated using Ohm’s
law across Rf ;
Vout = IinRf (4.1)
and thus the desired amplification is determined via Rf . The noise spectral density produced by
Rf increases with the square-root of Rf , whereas the output signal increases linearly, therefor the
signal-to-noise ratio is improved when all the required gain is placed at this amplification stage
[13]. To accomplish this, the feedback resistor was chosen to be 1MΩ. The total noise increases
with an increased bandwidth. Thus, the bandwidth of the TIA has been limited using a feedback
capacitor Cf across Rf . This approach serves as a low-pass filtering and also stabilize the TIA and
prevents oscillations in the required bandwidth range. Although, the PPG signal bandwidth is 0.1-5
Hz, it is important to take into account the switching rate of the LEDs as this will determine the
bandwidth of the TIA. The PPG for a given wavelength is acquired when the LED corresponding
to that wavelength, is turned on. It was chosen to apply a switching rate of 500 Hz. However, it is
possible to change this rate in the firmware of the PPG-patch as described in section 4.4.3. It was
decided to have 6 kHz as a cut-off of the TIA bandwidth to make it possible to increase the switching
frequency if this was desired. The feedback capacitor valueCf can therefor be calculated as follows:
Cf =
1
2piRff−3dB
= 26.5pF
(4.2)
where Rf and f−3dB is 1MΩ and 6kHz respectively. The employed feedback capacitor value was
27 pF. The TIA chosen for this application is a low noise OPA2381, which operates with a single
low voltage supply (2.7-5.5V), cf. Appendix B.
The output from the TIA contains a PPG signal including the AC and a DC components.
Filtering and Amplification
The next step is to split the DC part of the signal from the relatively smaller AC. Both signals are
processed independently as seen in Fig. 4.4. The DC signal is low-pass filtered using a passive low-
pass filter with cut-off frequency of 7 kHz. This filter is applied to filter out very high frequencies.
The AC part is high-pass filtered using a passive high-pass filter with cut-off frequency of 0.05 Hz.
This is applied to filter out any DC offset. The AC part is further amplified through a second stage
amplifier, A2. The amplification is applied such that the total dynamic range of the A/D converter is
used. The gain at this stage is 20 and can be changed manually by changing a corresponding resistor.
Usually this amplification is made changeable through software. But, this is not the case with the
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PPG-patch. The final part of the analog processing of the AC signal is a low-pass filter with cut-off
frequency of 7 kHz to suppress high frequencies. The DC signal is fed to a custom build Arduino
box and is used to regulate the intensity of the LEDs by determining the signal level of DC signal,
this regulation is explained in section 4.4.3. The AC signal is also fed to the Arduino board but is
only used for visualization purpose.
Both the AC and the DC signals contains a multiplexed PPG signal. The demultiplexing of the signal
into a DC and an AC of the red PPG and a DC and an AC of the infrared PPG is done in the post
processing stages.
4.4.2 LED Intensity Regulation
The photo detector does not discriminate between received wavelengths. Therefore, the LEDs are
switching on and off alternately. The switching frequency is 500 Hz and the LEDs are on each
for 2 ms giving a duty cycle of 50 %. The intensity of the LEDs is controlled using two digital
potentiometers, which can be modified through digital output pins in the Arduino microcontroller
board. The range of the digital potentiometers is from 0-100 Ω. At 0 Ω the maximum current is 17
mA when the red LED is on and 15 mA when the infrared is on. The minimum current is when the
potentiometer is at 100 Ω giving 1.6 mA and 1 mA for the red and infrared LEDs respectively. The
current for each LED is kept constant through a low-dropout regulator. The on and off switching is
controlled through the digital output pins of the Arduino microcontroller board. The timing diagram
for each LED is shown in Fig 4.7.
The way the AC and the DC signals are demultiplexed is by having a squared trigger signal generated
by the Arduino microprocessor as seen in Fig. 4.7. At the rising edge the red LED is on and at the
falling edge the infrared LED is on. Detecting of the rising and falling edges is done in the post
processing of the signals.
Prior to PPG recording the LED intensities are regulated based on the level of the DC signals. It is
important that the DC levels are equal both when the red and infrared LED are on. Otherwise the
second stage amplifier will make the AC signal get out of range. All the terminals from P1-P14 (seen
in Fig. 4.5) are connected to a socket from which a cable can be attached to and communicate with
the Arduino board. The terminals P9-P12 belong to the AC and DC output signals from each photo
detector. A photograph of the PPG-patch with the customized Arduino board (in the black box) is
shown in Fig. 4.8. The PPG-patch is powered through the Arduino board which is powered through
the USB.
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R on
IR on
2ms
Trigger
signal
R PPG 
sample 1
IR PPG 
sample 2
IR LED
R LED
Figure 4.7: Timing diagram of the red (R) and infrared (IR) LEDs on and off. The trigger signal
is created by the Arduino microcontroller. On the rising edge the sample belongs to the red PPG
signal and on the falling edge the sample belongs to the infrared PPG signal.
4.4.3 Data Acquisition and Processing
To drive the LEDs a firmware was programmed and flashed into the Arduino microprocessor. The
firmware can be modified and programmed on a computer. The purpose of the firmware is to control
the LED intensities and the switching rates of the LED. The recording of the PPG signal is not done
through the Arduino board but via a data acquisition device from AD instruments (Powerlab 8/35,
16 bit ADC, ADInstruments, USA). When the PPG-patch is attached to the sternum either via the
modified ePatch R© electrode or just via adhesive tape, the firmware loads an algorithm that starts
and regulate the intensities of the LEDs such that the DC levels are equal for both wavelengths. A
flowchart of this calibration process is shown in Fig. 4.9. First the red LED is turned on and the
DC level is read and saved, then it is turned off. Subsequently the infrared LED is turned on and a
DC level is detected and saved, and then it is turned off. The next step is now to compare both DC
levels. If the DC levels are different then the intensity of the red LED is changed. When a successful
calibration is made, the LEDs start switching and the trigger signal does also start. The algorithm
is made such that the DC level corresponding to the infrared signal always tries to be equal to the
one belonging to the DC level of the red PPG. During a recording, the calibration sequence can be
initiated by reseting the Arduino board.
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Figure 4.8: A picture of the PPG-patch and the customized Arduino box. With this ”toolkit” it
is possible to make PPG measurements when the Arduino box is connected to a PC through USB
communication. Connecting the BNC connectors with a data acquisition system the PPG signals
from both photo detectors can be acquired.
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Figure 4.9: A flowchart of the initial calibration process. This sequence continues as long the DC
levels of the RED (DCr) and the infrared (DCir) signals are not equal.
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The performance of the PPG-patch and data processing system was tested in the laboratory. Red and
infrared PPG signals were obtained both on the index finger and on the sternum. The laboratory
lights were switched off to eliminate any ambient light interference. Good quality PPG signals with
large amplitudes were acquired from all seven devices. A typical PPG signal recorded at the sternum
for both wavelengths is shown in Fig. 4.10. As seen the PPG signals are multiplexed. In the post
processing the PPG signal is demultiplexed into an AC and a DC signal for each wavelength. Fig.
4.11 shows the timing between the recorded PPG signals and the trigger signal. It is clearly seen how
important it is that the samples are taking when the LED current is stable because some times there
is an overshoot when the LEDs turns on. The result after the demultiplexing is seen in Fig. 4.12.
The result giving is four PPG channels for each photo detector; AC and DC for each wavelengths
with a sampling frequency of 256 Hz. The signal contains everything needed in order to calculate
the respiratory rate and the oxygen saturation in the blood.
Figure 4.10: PPG signals acquired at the sternum. The AC and DC signals are multiplexed. The
trigger signal (bottom) is used to separate the PPG signals into DC and AC for each wavelength.
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Figure 4.11: The timing between the PPG signals and the trigger signal.
Figure 4.12: Demultiplexed PPG signals. Raw Red and infrared AC and DC signals obtained at the
sternum. It is clearly seen how the cardiac pulses are superimposed on the respiratory component.
The segment is obtained during a controlled low paced respiration (6 breaths/min) in the laboratory.
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4.5 PPG-patch for Long-term Monitoring
As written in section 4.2 the main requirement was that the PPG-patch can be used for long-term
monitoring. For this reason the PPG-patch had to have a separate microcontroller and flash memory
in order to process and store the acquired PPG signal. For this purpose the ePatch R© electronic front-
end was connected together with the PPG-patch electronic front-end. The challenge here was that the
PPG-patch electronics was designed to work with an earlier version of the ePatch R© electronic front-
end and the new version came after the fabrication of PPG-patch. However, at the end it was possible
to embed the PPG-patch with the recently changed ePatch R© electronics. One of the ECG channels
that is usually used during a regular ECG measurement with the ePatch R© has been disconnected
and the DC output from the PPG-patch PCB has been wired to that terminal. It is only possible to
use one output from the PPG-patch because of limited analog input and the chosen one was the DC
signal after the trans-impedance amplifier. The PPG-patch pin terminals P1-P14 was connected to
the ePatch R© PCB except P9, P11 and P12.
The input to the ePatch R© front-end is a differential input with a voltage range of ±400 mV. This
challenges the PPG-patch because the output is single-ended. This issue was solved by connecting
a 1.5 V reference value from the circuit together with the PPG-patch output and adjust the LED
intensities for the PPG-patch so the output DC level becomes as close as possible to 1.5 V. A test
setup was constructed for this purpose and is shown in Fig. 4.13a. This configuration resulted in a
small PPG output because it is only the DC signal that is recorded. In the cage shown in Fig. 4.13a
the background noise was tested for all the developed devices. Fig. 4.13b shows another test setup
that was used to test recording duration and signal quality for all the devices at the same time. A
known ECG signal is fed to the input of the devices and recorded until shutdown.
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PPG-patch
Figure 4.13: Test setup of the PPG-patch connectivity with the ePatch R©. (a) The setup is placed
in a Faraday cage to avoid any electrical interference. (b) Shows three PPG-patches being tested. A
known ECG signal is fed into the devices and recorded. The LEDs are turned on to the maximum.
As for the PPG-patch firmware it was adapted to the existing firmware of the ePatch R© platform.
This part was very challenging because the ePatch firmware was not trivial to reprogram. However,
it was possible to modify it so that the PPG signal is splitted and saved into two signals red PPG
signal and infrared PPG signal. The samplings frequency is 64 Hz and the A/D converter resolution
is 24 bit which is very good because the PPG signal amplitude is relatively small. In addition to the
PPG signals, it is now possible to acquire ECG and triaxial accelerometer signals. The PPG-patch
electronic front-end is powered by the 3.7 V lithium battery with capacity of 375 mAh and the power
consumption can last for minimum 20 hours recording and if the LED intensity is at the minimum
it can last for 31 hours. The final version of the PPG-patch attached at the sternum and the modified
ePatch R© electrode is shown in Fig. 4.14. A representative plot of acquired signals in the laboratory
is shown in Fig. 4.15.
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Figure 4.14: PPG-patch at the sternum (the red light illuminating the skin is also seen.
Figure 4.15: Signals recorded with the wireless configuration of the PPG-patch. The viewed
snippet is from a recording at the sternum in the laboratory. All the signals in the plot are unfiltered.
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4.6 Summary
This chapter described the design and development of a reflectance mode PPG sensor, the PPG-
patch. The PPG-patch was successfully developed to operate in two modes; the first mode is for
short-term recording where it is possible to record PPG signals through a data acquisition device
and a second mode where it can record two PPG channels (red and infrared), one channel ECG and
triaxial accelerometer synchronously for 20 hours. All seven sensors were electrically identical and
passed all the tests in the laboratory. The functionalities of both mode of operations are summed in
Table 4.1.
Table 4.1: Summery of the functionalities of the PPG-patch in the two operation modes.
Properties
PPG-patch
mode 1
PPG-patch
mode 2
Samplings frequency (Hz) 256 64
ADC resolution 16 24
3-axis Accelerometer NA Yes
ECG NA Yes
Wireless NA Yes
Synchronization
with hospital equipment Yes NA
Operate without the modified
ePatch R© electrode Yes NA
Real time visualization of a
recording Yes NA
In an attempt of comparing the sternal signal quality when recording PPG with and without the
modified ePatch R© electrode we observed an 80 % increase in signal quality when the modified
ePatch R© electrode is not used [60]. It was decided that the PPG signal quality is sufficient to be
used in a clinical environment. Moreover, it is possible to conduct the recording without using the
modified electrode.
In order to be able to estimate the oxygen saturation in the blood using the PPG-patch, a sensor
calibration must be done. In this project the pulse oximeter calibration method is carried on through
a hypoxia in vivo study and is done in accordance with the ISO 80601-2-61:2011 guideline. The
protocol and method of this sensor calibration is explained in the next chapter.
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CHAPTER
FIVE
CLINICAL STUDY I: INVASIVE
CONTROLLED DESATURATION STUDY
Objectives In the previous chapter a description of the PPG-patch was given. Seven prototype PPG
sensors were developed successfully and used in three clinical trials. All three studies took place
at two different departments; the department of pulmonary medicine and the medical admissions
ward on Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen Denmark. The studies
were approved by the Danish regional ethical community (H-6-2014-013), the Danish Health and
Medicines Authority (CIV-15-01-013029), the Danish Data Protection Agency, and was monitored
by the regional good clinical practice (GCP) unit. In this chapter a description of the first clinical
study is given. The work of this chapter is also described in Paper IV.
5.1 Background
The ability to measure the SpO2 level from the sternum was investigated through an invasive con-
trolled desaturation study on healthy volunteers. The goal of this study is twofold. First, to investigate
the ability of measuring the SpO2 level in the blood at the sternum with the PPG-patch, and second
to calibrate the sensor so it can be used in the second and third clinical studies. The accuracy of
the PPG-patch is investigated by comparing the calculated SpO2 values with the ”gold-standard”
measurements of blood SaO2. This study was made in accordance with the ISO 80601-2-61:2011
guidelines.
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5.2 Method and Materials
5.2.1 Study Design
A total number of 14 healthy Caucasians (nine males and five females), nonsmokers participated in
this study. A written informed consent was obtained from the participants prior to the study. The
demographics of the subjects are provided in Table 5.1.
As mentioned previously, it is a desaturation study, which means that the level of oxygen saturation in
the blood is gradually reduced within the region of clinical interest (100 % to 70 %). The desaturation
process was controlled with a closed-loop breathing system. The subjects were breathing in a mask
with a manually controlled mixture of oxygen and nitrogen air from a 50 L container (a Douglas
bag). The subjects were lying in a supine position and, to avoid the influence of motion artifacts,
they were instructed to move as little as possible. The experimental setup is shown in Fig. 5.1. The
subjects were monitored using a Datex-Ohmeda AS/3 Compact Patient Monitor, recording the pulse
oximetry, the invasive blood pressure, the ECG and the fraction of carbon dioxide in the breathing air
from the closed system. Between the breathing mask and the air container there was a CO2 absorber
made of calcium hydroxide, Soda Lime. The experiment protocol procedure took place as follow
for each subject:
1. A medical doctor performed an Allen’s test on the hand before the subject was included. This
test ensures that both the radial and the ulnar arteries are able to individually supply the hand
with sufficient amount of blood during the experiment.
2. If the Allen’s test was passed, the medical doctor places a catheter in the radial artery un-
der local anesthesia. This catheter is used for collection of arterial blood samples during the
experiment.
3. The ECG electrodes are placed on the chest, the invasive blood pressure transducer is con-
nected through the catheter and the conventional finger pulse oximeter is attached to the index
finger of the opposite hand.
4. The PPG-patch was mounted at the sternum (using adhesive tape) and another one on the
thumb.
5. Finally, the breathing circuit was fitted to the subject and the gas mixture was tuned accord-
ingly.
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Table 5.1: Subject demographics.
Gender 9 males, 5 females
Age (years) Mean: 30.3, SD: 11, Range: 20-56
BMI (Kg/m2) Mean: 22,2, SD: 3, Range: 16-25.7
Breathing mask 
ECG
PPG-patch (ﬁnger)
PPG-patch
SaO2
& invasive BP
SpO2
a) b)
 (sternum)
Figure 5.1: The participants breathes a manually regulated composition of oxygen and nitrogen
in a closed breathing system. (a) The experimental setup. (b) A participant with attached sensors.
The PPG-patch is attached at the sternum. Arterial blood sample is taken from the radial artery and
the oxygen saturation in the blood (SaO2) is used as reference.
All equipments were connected to the data acquisition device (Powerlab 8/35, 16 bit ADC, ADIn-
struments, USA) and simultaneously acquired on a laptop. Another laptop was used to visualize the
PPG signals from the PPG-patch in real-time during the experiment. The room light was switched
off to minimize any ambient light interference.
During the recordings, up to 25 blood samples of 2 ml each were taken from each subject. The first
five blood samples were taken while the subject was breathing outside the closed system. Each time
a blood sample was taken a marker is placed in the data acquisition software, as seen in Fig. 5.2. This
ensures synchronization between the time instance for the blood samples and the recorded signals.
The oxygen saturation level decreased when the breathing mask was on and the air mixture was
regulated in the closed system. The air regulation is done by the medical doctor while monitoring
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the fraction of inspiratory oxygen (FiO2) and the tidal carbon dioxide (ETCO2) on the patient
monitor. The pulse oximeter from the patient monitor was used to check the actual level of oxygen
saturation. The blood samples were analyzed using Radiometer blood gas analyzer (ABL 800 Flex,
Radiometer Co.). The blood gas analyzer was calibrated prior to the experiment. The experiment
was stopped when 25 blood samples were obtained and are distributed in the range of 100 % to 70
%, when the subject reached an oxygen saturation of 70 % or when the medical doctor decided to
stop (whichever came first). The duration of the hypoxia inducement was different from subject to
subject. However, the average lasting time was 25 min. A representative 30 second segment of all
the recorded modalities of one subject is shown in Fig. 5.2.
a)
b)
c)
d)
e)
f)
f
Figure 5.2: All the recorded modalities from the experiments. (a) Contains AC and DC PPG
signals for each wavelength recorded from the PPG-patch placed at the sternum and (b) another
PPG-patch attached to the first index finger. The signals are inverted so they become similar to the
rest of the arterial PPGs, meaning that the peak symbolize the systolic cycle and the minimum end-
diastolic. The rest of the signals are recorded through the patient monitoring system; (c) Finger
PPG,(d) blood pressure plethysmogram, (e) ECG signal and (f) in- and exhaled carbon dioxide
fraction. The dashed line is a marker placed when a blood sample was taken.
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5.2.2 Normalization and Filtering
The preprocessing of the PPG data consists of two steps; normalization and filtering. In terms of
normalization it was shown in Eq. 2.4 in chapter 2 that the optical ratio R is derived by dividing
the value of the systolic peak by the value of the diastolic peak to cancel out any influence by the
non-pulsating tissue. However, if the signal contains any motion artifact the approach of finding
the systolic and diastolic peak for every cardiac cycle can be challenging and may lead to biased
results. To overcome this, and because the DC-level in the PPG signal is relatively larger than the
AC component the average of the DC-level can be used [13]. So the normalized signal yn(t) is
calculated as follows;
yn(t) =
x(t)−mean(x(t))
mean(x(t))
(5.1)
where x(t) is the PPG signal. For each 20 second window centered on the time marker for each of
the blood samples (corresponding to the window size of the finger pulse oximeter) the normalization
has been applied. The next step is band-pass filtering of the normalized signals. The most common
type of noise in pulse oximetry is the noise induced by motion artifacts [15]. Different types of
motions that affects the PPG signals have been investigated and characterized by Tobin et al. [61].
The study included 350 patients from different hospital wards and it was reported that almost all
kind of motions including patient transportations affected the PPG signal because of the overlapping
in the arterial pulsation frequency bands. Motion artifacts at the sternum is to our knowledge not yet
investigated. However, our observations showed that any movement of the hands do not influence
the sternal PPG signal as it does with PPG recorded from the fingertip. On the other hand any
movement involving the upper torso affects the signal. In addition, extreme cough does also affect
the sternal PPG signal. In order to reduce the motion impact on the PPG signal numerous research
groups have investigated different methods involving adaptive noise cancellation using active sensors
such as accelerometers [62–65]. Passive motion cancellation was proposed by Wang and Yang [66],
their approach were building on the assumption that when the LEDs are off the readings from the
photo detectors were only dominated by motion. The algorithm showed promising results during
rest and moderate exercise. A similar attempt is claimed in a patent by Nellcor [67], claiming that
it is possible to detect motion with PPG recorded with a wavelength above 940 nm where water has
a strong absorption. By subtracting the motion signal from the regular PPG signal they were able
to reduce the error on the SpO2 estimation to below 3 %. None of these methods is used in the
PPG-patch, but it could be useful features to add to such a device in the future.
To reduce the motion artifact a 4th order band-pass Butterworth filter was chosen, which is also
suggested by [65]. However, we added a modification to the filter design by replacing the fixed cut-
off frequency with adaptive cut-offs depending on the patients heart rate. We calculated the heart rate
(HR) as the frequency bin with the largest amplitude in the power spectral density of the 20-seconds
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ECG segment. Similar work is proposed by [68]:
Y (f) =
∞∫
−∞
y(t)e−2jpifT dt, (5.2)
HR = max(Y (f)), (5.3)
Consider only frequencies from 0.5 Hz to 4 Hz (corresponding to a HR of 30 to 240 beats per
minutes). The low cut-off frequency for each window (corresponding to one blood sample) was
found by subtracting 0.2 Hz from the detected HR and the high cut-off frequency was found by
adding 2 Hz to the detected HR for this specific window.
5.2.3 Estimation of the Optical Ratio R
The next step after the normalization and the band-pass filtering is to estimate the optical ratio
R. In recent years, various signal processing methods have been investigated for estimating the
optical ratio. Promising results were demonstrated using Fourier transform [68], Hilbert transform
[69] and independent component analysis [10, 70–72]. Another state of the art and commercially
available algorithm is the Discrete Saturation Transform (DST) algorithm by Masimo Corporation
[73]. Another method of calculating the optical ratio is by calculating the root mean square of the
normalized and filtered PPG signals, yr(t) and yir(t):
R =
√
1
N
N∑
t=1
y2r(t)√
1
N
N∑
t=1
y2ir(t)
(5.4)
where N is the number of samples (20 sec x 256 Hz). This calculation is an averaging of the am-
plitude size for each PPG signal. It requires a high signal to noise ratio and low level of motion
artifacts. As mentioned previously, not all the motion artifacts can be reduced with the band-pass
filtering because the motion can happen at the same frequency as the heart rate. The only way this
calculation can handle the noise from motion artifacts is by averaging and this may not be optimal.
However, by inspection of all the recorded signals, it was seen that the motion artifacts are relatively
low in the recordings in this study.
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5.2.4 Calibration Curve
The last step is now to mathematically link the calculated R values to the measured SaO2 reference
values. This provides a formula for future estimation of the oxygen saturation based on the PPG
signals directly.
A second-order polynomial was proposed by Fine and Weinreb [74], but the polynomial is not based
on any physical interpretation rather than the result of on empirical approach of best prediction of
the coefficients. Webster [13] proposed a linear regression given as
SpO2 = −aR+ b (5.5)
this linear regression is only valid in the range from 100% to 70% and it is known from the derivation
of Beer-Lambert’s law that the slope of the linear approximations should have a negative slope, cf.
chapter 2. We decided to use the linear regression defined in 5.5, where a and b are the regression
coefficients. To ensure a high generalization performance of our calibration curve and to gain knowl-
edge about the performance of the regression on new subjects, we used a leave-one-out scheme to fit
the calibration curve. This implies that all blood samples from one subject were left out, while the
calibration was conducted on all the blood samples from the remaining 13 subjects. This procedure
was repeated with all 14 subjects as the test subject. For each of the 14 iterations, the values of a and
b were found and the performance of the obtained calibration curve was evaluated as the root mean
squared error (RMSE) between the measured SaO2 reference values and the levels estimated based
on the calibration curve for the test subject. The final calibration curve was fitted as an average of
the regression coefficients obtained in the 14 iterations.
In accordance with the ISO 80601-2-61:2011 guidelines, the accuracy of the sternal PPG sensor was
then estimated according to:
Arms =
√√√√ n∑
i=1
(SpO2i − SaO2i)2
n
(5.6)
where n is the number of blood samples (n = 324). Furthermore a Bland-Altman analysis is done
to compare the calculated SpO2 values with the reference SaO2 values. The results is given in the
following section.
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5.3 Results
A total of 324 SaO2 values for all the subjects were used for the calibration. The SaO2 range was
from 99 % to 59 %. Fig. 5.3 shows two 20 seconds segments of the recorded PPG signals of one
subject measured in the beginning of the experiment, where the oxygen saturation level was high (98
%) and at the end where it was low (71 %). When the oxygen saturation level was decreased, larger
respiratory fluctuations was shown due to deeper breaths. However, these fluctuations were removed
by filtering. The result of the normalization and the band-pass filtering is shown in Fig. 5.4. What
is also seen in the figure is an increase in the heart rate, which is a normal physiological response to
hypoxia together with the deeper breathing. Additionally, it is seen how the amplitude ratio between
the red and infrared signals (i.e., the optical ratio) is less than 1 at high SaO2 values and increased
to larger than 1 at low SaO2 values.
Table 5.2 shows the coefficients of the linear curves functions according to Eq. 5.5. It is seen how
the coefficients are almost equal. The RMSE and coefficient of determination (r2) for each subject
is also given. The average RMSE and r2 for all fits are 1.73 % and 0.975 %, which indicates validity
to apply the linear regression to fit the data. The final calibration line together with the 324 SaO2
reference values are shown in Fig. 5.5. The calibration coefficients are -25.89 and 116.48 for a and
b respectively. Now for the validation, the calibration curve was used to calculate the SpO2 values
from the estimated optical ratios. The accuracy of the PPG-patch becomes in accordance to Eq. 5.6
1.75 %. In Fig. 5.6a the SpO2 values are plotted against the corresponding reference SaO2 values,
showing a strong correlation (Pearson correlation coefficient of 0.97). Fig. 5.6b shows the result
from the Bland-Altman analysis. The mean system bias is -0.21 % and the upper and lower limits of
agreements are 3.5 % and -3.9 % respectively over the whole SaO2 range.
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Figure 5.3: Examples of red (red dotted line) and infrared (black solid line) PPG signals recorded
with the custom build PPG sensor placed on the sternum with an oxygen saturation of 98 % (a)
and 71 % (b), respectively. Both the respiratory component (slow baseline changes indicated with
vertical dashed blue lines) and the cardiac component (high frequency fluctuations) are clearly
observed in both examples. Finally, it is observed how both the heart rate (HR) and the depth of
the breathing are increased during low oxygen saturation.
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Figure 5.4: Illustration of the effect of normalization and filtering. For comparison, the raw un-
processed signals are provided in Fig. 5.3. It is observed how the relation between the amplitude
of the red (dotted red line) and the infrared PPG (solid black line) signals shift for different oxygen
saturation levels.
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Table 5.2: Coefficients belonging to each calibration lines. a and b are coefficients of the Eq. 5.5,
r2 is the determination coefficient of fit, and RMSE is the root mean square error.
Subject # a b r2 RMSE
1 -25.8711 116.5141 0.965 0.583
2 -25.5058 116.1815 0.972 1.534
3 -25.8647 116.4556 0.979 0.874
4 -25.8634 116.4871 0.987 1.013
5 -25.4138 115.9021 0.977 2.175
6 -26.0423 116.7752 0.983 2.283
7 -25.7014 116.1643 0.987 0.821
8 -25.989 116.5954 0.937 2.980
9 -26.1708 116.6567 0.982 1.716
10 -25.9946 116.4586 0.974 2.109
11 -26.2852 116.7518 0.974 2.558
12 -25.8889 116.4552 0.970 1.273
13 -25.9276 116.6542 0.970 2.351
14 -25.9203 116.6051 0.986 1.977
Mean -25.8885 116.4755 0.975 1.732
Figure 5.5: Relation between the calculated R values and the measured SaO2 reference values (red
dots) and the final calibration curve (blue line). The final calibration coefficients were a = −25.89
and b = 116.48. The average RMSE for the 14 calibration iterations was 1.73 %. The green
dashed curve is the theoretical curve from Eq. 2.3 from chapter 2.
64 Chapter 5. Clinical Study I: Invasive Controlled Desaturation Study
-3.9
(a) (b)
Figure 5.6: (a) The correlation and regression line of SaO2 with SaO2 in the calibration exper-
iment. (b) Blandt-Altman plot of the comparison between SaO2 and SpO2. The middle solid
line represents the mean system bias, while the upper and lower dashed lines represent limits of
agreements ±1.96SD.
5.4 Discussion
In this experiment the PPG-patch device was calibrated during a controlled desaturation clinical
study on 14 healthy volunteers. This step is important in order to use the sensor in study two and
three for calculating the SpO2 levels. In this section different remarks and uncertainties regarding
the experiment will be pointed out.
PPG-patch at the Sternum
Due to different sternal anatomy between the subjects it was challenging to attach the PPG-patch to
the sternum via the modified electrode. The optical window does not make good contact with the
skin. For each subject the electrode was tried out and the PPG signal was evaluated just before the
actual recording. On all the subjects, the amplitude of the PPG signal was significantly larger by
placing the PPG-patch using adhesive tape on the sternum without the electrode. In addition, on one
of the subjects the PPG-patch was placed adjacent to the sternum on the chest muscle, because of
the lack of space at the sternum. Nevertheless, it did not affect the quality of the PPG signal. The
PPG-patch device that was attached to the finger did not always show a good signal, because it was
difficult to tape it to the index finger and because the subjects move their hands regularly. In general
the quality of the PPG signal at the sternum was excellent on all the subjects and it was observed that
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during the hypoxia the signal quality got better. This might be because of the rise in blood perfusion
at the sternum. The temperature under the PPG-patch was not measured, but the skin on the chest
felt warmer compared to the fingers. Additionally, sweating and thermal insulation under the sensor
may also enhance the skin and tissue interface.
Experimental Remarks
Different size of breathing masks were used in the experiment, not only to enhance the comfort
for the subjects, but to avoid any leakage of air from the closed system. This was the case from
one of the subjects, where the experiment duration was above 50 min. Additionally, there was an
air flow resistance which made the subject feel uncomfortable during in- and exhalation. For the
future shorter tubes with larger diameter is highly suggested. Furthermore, these tube and leakage
problems made it difficult to control the breathing air and the oxygen concentration level, which is
why saturations level under 70 % was recorded on some of the participants.
Oxygen saturation plateaus were difficult to obtain throughout the whole hypoxia duration. Al-
though, it is suggested by the ISO 80601-2-61:2011 guidelines. So in our case we barely got 30
seconds between the blood samples during hypoxia. All the taken blood samples were placed in a
container with crushed ice. For the first five subjects no blood gas analyzer was available during the
experiment, so the analysis were performed after the experiment (at least after 30 min). The guide-
lines for arterial puncture suggested by Radiometer reports that a blood sample should be analyzed
within 30 min. If the blood sample analysis will be delayed for more than 30 min, glass syringes
stored in ice slurry water should be used to avoid any effect on the sample values. Unfortunately, for
the first five subjects some of the blood samples may have been affected by the time delay.
The SpO2 values displayed on the Datex-Ohmeda patient monitor system were delayed and the
values did not always correlate well with the values of the blood samples when the actual oxygen
saturation levels were below 80 %. The patient monitor has a standard deviation in SpO2 of 3 %
points in the range 80 % to 50 %. Meaning that 99.7 % of the SpO2 values fall within ±9 % points.
Besides, during hypoxia the patient monitor was displaying ”low perfusion”, which implies low
signal strength.
5.5 Conclusive Remarks
The result shows that there is an excellent agreement between the SpO2 values estimated from the
sternal PPG signals and the SaO2 reference values (n = 324 blood samples) in the clinical region
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of interest (100 % to 70 %). All the patients were at rest in supine position, which minimized any
sort of motion artifacts during the recording. The use of the ECG signal to determine the heart rate
and thereby choose the cut-off frequencies for the band-pass filter for the PPG signal based on that
seems to be a promising approach. Specially because DELTA’s ePatch R© records the ECG already.
The accuracy of the PPG-patch was calculated to 1.75 % which is acceptable according to the ISO
80601-2-61:2011 standards (< 4%). Commercially available pulse oximeters such as Masimo R25-
L and NellCore Oximax N-65 reports accuracy of 1.79 % 1.3 % respectively. Furthermore, another
recent desaturation study conducted with a sternal PPG sensor has obtained an accuracy of 1.7 %
[20]. The calibration thus indicates an accuracy that is well within both the state of the art per-
formance and the clinically acceptable range. We consider the calibration to be successful and we
therefore find it reasonable to apply the estimated calibration curve to investigate the clinical perfor-
mance of the sternal PPG signals on the patient population (study II and III).
Now with this controlled desaturation study the PPG-patch device has been calibrated and validated.
So, it is now possible to estimate the oxygen saturation using the developed device. But, the valida-
tion was on healthy volunteers. In the next chapter the second clinical study is described. The aim
of the study is to investigate whether the sternal PPG can be clinically useful for calculating the RR
and the SpO2 level on patients with obstructive lung diseases.
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CHAPTER
SIX
CLINICAL STUDY II: SHORT-TERM PPG
MEASUREMENT ON COPD AND
ASTHMA PATIENTS
Objectives The PPG-patch has been designed tested and calibrated as described in the previous
chapters. However, the PPG measurement has only been conducted on healthy participants. The
current chapter will consist of an assessment of short-term sternal PPG monitoring and an estima-
tion of the RRs and the oxygen saturation levels on patients with Chronic Obstructive Pulmonary
Disease (COPD) and asthma. The chapter is based on Paper III and IV.
6.1 Background
As mentioned in chapter 3, the application of PPG has previously been studied and is well doc-
umented in terms of measuring the RR. The RR derived from PPG was shown to be clinically
applicable in terms of age, gender, anesthesia, and mode of ventilation [37, 75]. It was also shown
in the pre-clinical study (chapter 3) that the sternal PPG signal has an extremely clear respiratory
oscillations in healthy subjects. Therefore, the aim of the current clinical study is to assess the RR
from a clinical relevant patient group using sternal PPG. Moreover, the calculation of the SpO2 level
from the sternal PPG is also validated on the patient group.
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Table 6.1: Subject demographics.
All COPD Asthma
Gender (male/female) 11/18 9/15 1/4
Age (years) Mean: 64.3, SD:14.4 Mean: 64.4, SD:14.2 Mean: 62.4, SD:15
BMI (Kg/m2) Mean: 25.8, SD:8.8 Mean: 25.8, SD:8.7 Mean: 25.7, SD:9.1
Recording length (min) Range: 10-54
6.2 Method and Materials
6.2.1 Study Design
The data was collected from 30 patients with obstructive lung disease, either COPD or asthma. One
of the COPD patients was excluded due to missing data in the recording. The patients provided
written informed consent for study participation. The inclusion criteria required that the patients
were diagnosed with COPD or asthma and were admitted to the hospital due to an exacerbation of
their condition for at least 24 hours prior to their inclusion in the study. The patien’t demographics
are listed in Table 6.1.
The patients were monitored using the Datex-Ohmeda AS/3 Compact Patient Monitor, recording
the fraction of carbon dioxide (fCO2) via nasal catheter and the lead II ECG. The PPG-patch was
positioned on the skin at the sternum using adhesive tape. A second PPG-patch was positioned on
the first index finger and a conventional finger pulse oximeter was positioned on the second index
finger. All signals were collected synchronously on the Powerlab data acquisition system. During
the experiment the patients were at rest in a semi-supine position and the patients were instructed
not to make any unnecessary movements during the measurements, though, physiological artifacts,
e.g. coughing, was unavoidable. The recording duration was intended to be between 10 and 60
minutes. However, the maximum recording length was 54 minutes, cf. Table 6.1. A photograph of
the experimental setup is shown in Fig. 6.1.
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Figure 6.1: A photograph of a typical recording situation during the clinical study at Bispebjerg
Hospital.
6.2.2 Data Analysis
Regarding the calculation of the RR, the infrared PPG signal was used. But both wavelengths were
of course used for the estimation of the SpO2.
Calculation of the RR
Automatic extraction of the RR from the PPG signal is emerging and has been reported by numerous
authors. The most common method is based on the Fast Fourier Transform (FFT) [25, 76, 77].
Digital filtering such as applying 3rd order Butterworth band-pass filter with cut-off frequencies at
0.1 and 0.3 Hz, corresponding to 6 and 18 breaths/min followed by a peak detection algorithm that
marks the events of respiration was reported by Nilsson et al. [37, 75]. They reported an average
error of 0.5 breaths/min, where addison et al. [78] developed an algorithm based on the wavelet
transform and reported an average error of 1 breaths/min. In an attempt of using autoregressive
modeling method to extract the RR from PPG, Fleming and Tarassenko [79] reported an average
error of 0.04 breaths/min. Most of the mentioned algorithms requires a long-time period of
processing or high computational power, which is not suitable for the future perspective of the
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PPG-patch. It is assessed to use the digital filtering method proposed by Nilsson et al. [37], but
instead of using a peak detection algorithm after the digital filtering, we used a manual annotation
of the peaks conducted by a medical doctor.
The sternal PPG signal was filtered to suppress the cardiac related AC component and in-
crease the respiratory related DC component (using a 3rd order Butterworth band-pass filter with
cut-off frequencies at 0.1-0.7 Hz which corresponds to 6 - 42 breaths/min). After the filtering,
both the sternal PPG and the capnographic signal were divided into one-minute non-overlapping
segments. This yields a total of 1250 segments (half from the PPG and half from the capnographic
signals). The 1250 segments were randomized and a medical doctor was asked to visually go
through all 1250 segments and manually detect the RR in each one-minute segment. After the
manual detection of the RR in each segment, the segments were paired to allow a direct comparison
of the RRs obtained with synchronous measurements from the two recording systems. The Bland-
Altman assessment for agreement was used to compare the RRs estimated from the two methods.
The correlation between the two measurement techniques was calculated using Pearson’s correlation
coefficient. A p-value less than 0.05 was considered statistically significant. Additionally, the power
spectral content analysis that was applied in the pre-clinical study (3) is also done in this study, but
because we are able to compare the power spectral content of the finger PPG with the sternal PPG,
the work is further extended.
Calculation of the SpO2
The calculation of the SpO2 is achieved using the calibration curve calculated during the first study,
cf. chapter 5. For this purpose the PPG signals are divided into 20-second non-overlapping segments.
This yields a total of 1784 segments. Each of them is normalized, band-pass filtered, and the optical
ratio R is estimated and fed into the calculated linear calibration curve. Then the SpO2 values
calculated from the sternal PPG is compared to SpO2 values given by the Datex-Ohmeda AS/3
patient monitor.
6.3 Results
Figure 6.2 illustrates three filtered segments from sternal PPG (black) and the corresponding flow
signal from capnography (blue) at different RRs. The distribution of all the RRs derived from the
capnographic signals and the sternal PPG signals are shown in Fig. 6.3. The RRs are ranged from
11.3 to 35.5 breaths/min. The mean rate was 20.4 breaths/min with a standard deviation of 4.7
breaths/min. Figure 6.4 contains the distribution of the differences between the sternal PPG derived
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RRs and the RRs derived from simultaneous measurements obtained with the capnographic signals.
The mean bias between the rates was 0.6 breaths/min with a standard deviation of 1.7 breaths/min.
The accuracy of the measurement defined as the root mean squared (Arms) difference between mea-
sured values of sternal PPG and the reference values from capnography was 1.9 breaths/min. A
more detailed view of the differences is further provided in Fig. 6.5. The Bland-Altman analysis
demonstrated a mean system bias of 0.6 breaths/min and the 95 % limits of agreement to be -2.8 to
4 breaths/min. Additionally, Pearson’s correlation coefficient between the two techniques showed a
significant correlation (r = 0.93, p < 0.001).
Figure 6.2: Filtered respiration signals from sternal PPG (solid) and the reference flow signal
from capnography (blue dashed) respectively. These segments are six of the 1250 segments that
the medical doctor annotated.
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Figure 6.3: Distribution of all the RR of the patients included in this study. (a) The RR are
calculated from the capnographic signal (b) and derived from sternal PPG.
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Figure 6.4: The distribution of all the differences between the sternal PPG derived RRs and the
RRs estimated from the capnographic signal. The solid curve shows a normal distribution curve of
the differences.
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Figure 6.5: The Blandt-Altman plot of the data. The three red squared markers represent the mean
and differences for signals shown in Fig. 6.2.
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Figure 6.6: The respiration and cardiac spectral power from sternal PPG and reflective finger PPG.
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As shown in chapter 3, Fig. 3.6 the respiration and cardiac spectral power content was derived from
the sternal PPGs for each subject. For the current clinical study the same method was used on the
group of patients. The result is shown in Fig. 6.6. The respiration and cardiac power spectral content
(median and interquartile range) for sternal PPG is 76.5 (16.3) % and 14.9 (11.7) % respectively. For
the reflective finger PPG it is 3.8 (3.1) % and 91 (4.9) % respectively.
As for the SpO2 levels from sternal PPGs compared to the values from the finger PPGs is shown in
Fig. 6.7. The Pearson correlation was found to be 0.89 (p < 0.05). A representative example of
the calculated SpO2 levels from one patient is illustrated in Fig. 6.8 together with the SpO2 values
simultaneously obtained from the finger pulse oximetry. For this patient, it is seen (at the 5th minute)
how the SpO2 levels for both devices increased as a result of oxygen therapy.
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Figure 6.7: The Blandt-Altman plot of the comparison between the two measurement systems.
Each dot corresponds to the difference between the obtained SpO2 in one of the 20 second analysis
windows. The study included a total of 1784 non-overlapping 20 second analysis windows.
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Figure 6.8: Time course of the SpO2 measured on the finger (blue dashed line) and estimated from
the sternal PPGs (red solid line) for one of the patients. Just before the increase of SpO2 values,
the patient received oxygen therapy.
6.4 Discussion
The purpose of this study was to examine whether the RRs derived from sternal PPGs can be used
for reliable monitoring of patients with obstructive lung disease like COPD or asthma. Besides
the importance of monitoring the RR on these patients, it was also important to evaluate how well
sternal PPG derived RR could be correctly identified in a clinical setting over a broad range of RRs.
Furthermore, the study extends the previous work regarding the respiratory and cardiac content of
sternal PPG that was conducted in the pre-clinical study (chapter 3). In addition, the calibration
curve for the SpO2 calculation that was derived in the first study was validated on the included
patients.
The RR for a healthy adult at rest is between 9-16 breaths/min. Also it is known that COPD
and asthma patients may have higher RRs [6]. This is reflected in the distribution plots provided in
Fig. 6.3. In addition, it is reflected in the figures that there are two main epochs in the distributions,
one around 16 breaths/min and one around 24 breaths/min. By further inspection of the recorded
data, it was clear that the reason behind the two epochs is because the fact that the study took place
at two different hospital wards having the majority of the patients with higher RRs at the department
of pulmonary medicine. One of the inclusion criteria of this study was that patients should be
hospitalized for at least 24 hours prior to the measurement and when COPD or asthma patients
are admitted to the medical admission ward, they receive the needed treatment and some will be
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dismissed, while others may need more medical attention. This means that we may have monitored
a more stable group of COPD and asthma patients at the medical admission ward than the patients
at the pulmonary medicine. Usually when patients require more medical treatment, they will be
transferred to the pulmonary medicine ward. The majority of the segments (90 %) with RRs above
28 breaths/min belong to the asthma patients. In conclusion, the patient population in this study
seem to provide a realistic clinical basis for investigating the performance of sternal PPG obtained
RRs.
The standard procedure of measuring the RR at the pulmonary ward and the medical admission
ward at Bispebjerg Hospital in Denmark is by physical assessment, either by direct observation of
the chest movement or via breath sounds with a stethoscope. This procedure is done at least once
a day. Though, in some rare cases the conventional capnography is used for continuous monitoring
of the patients. In this study we compared RRs derived from the sternum with capnography mea-
surements. Good agreement was found between the two measurement methods. The documented
accuracy of the used capnograph (Datex Ohmeda AS/3 Compact Patient Monitor) is± 5 breaths/min
and the result from the Blandt-Altmann analysis showed that the upper 95 % limits of agreement was
4 breaths/min and the lower limit was -2.8 breaths/min. Even though the two methods are signif-
icantly correlated the mean bias in the Blandt-Altmann plot is slightly RR dependent, which may
indicate some sources of error in the two methods. Capnography readings is known to have sources
of error [80], but still it is a common used system for monitoring the RR at the hospital. We achieved
an average root mean squared of the differences of 1.9 breaths/min, which indicates precise estimate
by sternal PPG compared with capnography based RR. Comparing the result with the performance
of manual respiration counting reported in [81]. They found that the repeatability coefficient for
the RR monitoring made consecutively by the same observer is 4.9 breaths/min and a repeatability
coefficient of 5.7 breaths/min for RR monitored consecutively by a different observer, and finally a
repeatability coefficient of 4.2 breaths/min when simultaneous observers were investigated. Based
on this reporting and compared to the results of this study we can say that the RR monitoring using
PPG at the sternum is well within the currently clinically accepted tolerance. Importantly, the dis-
tribution of the differences seems to follow a normal distribution with a small bias as seen in Fig.
6.4.
As discussed in chapter 3, the respiratory induced variations are also seen in PPG signals from more
peripheral located body sites, for example the finger and forearm as shown by Nilsson et al. [26] and
that the strength of the respiration component in the PPG signal depended on the measuring site. It
was also reported that the largest respiratory induced variations seem to be more prominent proximal
to the chest (the largest component was found on the forearm). As seen in the Bland-Altman analysis,
there was a good agreement in the whole range of RRs from 11 to 35 breaths/min. The respiratory
and cardiac content in sternal PPG for the patient groups was in the same range of the one showed in
the pre-clinical study; For the respiratory content the median and (interquartile) is 76.5 (16.3) % for
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the patients (n=29) and 78.8 (38) % for the healthy group (n=10). As for the cardiac content, it was
14.9 (11.7) % for the patients and 19 (18.4) % for the healthy subjects. Additionally, it should be
noted that the studies were conducted with two different PPG probes, but same wavelength (λ = 940
nm) and the analysis was done on the same segment length of 8 minutes. The spectral content of the
PPG signal at the finger showed significantly lower respiratory content and higher cardiac content
compared to sternal PPG as seen in Fig. 6.6. The cardiac content of the sternal PPG is assessed
to be sufficient in terms of SpO2 calculation which is also confirmed by the result of the Blandt-
Altman analysis. As seen in the plot in Fig. 6.7 there is a good agreement with the result from the
conventional pulse oximeter, especially when the accuracy of the pulse oximeter is considered. The
accuracy is reported as a standard deviation in SpO2 of 2 % points in the range 100 % to 80 % and
3 % points in the range 80 % to 50 %.
One of the limitations of this study is that the recording length for each patient is not equal. This
means that one recording potentially may bias the results in a negative or a positive direction. Fur-
thermore, lung function data are missing, which would give a picture about the severity of obstructive
lung disease of the included patients. According to the measurements, some patients contributed to
a normal range of the RR and others to higher rates. If patients were screened using for example
spirometry it would be possible to divide the COPD patients into subgroups during the analysis.
In regarding the SpO2 values, only four subjects did not receive oxygen therapy, the rest did and
therefore 89 % of all data points (n=1784) are above 90 % SpO2 level. In spite of this high level of
SpO2 level it is considered accepted for the validation of the sternal PPG, because it will always be
the case at least at Bispebjerg hospital, that if a patient has SpO2 level below 90 % when it is in bed,
it will receive oxygen therapy.
PPG-patch at the Sternum
As in the first study the PPG-patch was positioned at the sternum via adhesive tape. However, this
was not the case for all the patients. On ten patients, the modified ePatch R© electrode was used to
attach the PPG-patch to the chest. All the ten patients had a prominent sternal bone similar to what
is seen in Fig. 6.9a, which made the placement almost impossible without the electrode because
the skin site was too thin. Figure 6.9b shows the ePatch R© electrode attached at the sternum. The
PPG-patch is embedded into the electrode just before the recording as seen in Fig. 6.9c. A picture
of the sternum after the recording is seen in Fig. 6.9d. Marks of the location of the optical window
is clearly seen.
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Figure 6.9: Pictures of the sternum of one patient. a) Before recording, shows the different
anatomy of the sternal bone. Fortunately suitable for the PPG-patch and corresponding electrode.
b) The modified ePatch R© electrode is attached at the sternum. c) The PPG-patch is embedded
into the electrode. d) Shows clear marks from the optical window that is sticking out from the
PPG-patch.
80 Chapter 6. Clinical Study II: Short-Term PPG Measurement on COPD and Asthma
Patients
6.5 Conclusive Remarks
To our knowledge, no study has previously reported results regarding the possibility of deriving the
RR and the SpO2 level from sternal PPG on COPD and asthma patients. In this clinical study we
have demonstrated that the RR and the SpO2 level can be calculated from sternal PPG on COPD
and asthma patients. The results showed good agreement with capnography. Moreover, this may
provide a useful clinical relevant improvement over manually obtained RRs in terms of time and
early detection of exacerbations. In this clinical study the patients were instructed to move as little
as possible. In the next and last study the patients are being monitored without any wires and
therefore they were asked to follow their daily routine during the hospitalization. This will lead to
an investigation of the ability to conduct and analyze long-term PPG recordings at the sternum. The
whole optical window / electrode problem will be a key factor, because the PPG-patch can only
work for long-term recording, if it is attached to the modified electrode. However, this utilizes PPG
recordings, triaxial accelerometer signals and ECG signal, simultaneously.
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CHAPTER
SEVEN
CLINICAL STUDY III: LONG-TERM PPG
MEASUREMENT ON COPD AND
ASTHMA PATIENTS
Objectives The current chapter will consist of an investigation of the reliability of long-term contin-
uous sternal PPG monitoring and the estimation of the SpO2 levels and the RRs on patients with
COPD and asthma and on a group of healthy participants. Some of the outcomes of this chapter is
based on Paper V.
7.1 Background
We have in the previous chapters shown that the SpO2 levels and the RRs can be obtained from short-
term sternal PPGs recorded on admitted patients with COPD or asthma. These findings show that
sternal PPGs are highly applicable for reliable calculation of clinically relevant SpO2 levels and RRs
in controlled conditions with a minimum influence of artifacts. However, in real-life applications,
the recorded PPGs will be influenced by varying amounts of unavoidable artifacts. This includes for
instance artifact from motions, changes in the amounts of ambient light, and poor contact between
the skin and the sensor. When the PPG signals are affected by these artifacts, the calculation of
the SpO2 levels and the RRs might be unreliable. From a clinical point of view, it is acceptable to
estimate the SpO2 level and the RR in quasi-continuous periods with sufficient signal quality, e.g.
provide a reliable calculation six times per hour or provide a reliable trend curve for each vital sign.
This implies that periods of poor data quality are clinically acceptable as long as they alternate with
periods of data that permits a reliable calculation of the SpO2 level and the RR.
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Table 7.1: Demographics for the patient group and the group of healthy participants.
COPD & Asthma Healthy
Gender (male/female) 3/12 11/2
Age (years) Mean: 67.4, SD:19 Mean: 45, SD: 14
BMI (Kg/m2) Mean: 25, SD:4.5 Mean: 24.7, SD:3
7.2 Method and Materials
7.2.1 Study Design
The population of this study is divided into two groups; a group of 15 patients with obstructive
airway diseases (2 asthma patients and 13 COPD patients). The second group constitutes of 13
healthy participants. The enrollment of the patients has be conducted using the per protocol ap-
proach. Meaning that out of a total of 28 patients, only the patients who completed a full recording
and the recorded data are assessed to be analyzable are included in this clinical study. All the pa-
tients were admitted at the Department of Pulmonary Medicine at Bispebjerg University Hospital,
Denmark. Furthermore, all 15 patients received oxygen therapy when they were included. As for
the group of healthy subjects, 15 were enrolled but two subjects were excluded due to sensor shut
down error. Both patients and the healthy subjects were instructed to follow their daily routine (ex-
cept showering). This ensures a realistic impression of the amount and type of artifacts present in
long-term recordings obtained from hospitalized patients and from the healthy subjects outside the
hospital environment. The demographics for both groups are shown in Table 7.1.
The developed PPG-patch is attached to the sternum via the modified ePatch R© electrode. This is
illustrated in Fig. 7.1. In the beginning of each recording, the SpO2 level was measured using a
conventional finger pulse oximeter (Nellcor OxiMax N-65). The PPG-patch is programmed to have
a maximum recording length of 20 hours. An example of a full recording of all the modalities is
shown in Fig. 7.2 and a more detailed one-minute segment is shown in Fig. 7.3. The figure shows
how movement may impact the PPG signal and how the respiration component dissapear when the
patient stops breathing for few seconds.
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Figure 7.1: (a) A photograph of the chest of a patient before application of the PPG-patch. (b)
A photograph showing the the prototype PPG sensor attached to the sternum of the patient using
the modified ePatch R© electrode. The three dimensional axes defines the coordinate system of the
triaxial accelerometer.
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Figure 7.2: Plots showing the raw signals of the recorded modalities at the sternum with the PPG-
patch. (a) Infrared PPG signal (b) Red PPG signal. (c) ECG signal. (d) Triaxial accelerometer
signals. The blue, green and purple corresponds to x, y and z axes.
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Figure 7.3: Plots showing a one-minute segment of the raw signals of the recorded modalities at
the sternum with the PPG-patch. (a) Red and infrared PPG signal (b) ECG signal. (d) Triaxial
accelerometer signals. Where the blue, green and purple corresponds to x, y and z axes. Interest-
ingly, this current segment shows spontaneous respiration, movement and stop of respiration. The
small spikes corresponds to the cardiac pulses in the PPG signals, while the larger corresponds to
respiration.
7.2.2 Data Analysis
The data analysis is separated into two sections; reliability investigation in terms of the SpO2 level
and in terms of the RR.
Reliability of Sternal PPG in terms of the SpO2 level
The recorded signals are divided into non-overlapping windows of 20 seconds and the SpO2 level is
calculated in each of these windows in the same way as described in chapter 5. The SpO2 level was
calculated as follow:
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SpO2 = −25.89 ∗R+ 116.48 (7.1)
where R represents the relation between the red and infrared PPG signals after normalization and
filtering. The window length is chosen to represent enough physiological information to provide a
reliable calculation of the changes in the SpO2 levels over time. In order to investigate the reliability
of the calculated SpO2 values, we implemented four criteria to classify the calculated SpO2 values
into reliable (indicated as binary one) and unreliable (indicated as binary zero) values. An overview
of the analysis is provided in Fig. 7.4. The classification is made based on the following criteria:
Cross-correlation: From the basic theory of pulse oximetry, it is known that the red and infrared
PPG signals should be highly correlated [13]. However, no specific value is given. But looking at
one of the most powerful state of the art algorithms patented by Masimo Inc. it is reported that if
the cross-correlation between the red and infrared PPG signals is less than 75 % the signal segments
does not qualify for the calculation of the SpO2 levels [82]. The same cross-correlation ”limit” is
used in the current analysis.
Rate of ∆SpO2: From the inherent physiological regulation of the SpO2 levels it is expected
that the SpO2 change observed within one minute may vary very little in healthy subjects with
normal lung function [83]. In COPD patients, it is well known that the SpO2 levels may fall
rapidly when making a relatively small effort [84]. A study conducted on 60 COPD patients who
participated in a six minute walk test, it was reported that all the patients desaturated and in 46 % of
the patients had ∆SpO2 > 3 % within the first 1.2 min and during low endurance cycling exercise
57 % of the patients had ∆SpO2 > 3 % after 4.6 min [85]. So the desaturation rate also depends
on the type of movement because different group of muscle groups is used to compensate for the
demand of ventilation in the different daily situations. The COPD patients in our study have severe
COPD and they all received oxygen therapy at least in the beginning of the recording. We will
investigate the reliability of the SpO2 levels based on different ∆SpO2 limits: ∆SpO2 > 3 %, 4 %,
and 5 %. So, the one-minute segment is classified as unreliable if the absolute difference between
the maximum and minimum SpO2 values obtained in the one-minute segment exceeded 3 % (same
procedure is done with 4 %, or 5 %).
Accelerometer threshold: To detect a certain movement during a recording, the magnitude
of the resultant vector is used. The resultant vector is a net acceleration, which can be used as an
indicator of overall body movements. The net accelerations is given by the following equation:
anet =
√
a2x + a
2
y + a
2
z − 1 (7.2)
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where the magnitude of the static acceleration (gravity) is subtracted. Furthermore, the signal is
further smoothed over time (window size of 0.5 seconds). After inspection of all the recordings a
difference between motion and non-motion is clear when using a static threshold of 0.1 g. So we
chose to define this value as a threshold to distinguish between motion or non-motion. Therefore,
all SpO2 values calculated in the 20-seconds segments where the magnitude of the net acceleration
is greater than 0.1 g, are classified to be not reliable.
Upper and lower limits of the SpO2 level: SpO2 values outside a range of 100 %-80 % are classi-
fied to be not reliable. This is because it is impossible to have values greater than 100 % and based
on previous experiments it was not observed that any patients had a SpO2 level less than 80 %.
Input 
data
1) Cross-correlation
2) Rate of SpO2 change
3) Accelerometer threshold
4) SpO2 upper & lower limits
...
1 min20 s
...
Reliability 
check:
Reliability
vector 1 1 1 0 001
SpO2 
calculation:
98 99 90
1111111111 1 1
Figure 7.4: Schematic overview of the analysis. The reliability is checked based on the SpO2
levels calculated from three consecutive 20-second windows (corresponding to a one-minute data
segment). If the input data from the one-minute segment is classified as unreliable, all three corre-
sponding 20-second windows are also classified as unreliable and they are excluded from further
analysis (illustrated by zeros in the reliability vector).
The reliability check was conducted as a sliding window with an overlap of two 20-second windows.
This implies that each 20-second window is included in three different runs of the reliability check.
If it is classified unreliable in at least one of the three checks, the 20-second segment is consid-
ered unreliable. Figure 7.5a shows all the calculated SpO2 values from one patient in a five hour
recording sequence during the night. Each marker is a value calculated from a 20-second segment.
The performance of the reliability check of the ∆SpO2 > 3 % (red markers) and the accelerometer
threshold (green markers) is also illustrated in Fig. 7.5b. These markers are classified to be non
reliable. Removing those non reliable SpO2 values gives a more stable time course as seen in Fig.
7.5c. Fig. 7.5(d-e) shows the band-pass filtered red and infrared PPG signals. Fig. 7.5f shows the
overall acceleration. The dashed red line corresponds to 0.1 g as described previously. Over time
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the segments have a certain variation around a baseline SpO2 level. To estimate this variation, we
introduce an estimated reference SpO2 trend curve. This curve is calculated with an average filter
with 30 points (corresponding to 10 minutes). All unreliable segments were excluded for calculation
of this reference trend curve. An example of the trend curve (red line) is provided in Fig. 7.5(c).
We then defined the long-term accuracy of the SpO2 calculation as the Root Mean Squared error
(RMSE) between this reference curve and the SpO2 values that were classified as reliable.
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Figure 7.5: (a) An example of the time course of all calculated SpO2 values for five hours during
the night for one patient. (b) An illustration of the reliable segments (blue markers) and the unre-
liable segments (red markers). These markers are detected due to the second criteria where in this
particular example ∆SpO2 > 3 % between the minimum the maximum value within a one-minute
segment. The green markers are also from unreliable segments detected due to the accelerometer
criteria. (c) The time course of all the extracted reliable segments (blue marks) together with the
estimated average reference curve (red line). (d-e) Time course of the band-pass filtered red and
infrared PPG signals are shown. Furthermore, it is observed how segments with high amounts of
artifacts in the PPG signals are considered unreliable and therefore excluded from the SpO2 analy-
sis. (f) Time course of the magnitude of the net accelerometer signal. Segments with accelerations
above 0.1 g (dashed red line) are classified as unreliable.
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Reliability of Sternal PPG in terms of the RR
Investigating the RR over a long-term recording without any reference is not a trivial task. The RR
can fluctuate a lot during a recording. For instance while, talking, eating or walking. However,
the RR during these circumstances will be treated as unreliable calculations due to the applied
conditions.
The infrared PPG signal was used and was filtered using a Butterworth band-pass filter with
two 4th order slopes at 0.1 Hz and 0.7 Hz corresponding to RRs from 6 to 42 breaths/min. The
upper limits is chosen because it was seen in the previous study that COPD and asthma patients can
have higher RRs than 30 breaths/min. Afterwards, a simple peak detection method was applied with
two criteria: The height of the peaks must be more than 50 % of the root mean square value of the
signal. And the inter-peak distance is minimum 1.4 seconds, corresponding to a maximum RR of
42 breaths/min. Now the calculated RR can be given by the inverse of the mean inter-peak distance
in the 20-second segment.
In terms of the reliability check the same procedure as described in the previous section was
used. So the RR is calculated in three 20-seconds segments in one-minute, giving three values of the
RR. Then the maximum and the minimum absolute RR value is compared within this one-minute.
If the difference in RR is greater than 3 breaths/min within one-minute then the value is classified as
unreliable estimate of RR. Additionally, the acceleration criteria will also be used in the reliability
check. It was chosen not to set any lower and upper limit check of the RR. Because this constrain is
already applied in the peak detector algorithm. An example of the time course where the described
conditions are applied is illustrated in Fig. 7.6. The segment is exactly at the same time as shown
in Fig. 7.5, except that now in Fig. 7.6b the red markers corresponds to the unreliable RR values.
It is assessed due to RR stability and low accelerometer activity that the time segment shows a
transition to bedtime. During the night it is expected that the ∆RR is low, which seems like that in
this example from 23:00 to 02 o’clock.
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Figure 7.6: (a) An example of the time course of all calculated RR values in a five hour recording
segment.(b) An illustration of the reliable segments (blue markers) and the unreliable segments
(red markers). These markers are detected due to ∆RR > 3 breaths/min within a one-minute
segment. The green marks are also from unreliable segments detected due to the accelerometer
criteria. (c) An illustration of the time course of all the reliable RR values (blue marks) together
with the estimated average reference curve (red line). This curve is applied to calculate the long-
term accuracy of the calculated reliable RR values. (d) Time course of the band-pass filtered
infrared PPG signal are shown. (e) Time course of the magnitude of the resultant accelerometer
signal. Segments with accelerations above 0.1 g (dashed red line) are classified as unreliable.
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The variation over time is also used by introducing an estimated reference RR trend curve. This
curve is calculated with an average filter with 30 points (corresponding to 10 minutes). All unreliable
segments were excluded for calculation of this reference trend curve. The trend curve (red lines) is
illustrated in Fig. 7.6(c). The long-term accuracy of the RR calculation is then defined as the Root
Mean Squared error (RMSE) between this reference curve and the reliable RR values.
7.3 Results
The result will be presented in two sections, the first section is related to the SpO2 level and the
second is related to the RR. In each section the result will be presented with and without the ac-
celerometer criteria.
7.3.1 Long-term Monitoring of the SpO2 Level
For the group of patients the RMSE between the SpO2 values calculated from sternal PPGs in the
beginning of the recording and the SpO2 values obtained from the conventional finger pulse oximeter
was only 2.3 %. No reference value was taken for the healthy group because it was expected that
the SpO2 level is above 95 %. For each hour in the recordings the percentage of reliable segments
(defined as the percentage uptime) is calculated when all the previously mentioned conditions are
applied.
The effect of different values of ∆SpO2 on the average percentage uptime and the RMSE is pre-
sented in appendix A. It is chosen to use the ∆SpO2 > 3 % for further analysis because it is as-
sessed that this constrain is applicable for the type of patients used in this study. Without including
the accelerometer criteria the average percentage uptime during the whole recording for the patients
and the healthy subjects is 57.6 % and 58.1 % respectively. The RMSE is accordingly 2.5 % and
2 %. Figure 7.7 and Fig. 7.8 shows the uptime for every hour during the recordings. Interestingly,
how the percentage uptime is almost the same for the group of patients while there is a remarkable
increase during the night for the group of healthy subject. For the patients, the recording started in
between 09 and 11 o’clock in the morning. While it was between 10 and 13 o’clock for the healthy
subjects and therefore the percentage uptime decreases in the last hour because of activity.
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Figure 7.7: A box-plot of the percentage uptime for every hour of the calculated SpO2 values
for the patients, when using all the conditions except the accelerometer condition. The horizontal
dashed line corresponds to the average. The recordings started between 9 and 11 o’clock.
Δ Δ
a) b)
Figure 7.8: A box-plot of the percentage uptime for every hour of the calculated SpO2 values
for the healthy subjects, when using all the conditions except the accelerometer condition. The
horizontal dashed line corresponds to the average. A noticeable difference of the increase uptime
between day and night. The recordings started between 10 and 13 o’clock.
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Instead of only looking at the percentage uptime, we can also look at the span distribution of unre-
liable time segments for each patient. This is illustrated in a box plot in Fig. 7.9. Almost all the
excluded time periods are less than ten minutes. For patient number 12, it is seen that there has been
a segment of approximately 70 minutes where there has not been any reliable SpO2 levels.
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Figure 7.9: A box-plot of the distribution of the length of unreliable (excluded) time segments in
terms of the SpO2 level for each patient. The red marks indicate outliers.
Now looking at the accelerometer condition without including the ∆SpO2 > 3 % criteria. The
average percentage reliable SpO2 values for the patients and for the healthy group is 50.2 % and 43.4
% respectively and the RMSE is accordingly 3.06 % and 2.4 %. For both groups it is seen in Fig.
7.10 and Fig. 7.11 that the percentage uptime during the day has decreased when the accelerometer
criteria was applied, whereas during the night no remarkable differences is seen.
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Figure 7.10: A box-plot of the percentage uptime for every hour of the calculated SpO2 values for
the patients. The classification of reliable data is based on all the conditions except the ∆SpO2 >
3 % criteria. The horizontal dashed lines corresponds to the average. The recordings started
between 9 and 11 o’clock.
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Figure 7.11: A box-plot of the percentage uptime for every hour of the calculated SpO2 values
for the healthy subjects. The classification of reliable data is based on all the conditions except
the ∆SpO2 > 3 % criteria. The horizontal dashed line corresponds to the average. The recordings
started between 10 and 13 o’clock.
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Applying all the conditions on both groups gives an average reliable uptime of 37.6 % and 37 % for
the patients and the group of healthy subjects respectively. And the RMSE is 2.7 % and 1.7 %. The
progression over time is shown in Fig. 7.12 and Fig. 7.13 for each group.
Δ Δ
a) b)
Figure 7.12: A box-plot of the percentage uptime for every hour of the calculated SpO2 values
for the patients. The classification of reliable data is based on all the conditions: ∆SpO2 > 3 %,
cross-correlation, limited SpO2 range and accelerometer conditions. The horizontal dashed line
corresponds to the average. The recordings started between 9 and 11 o’clock.
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Figure 7.13: A box-plot of the percentage uptime for every hour of the calculated SpO2 values for
the healthy subjects. The classification of reliable data is based on all the conditions: ∆SpO2 >
3 %, cross-correlation, limited SpO2 range and accelerometer conditions. The horizontal dashed
lines corresponds to the average. The recordings started between 10 and 13 o’clock.
7.3.2 Long-term Monitoring of the RR
The same calculations procedure was conducted in terms of the RR. For each hour in the recordings
the percentage of the reliable segments is calculated when all the previously mentioned conditions
are applied. The result when the ∆RR > 3 breath/min, criteria is applied is shown in Fig. 7.15
and Fig. 7.16. The average percentage of reliable RRs for the patients group and the group of
healthy subjects is 58 % and 59 %, respectively. The RMSE is 2.9 breaths/min and 3 breaths/min
correspondingly.
The distribution of unreliable time segments for each patient is illustrated in a box plot in Fig. 7.14.
Almost all excluded time periods are less than ten minutes, meaning that most likely we can obtain a
reliable RR measure six times per hour. As seen before patient number 12 has an unreliable segment
of approximately 70 min in terms of the SpO2 level. The same result is obtained in terms of the RR.
By further inspection of the PPG segment it was seen that the signal in this 70 minutes was very
noisy and it was not possible to detect any valid PPG signal.
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Figure 7.14: A box-plot of the distribution of the length of unreliable (excluded) time segments in
terms of the RR for each patient. The red marks indicate outliers.
Adding the accelerometer condition changes the percentage uptime to 37.9 % for the patients and
38.1 % for the healthy subjects. The RMSE becomes 2.6 breaths/min and 2.8 breaths/min respec-
tively. The percentage uptimes is shown in Fig. 7.17 and Fig. 7.18.
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Figure 7.15: A box-plot of the percentage uptime for every hour of the calculated RRs for the
patients, when using all the conditions except the accelerometer condition. The horizontal dashed
lines corresponds to the average. The recordings started between 09 and 11 o’clock.
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Figure 7.16: A box-plot of the percentage uptime for every hour of the calculated RRs for the
healthy subjects, when using all the conditions except the accelerometer condition. The horizontal
dashed lines corresponds to the average. A noticeable difference of the increase uptime between
day and night. The recordings started between 10 and 13 o’clock.
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Figure 7.17: A box plot of the percentage uptime for every hour of the calculated RRs for the
patients. The classification of reliable data is based on ∆RR > 3 breaths/min and accelerometer
conditions. The horizontal dashed line corresponds to the average. The recordings started between
9 and 11 o’clock.
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Figure 7.18: A box-plot of the percentage uptime for every hour of the calculated RRs for the
healthy subjects. The classification of reliable data is based on the ∆RR > 3 breaths/min and the
accelerometer conditions. The horizontal dashed line corresponds to the average. The recordings
started between 10 and 13 o’clock.
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7.4 Discussion
In this long-term clinical study, it was important to restrict the patients’ and the healthy participants’
daily activity as little as possible. For the patients this ensures a realistic impression of the pos-
sibilities for future quasi-continuous calculation of the SpO2 level and the RR in the presence of
artifacts arising from normal daily or in-hospital activities. It was therefore not feasible to compare
the calculated values with conventional vital sign monitors throughout the recording length.
The Long-Term SpO2 Recording
As a baseline accuracy measure, we compared the SpO2 values calculated from sternal PPGs with
a conventional finger pulse oximeter in the beginning of the recordings. Based on our findings from
the previous study and the very low RMSE between the two methods, we presume that the SpO2
levels calculated from the long-term sternal PPGs are reliable in segments of sufficient data quality.
For the rest of the recording time, we therefore investigated the reliability based on knowledge about
the inherent physiological regulation of the SpO2 levels and the basic theory of pulse oximetry. By
visual inspection of challenging data segments, we found that the ∆SpO2 > 3 % criteria seems
reliable for this patient population. Taking the accuracy of the calibration for the PPG-patch into
account this limit seems also reliable for the healthy participants. It is observed from Fig. 7.5 how
the reliability classification correctly removes outliers. These outliers are expected to be caused by
poor data quality due to motion artifacts or poor light and tissue interface. This finding is confirmed
when using the accelerometer criteria to determine which of the segments that can be considered
reliable. Generally, it was seen that the accelerometer criteria slightly underestimated the reliability
percentage of the recordings compared to the ∆SpO2 > 3 % condition. As for the patient group
the accelerometer condition resulted in a percentage uptime of 50.2 % and with the ∆SpO2 > 3 %
condition it was 57.6 %. And the difference was even larger between the two conditions (approxi-
mately 14 % difference) for the healthy subjects. This is because the activity levels between the two
population are different. During the day time the activity level of the healthy subjects is expected
to be larger compared to the night. This is also confirmed when looking at the percentage uptime
for each hour during the entire recording. The uptime was larger during the night than the day. As
expected the difference in the uptime during the night and day was not significant for the patients.
Generally, it is experienced that the accelerometer condition results in more false negative error.
More interestingly, it is found that segments of reliable SpO2 values could be extracted throughout
the recording length. This indicates that when the SpO2 level calculation temporarily becomes
unreliable due to artifacts, it becomes reliable again after the artifact event. This is also the fact for
the RR and it is also observed in the raw signals illustrated in Fig. 7.3. Another interesting outcome
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is seen in Fig. 7.13. From recording hour 10 to 12 corresponding to approximately 19 to 22 o’clock
the variability of the data is relatively large compared to the rest of the recording time for the group
of healthy subjects. The reason to this may be ”getting prepared just before bedtime”. The same
thing is seen at hour 19 corresponding to clock time between five and eight o’clock in the morning.
Another interesting result is the lengths of successively unreliable segments. The maximum length
was 70 min in terms of the SpO2 calculation. However, the average for all the patients is 23 min and
most of the lengths are under 10 min. This is very promising for quasi-continuous measuring of the
SpO2 level.
The Long-Term RR Recording
As described earlier the RR is measured by manual inspection of the thorax. A nurse holds the hand
of a patient and acts like s/he is measuring the heart rate, while s/he actually is looking at the thorax
and counting the movements. The main idea is not to bias the patient’s breathing pattern during the
measurement. So in order to calculate a reliable RR on any patient the person should not be moving.
Furthermore, talking or eating should be avoided during the measurement. All these factors are of
course impossible to apply during long-term recordings. The most important is to find the segments
where the patient is at rest and then calculate the RR. For this reason the accelerometer threshold
criteria is convenient in regarding the calculation of the RR compared to the SpO2 level. If there is
good contact between the PPG sensor and the skin it is still possible to measure the SpO2 level while
moving. This is however not possible with the RR because the inherent variation would be large.
This is also what was reflected in the results. During the night, the percentage uptime was clearly
higher compared to the rest of the day. This was seen for both groups. What should be noticed is that
although the used peak detection method is not a robust and verified algorithm it was still possible
to find a trend and to show a possibility of quasi-continuous calculation of the RR. It was shown
in the previous study how accurate the RR can be estimated when a medical doctor annotated the
data. However, automated calculation of the RR in long-term recordings still needs a lot of attention
in terms of reliability. As it was noticed the variability of data is somehow stable for the patients
during the whole recording time, while it was at specific times for the group og healthy subjects.
Just before, bedtime and in the early morning the interquartile range is large compared to the rest of
the recording time. The reliability estimates for the SpO2 level and the RR was almost the same (58
%) which may indicate that the quality of the PPG signal is sufficient to calculate both parameters
throughout a long-term recording and most importantly, it was also observed from Fig. 7.9 and Fig.
7.14 that it would be possible to measure the SpO2 level and the RR at least six times per hour.
This is very promising for future quasi-continuous calculation of the SpO2 levels and the RRs from
sternal PPGs.
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Experimental Remarks
As experienced from study I and II the optical window does not make good contact with the skin
when the modified adhesive electrode is used. Therefor the quality of the PPG signals may be
compromised in this study. Furthermore, the data collection was very challenging. All the patients
included in this study had severe COPD or athma. Temporary exacerbation occurred in almost all
the enrolled patients during the day or night recordings. This was very challenging for a prototype
sensor. Twenty-eight patients were enrolled in order to get 15 full recordings. The problems can be
grouped into three categories: The first category is the hardware/software problems because of the
lack of DC calibration during the recordings, which may result in a high percentage of saturated data.
Furthermore, the device has a fixed gain, which makes it difficult to adapt to the tissue interfaces
when for example a patient is sweating. The second category is the adhesive problem. Sweating
makes the adhesive electrode less adhesive and the optical interface with the skin changes, which
requires new calibration. The last category, the diversity of thorax anatomy makes it challenging to
attach the sensor at the sternum, where on some patients it was impossible to position the PPG-patch
because of the sternal curvature.
7.5 Conclusive Remarks
In this preliminary study, it was thus demonstrated the ability to calculate clinically relevant and
reliable SpO2 levels and RR from long-term sternal PPG recordings obtained from patients suffering
from obstructive lung diseases and from healthy participants. This finding is very promising for
future implementation of the SpO2 and the respiratory measures in a sternum based vital sign patch.
In the future, such a patch might assist in early detection of worsening in the condition of these
patients (or other patient groups with chronic diseases) and thereby ensure timely treatment of the
patients. Furthermore, it might be possible to design new algorithms for automatic detection of
data segments that would provide a reliable SpO2 and RR measures. The low RMSE between the
included SpO2 values and the estimated average reference curves as well for the RRs indicates a
high long-term accuracy of the calculated values. It also indicates that we have obtained a high
attenuation of artifacts in the originally calculated values. It might be possible to increase the uptime
even further, e.g. by optimizing the sensor design, implementing adaptive noise cancellation from
additional recording modalities, or implementing more advanced algorithms for calculation.
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CHAPTER
EIGHT
CONCLUSION
The main purpose of this Ph.D project is to investigate the possibility of making reliable long-term
monitoring of the respiratory rate and the oxygen saturation of the blood from sternal PPG. We have
pursued this through four studies that each contributed to the overall investigation of sternal PPG.
The project started with a pre-clinical proof of principle study to acquire knowledge about sternal
PPG in terms of the RR and the SpO2 level. Afterwards, three clinical studies were designed and
conducted to increase the currently limited amount of knowledge about the clinical applicability of
sternal PPG. In the first study, we desaturated a group of healthy subjects and calculated the SpO2
level in a clinically relevant range between 100 %-70 %. In the second study, the aim was to validate
the reliability of sternal PPG in short-term recordings on COPD and asthma patients. In the third
study we focused on the clinical reliability of long-term recordings on the same group of patient
(different people) and we extended the recording to a healthy group of subjects. Giving a total
number of 82 included participants used in this research project.
For the purpose of conducting the clinical studies, two different designed PPG sensors were devel-
oped and used for the PPG recordings along with other modalities. In order to conduct the clin-
ical studies, applications were written to the Danish regional ethical community (H-6-2014-013),
the Danish Health and Medicines Authority (CIV-15-01-013029), and the Danish Data Protection
Agency. All three studies were approved and monitored by the regional good clinical practice (GCP)
unit.
The developed PPG sensor (PPG-patch) can operate in two modes; a mode where it is connected to
a data acquisition system and a wireless mode. This utilizes short and long-term recordings. In the
second mode the PPG-patch used DELTA’s ePatch R© framework to save the recorded PPG signals
along with ECG and triaxial accelerometry from the sternum. Moreover, it also uses the ePatch R©
adhesive electrode to be positioned at the sternum. Both operation modes were very useful for the
understanding of the clinical applicability of sternal PPG. However, it should be noticed that the
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signal quality is 80 % better when the electrode is not used and the PPG-patch is directly attached to
the sternum.
From the pre-clinical proof of principle study, it was shown that the respiratory component in the
power spectral content of the sternal PPG signal was 76 % and the cardiac component was 22 %.
Moreover, the respiratory and cardiac component was highly correlated with the corresponding res-
piratory fCO2 reference signal and the ECG signal, respectively. In regards to the RR no significant
difference was between the PPG signal and the respiratory fCO2 reference signal during sponta-
neous or paced breathing in the range from 6 to 27 breaths/min. Furthermore, the quality of the
PPG signal was superior in terms of the signal morphology. For example the dicrotic notch was
observable in the AC part of the signal, verifying the quality of the recorded signal. Finally, we have
demonstrated the ability of pulse wave analysis in terms of pulse rate variability, which can be used
in the assessment of cardiovascular diseases [15].
The first clinical study was a controlled desaturation study. For all the 14 subject the oxygen satura-
tion was gradually reduced within the region of clinical interest (100 % - 70 %). The results showed
that there is good agreement between the calculated SpO2 values and the measured SaO2 reference
values (n=324 blood samples). The accuracy of the sternal PPG system was found to be Arms = 1.75
%. This accuracy is acceptable according to the ISO 80601-2-61:2011 guidelines that allows Arms
values of up to 4 %. Commercially available pulse oximeters such as Masimo R25-L and NellCore
Oximax N-65 reports accuracies of 1.79% and 1.3%, respectively. This study served as a calibration
of the PPG-patch in terms of the SpO2 level.
In the second clinical study we conducted short-term PPG recordings on 30 COPD and asthma pa-
tients being in a semi-supine position. In regards to the SpO2 level the Pearson correlation between
SpO2 level measured on the finger with a conventional pulse oximeter and the SpO2 level calculated
from the sternal PPGs was found to be 0.89 (p < 0.05). Furthermore, the Blandt-Altman analysis
showed good agreement between the two methods. Taking the individual accuracy of the two sys-
tems into account, we thus consider the agreement to be excellent. This shows that PPGs recorded
on the sternum is reliable for estimation of SpO2 levels in admitted COPD and asthma patients. In
terms of the RR the sternal PPG signal and the respiratory fCO2 reference signal from a conven-
tional patient monitor system was compared. The signals were divided into one-minute segments
and a medical doctor annotated the data. The RR obtained from the patients ranged from 11 to 36
breaths/min and was highly correlated (r = 0.93, p < 0.001) with the referent signal.
In the third and last clinical study, we used the wireless version of the PPG-patch. We recorded
19 hours PPG, ECG and triaxial accelerometer signals on 15 COPD and asthma patients and on
a group of 13 healthy participants. We implemented a check to assess the reliability of long-term
sternal PPG recordings. Overall, the average percentage of reliable PPG segments from the patients
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and the healthy participants was 58%. In terms of the RR the percentage of reliable PPG segments
was 58 % and 59% for the patients and the healthy participants. More importantly, we generally
found that segments of reliable SpO2 and RR values could be extracted throughout the recording
length. The average longest period of time with unreliable data was 23.6 min in terms of the SpO2
level and 20 min in terms of the RR. In this clinical study, we have thus demonstrated the ability to
calculate clinically relevant and reliable SpO2 values in long-term sternal PPG recordings obtained
from patients suffering from obstructive lung diseases and on a group of healthy subjects. This
finding is very promising for future implementation of SpO2 and RR measures in a sternum based
vital sign patch. In the future, such a patch might assist in early detection of worsening in the
condition of these patients and thereby ensure timely treatment of the patients.
Thus, all four hypotheses of this research project have been confirmed.
8.0.1 Future Perspectives
In the future, it might be possible to design new algorithms for automatic detection of data segments
that would provide a reliable SpO2 and RR measures. This would allow for a real-time quasi-
continuous setup for long-term monitoring in chronically ill patients. Furthermore, we suggest the
following future work to improve the applicability of the sternal PPG:
1. Optimizing the sensor design in terms of good skin contact with the challenging anatomy of
the sternum. The curvature of the sternum is very challenging and needs much more attention.
2. Implementing algorithms that use the multi-modality approach. Including the ECG signal and
triaxial accelerometer signals in the algorithm is highly recommended. Moreover, adaptive
noise cancellation can be utilized by the use of the accelerometer signal. PPG recording with
other wavelengths may also be very useful for adaptive noise cancellation.
3. Electrical optimization by using recently available front-end electronics.
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APPENDIX: DATA OF STUDY III
A.1 Long-Term SpO2
The effect of the reliability during the recording is shown when using different values of the ∆SpO2
criteria. Fig. A.1a shows a box-plot of the percentage of the reliable SpO2 levels (uptime) during a
recording when the ∆SpO2 criteria is set to 3 %, 4 %, and 5 % respectively for the patient group. In
this case the accelerometer criteria is not included. Correspondingly, the RMSE values is shown in
Fig. A.1b. It is seen how the uptime increases when larger ∆SpO2 is allowed. Whereas the RMSE
value does not have a remarkable increase. However, the interquartile range decreased remarkably,
which means less variability in RMSE when higher ∆SpO2 is used. As for the group of healthy
subjects the ∆SpO2 > 2 % is added to the plots shown in Fig. A.2a and b. Clearly it is seen how
the uptime increase with larger ∆SpO2.
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Figure A.1: (a) Shows the percentage of reliable SpO2 values (uptime) of all the recordings from
the patients, when using all the conditions except the accelerometer condition. The red line cor-
responds to the median value and the dot corresponds to the mean value. (b) Shows the RMSE
between the reliable SpO2 values and the calculated reference.
Δ Δ
a)
b)
b)
Figure A.2: (a) Shows the percentage of reliable SpO2 values (uptime) of all the recordings from
the healthy participants, when using all the conditions except the accelerometer condition. (b)
Shows the RMSE between the reliable SpO2 values and the calculated reference. The red line
corresponds to the median value and the dot corresponds to the mean value.
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Sternal Pulse Rate Variability Compared with Heart Rate Variability
on Healthy Subjects
Shadi S. Chreiteh, Bo Belhage, Karsten Hoppe, Jens Branebjerg, and Erik V. Thomsen
Abstract— The heart rate variability (HRV) is a commonly
used method to quantify the sympathetic and the parasympa-
thetic modulation of the heart rate. HRV is mainly conducted
on electrocardiograms (ECG). However, the use of photo-
plethysmography (PPG) as a marker of the autonomic tone is
emerging. In this study we investigated the feasibility of deriving
pulse rate variability (PRV) using PPG signals recorded by a
reflectance PPG sensor attached to the chest bone (sternum)
and comparing it to HRV. The recordings were conducted on 9
healthy subjects being in a relaxed supine position and under
forced respiration, where the subjects were asked to breathe
following a visual scale with a rate of 27 breaths/min.
HRV parameters such as the mean intervals (meanNN), the
standard deviation of intervals (SDNN), the root mean square of
difference of successive intervals (RMSSD), and the proportion
of intervals differing more than 50 ms (pNN50) were calculated
from the R peak-to-R peak (R-R) and pulse-to-pulse (P-P)
intervals. In the frequency domain the low and high frequency
ratio of the power spectral density (LF/HF) was also computed.
The Pearson correlation coefficient showed significant correla-
tion for all the parameters (r > 0.95 with p < 0.001) and the
Bland-Altmann analysis showed close agreement between the
two methods for all the parameters during resting and forced
respiration condition. Thus, PRV analysis using sternal PPG
can be an alternative to HRV analysis on healthy subjects at
rest.
I. INTRODUCTION
The heart rate variability (HRV) obtained from elec-
trocardiographic (ECG) recordings is a commonly used
method that reflects the balance between sympathetic and
parasympathetic modulation of the heart rate [1]. HRV is
used in many clinical areas especially in the research of
diabetes, cardiovascular diseases, and stress management [1].
Predominance of sympathetic activity and reduced parasym-
pathetic cardiac control have been seen in patients with acute
myocardial infarction [2]. As a complication of diabetes
mellitus, autonomic neuropathy occurs and this often affects
the autonomic control of the heart. Pontet et al. [3] reported
that a depressed autonomic modulation may be an early
indication of deterioration of septic patients in the intensive
care unit. This finding was confirmed by Barnaby et al.
The study was supported by the Danish Business Innovation Fund, the
Danish Ministry of Science, Innovation and Higher Education.
Shadi S. Chreiteh is with the Department of Micro- and Nanotechnology,
Technical University of Denmark, 2800 Kgs. Lyngby, Denmark and also
with DELTA Microelectronics, Venlighedsvej 4, 2970 Hørsholm, Denmark
(e-mail: ssc@delta.dk).
Bo Belhage is with the Bispebjerg Hospital, University of Copenhagen,
2400 Copenhagen NV, Denmark.
Karsten Hoppe and Jens Branebjerg are with DELTA Microelectronics,
Venlighedsvej 4, 2970 Hørsholm, Denmark.
Erik V. Thomsen is with the Department of Micro- and Nanotechnology,
Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.
[4] and in addition they reported that HRV may predict
significant morbidity and mortality rates for septic patients
in the emergency department.
Currently, HRV parameters are derived by analysis of the
temporal relationship between successive heart beats (R-R
intervals) in the ECG signal. From these intervals we can
compute time and frequency domain, and nonlinear dynamics
analysis to extract features to assess the autonomic nervous
system (ANS) modulation of the heart rate [1].
A wide range of studies have investigated the use of Pho-
toplethysmography (PPG) to quantify the cardiac autonomic
tone as an alternative to ECG. PPG is a low-cost noninvasive
optical technique for monitoring beat to beat relative blood
volume changes in the microvascular bed of peripheral
tissues [5]. The PPG signal contains two components; a small
pulsatile component (AC), which corresponds to arterial
pulsations from the cardiac cycle. The AC component is
superimposed onto a large quasi-DC component that relates
to the optical character of the underlying tissue, the ambient
light, and the average blood volume. The DC component also
varies due to respiration [6]. The morphology of the PPG
signal is useful for the study of autonomic control of the
peripheral vascular tone [5]. In fact, Wong et al. [7] reported
that the PPG signal might have an additional information
in regards to cardiac autonomic tone compared to the ECG,
because the peripheral vasculature is also modulated by the
ANS. The physiological information derived from the R-R
intervals can also be derived from the pulse-to-pulse (P-P)
intervals of the PPG signal. Studies on pulse rate variability
(PRV) have been conducted on the peripheral location of
the body, mainly at the fingertip and the earlobe using a
traditional pulse oximetry probe [8]. Lu et al. [9] have shown
that PRV obtained from a finger can be used as surrogate
for HRV. However, Wong et al. [7] reported the opposite
finding and reported that it could be due to the pulse wave
modification in the arterial system. Constant and colleagues
[10] conducted a study on pulse wave recordings on the 3rd
finger of the right hand, and showed that the PRV did not
precisely reflect HRV in healthy subjects.
In the literature there is a lack of results about the influence
of sensor location, when extracting HRV parameters using
the PPG. However, Johnston et al. [11] and Schafer et al.
[12] reported that an approach to place a PPG sensor on a
more central location could be beneficial for the assessment
of the cardiac autonomic tone. To our knowledge the PRV
has not been investigated at the sternum. Thus, in this study
we examine whether the PRV at the chest bone (sternum)
can be used as a marker of the cardiac autonomic tone when
978-1-4244-7929-0/14/$26.00 ©2014 IEEE 3394
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Fig. 1. Placement of the PPG sensor on the sternum. For this controlled
experiment the sensor is positioned using adhesive tape.
comparing to traditional HRV in healthy subjects at rest and
under paced respiration.
II. METHODS & MATERIALS
A. Data acquisition
A group of 9 healthy volunteers (8 males, 1 female)
with mean age of 41.1±11.7 years and a mean Body Mass
Index of 24.7±3.2 kg/m2 were recruited for this preliminary
study. The Danish Law and the Helsinki Declaration does
not require a clinical protocol for this setup. The room
temperature was 20−22 ◦C. A novel infrared reflective PPG
prototype sensor was used to obtain the PPG signals. The
sensor was positioned on the skin over the sternum with
adhesive tape, cf. Fig 1. ECG electrodes were attached to the
subject and used to record standard lead-II ECG signals. All
analog signals were collected simultaneously and digitized
with a sampling rate of 1000 Hz (Powerlab 8/35, 16 bit ADC,
ADInstruments, USA) and stored on a laptop computer using
Lab Chart 7 Pro (Lab Chart Version 7.3.7, ADInstruments,
USA) as data acquisition software. For each subject being in
supine position 10 min recordings has been conducted under
natural respiration and under paced respiration frequency of
27 breaths/min. However, a 5 min segment of each recording
was used for HRV analysis. The analysis was computed using
MATLAB (MATLAB R2012b, The MathWorks, Inc., USA).
B. Heart rate and pulse rate analysis
Prior to the extraction of R-R and P-P intervals, the
ECG signals were bandpass filtered using a second order
Butterworth filter with cut-off frequencies of 0.05 Hz and
40 Hz. As for the PPG signals the cut-off frequencies were
0.05 Hz and 15 Hz. The QRS detection was performed using
Pan and Tompkins QRS detection algorithm [13]. The R-R
intervals were extracted from the located R peaks. As for the
PPG signals, the systolic peaks were located using a custom
made peak detection algorithm, cf. Fig. 2. The systolic peaks
were then used to produce the P-P intervals. Fig. 3, shows a
P-P and R-R interval from one of the subjects.
To compare the HRV and PRV methods, the commonly
used time and frequency domain parameters were computed
according to the standard definitions of HRV parameters [1].
As for the time domain parameters, the mean value of the
R-R and P-P intervals (mean NN), the standard deviation
of NN intervals (SDNN), the square root of the mean of
the squares of differences between successive NN intervals
(RMSSD), and the pNN50, which is the proportion of
differences of successive intervals differing more than 50 ms
was calculated. Prior to the frequency domain calculations
the R-R and P-P intervals were resampled at 4 Hz and cubic
spline interpolated [1]. From the power spectrum density
the normalized low frequency (LF) power (0.04-0.15 Hz),
the normalized high frequency (HF) power (0.15-0.4 Hz),
and the LF/HF ratio has been computed. The time domain
parameters are related mostly with the overall variability of
the heart rate. The LF components represents the sympathetic
and parasympathetic tones, while the HF components is more
related to parasympathetic modulation.
C. Statistics
The Pearson correlation coefficient was used to correlate
the calculated parameters derived from the ECG and PPG
respectively. In addition the lower and the upper limits of
agreement (LOA) and the mean system bias between the
two methods is compared using a Bland-Altman analysis.
Furthermore, the mean squared error is computed between
the values of the HRV parameters derived from the R-R and
P-P intervals.
III. RESULTS
Fig. 2 shows a 10 seconds segment of a typical recording.
The upper graph represents the PPG signal and the lower
represents the ECG signal. Fig. 3, shows a time series of
R-R and P-P intervals derived from the PPG and the ECG
respectively. For all subjects the derived parameters obtained
from PRV and HRV are represented in Table I. All the
computed parameters derived from the PRV had correlation
coefficients of > 95% (p <0.001) when compared to HRV.
The error analysis showed insignificant differences between
the parameters derived from the two methods (p <0.05). The
Bland-Altmann analysis showed close agreement between
the parameters derived from ECG and PPG. During natural
respiration the average system bias for the mean NN interval
was -0.03 ms and the lower and upper LOA was -0.561 ms
and 0.501 ms respectively, cf. Fig. 4. As for the LF/HF ratio,
the average system bias was -0.0064 ms and the lower and
upper LOA was -0.27 ms and 0.25 ms respectively as seen
in Fig. 5. Similarly, high degree of agreement was found for
the rest of the parameters under natural respiration. During
forced respiration the average system bias increased in the
same direction for all parameters. It is also seen in Table I,
that the LF/HF ratio increased from 1.045 to 2.99 for HRV
and from 1.05 to 2.76 for PRV.
IV. DISCUSSION
The results of this study clearly showed a close agreement
between the HRV parameters derived from the PPG signals
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TABLE I
THE TIME AND FREQUENCY DOMAIN PARAMETERS, CORRELATION COEFFICIENTS AND BLAND-ALTMANN ANALYSIS DERIVED FROM P-P AND R-R
INTERVALS RESPECTIVELY.
Parameters HRV PRV Bias Lower Upper Correlation Absolute
(Mean±SD) (Mean±SD) LOA LOA coefficient error
N
at
ur
al
re
sp
ir
at
io
n Time domain:
Mean NN (ms) 1011.49±133.95 1011.52±133.86 -0.03 -0.56 0.5 0.999 0.000
SDNN (ms) 63.25±34 63.43±34.58 -0.178 -2.50 2.15 0.999 0.0028
RMSSD (ms) 50.51±41.23 50.64±41.58 -0.132 -5.79 5.53 0.998 0.0026
pNN50 (%) 21.01±23.65 20.97±23.27 0.041 -5.86 5.94 0.993 0.0019
Frequency domain:
LF/HF 1.045±0.61 1.05±0.65 -0.0064 -0.27 0.25 0.98 0.006
Fo
rc
ed
re
sp
ir
at
io
n Time domain:
Mean NN (ms) 953.34±111.86 953.48±112 -0.13 -1.35 1.07 0.999 0.000
SDNN (ms) 51.68±23.6 54.74±23 -3.07 -9.09 2.96 0.992 0.056
RMSSD (ms) 45.12±32.8 53.78±35.68 -8.65 -23.2 5.89 0.98 0.16
pNN50 (%) 22.5±21.7 29.45±24.62 -6.93 8.83 -22.69 0.95 0.24
Frequency domain:
LF/HF 2.99±1.86 2.76±1.68 0.23 -0.89 1.35 0.95 0.08
N
o
rm
al
iz
ed
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ag
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Fig. 2. A characteristic block of signals: (a) The sternal PPG signal. Note
the signal waveform is inverted, upside deflection represents the systole. (b)
the ECG signal. The circular markers corresponds to the detected peaks.
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Fig. 3. Comparison of the (a) P-P interval derived from the sternal PPG
signal and (b) R-R interval derived from the ECG signal.
and the ECG signals on a healthy group of subjects at rest
and under forced respiration. Although, the average system
bias increased between the parameters derived from PRV and
HRV, the absolute values changed in the same direction as
Mean NN interval (ms)
M
ea
n
 R
R
 -
 M
ea
n
 P
P
(m
s)
0
-0.4
700 800 900 1000 1100 1200
-0.2
0.2
0.6
0.4
-0.6 -1.96 SD
Mean
+1.96 SD
-0.8
0.8
Fig. 4. Bland-Altman plot of the Mean NN derived from the sternal PPG
signal and the Mean NN derived from the ECG signal. The majority of
points are close to zero and within the 95% confidence interval showing a
close agreement between the two methods.
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Fig. 5. Bland-Altman plot of the LF/HF ratio derived from the sternal PPG
signal and the LF/HF ratio derived from the ECG signal. The majority of
points are close to zero and within the 95% confidence interval showing a
close agreement between the two methods.
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seen in Table I. The LF/HF ratio derived from PRV increased
during forced respiration, confirming that the change in the
autonomic tone was also reflected in the PRV as it did in
the HRV. The sternal PPG sensor is reliable for recording a
PPG signal from, which HRV parameters can be derived, at
least in healthy subjects at rest. The morphology of the PPG
signal acquired at the sternum has also a clear systolic, end-
diastolic and diacrotic notch as seen in Fig. 2. This might be
useful for different types of pulse wave analysis since other
clinically relevant features may be extracted. As explained
in the introduction, recent studies have reported that the use
of PPG recordings might be a more convenient method for
the measurement of HRV in clinical environments and for
ambulatory recordings than ECG. However, there has been
a difference in the accuracy between the PRV derived from
finger PPG and HRV both at rest and during physical and
mental tasks [12]. Furthermore, there is a clear uncertainty
regarding the measuring site [12].
We suggest that the reason behind the close agreement of
both methods in our study is the proximal measuring site
relative to the heart. This is in agreement with Johnson and
Mendelson [11], who reported similar correlations between
heart rate intervals derived from ECG and reflective forehead
PPG. Our findings are also in agreement with [14], who
reported high accuracy between the two methods when
measuring on the earlobe. Although, the PPG also reflects the
cardiac rhythm, the pulse wave and the heart rate are different
by nature. The ECG signals are electrical signals originating
from the SA node, while the pulse waves are mechanical
signals mainly measured in the periphery. The blood vessels
can be considered as transmission lines rather than a (rigid)
pipe system. So when the pulse waves propagate from the
heart to the periphery it undergoes significant changes in the
arterial system due to for example the ANS modulation on
the blood vessels and the viscosity of the blood. These factors
will impact the pulse waveform, resulting in difference
between the HRV and PRV. We expect that most of these
factors are minimal when measuring at the sternum because
of the relative location to the heart. However, it is worth to
notice the change in the average system bias and limits of
agreements when the subjects were asked to breathe with a
rate of 27 breath/min.
It is known that motion artifacts impact PPG signals [5].
Therefore, future perspectives are to examine the correla-
tion between the HRV and the PRV parameters in more
demanding conditions like; during different body motion; in
different postural positions and in long-term recordings. This
can be useful in sleep studies. Additionally, elderly people
who suffer from cardiovascular diseases might also be an
interesting group to examine the similarities between the two
approaches.
The concept of PPG and pulse oximetry at the sternum
is has been demonstrated recently by [15]. Our findings
showed that the parasympathetic and sympathetic autonomic
modulation of the heart rate can be measured from PRV
analysis using sternal PPG on a healthy group of subjects
at rest. Thus, being able to monitor these physiological
parameters using a low-cost sternal PPG sensor will simplify
many aspects of monitoring systems.
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Estimation of Respiratory Rates based on Photoplethysmographic
Measurements at the Sternum
Shadi S. Chreiteh, Bo Belhage, Karsten Hoppe, Jens Branebjerg, Rasmus Haahr, Sune Duun and Erik V. Thomsen
Abstract— The respiratory rate (RR) is a clinically important
vital sign and is a frequently used parameter in the general
hospital wards. In current clinical practice, the monitoring
of the RR is by manual count of the chest movement for
one minute. This paper addresses a new approach where
the respiratory rate is extracted using photoplethysmography
(PPG) on the chest bone (sternum).
Sternal PPG signals were acquired from 10 healthy subjects
resting in a supine position. As reference signals, finger PPG,
electrocardiogram (ECG), and capnography were simultane-
ously recorded during spontaneous and paced breathing. The
sternal PPG signals were then compared with the reference
signals in terms of Bland-Altman analysis, the power spectrum
analysis and the magnitude squared coherence.
The Bland-Altman analysis showed an average bias of 0.21
breaths/min between RR extracted from sternal PPG and
capnography. The respiratory power content at the sternum was
78.8 (38)% in terms of the median and (the interquartile range).
The cardiac content was 19 (18.4) % within the cardiac region.
The results from the magnitude squared coherence analysis was
0.97 (0.09) in the respiratory region (6 to 27 breaths/min) and
0.98 (0.01) in the cardiac pulse region (30-120 beats/min).
This preliminary study demonstrates the possibility of moni-
toring the RR from sternal PPG on a healthy group of subjects
during rest.
I. INTRODUCTION
The respiratory rate (RR) is known to be an early indicator
of disease. A change in RR is one of the earliest and
most important indicators of clinical complications such as
hypercarpnia, hypoxia and chronic obstructive pulmonary
disease. Besides being a valuable early warning indicator,
changes in RR may often precede changes in other monitored
vital signs such as heart rate (HR) or reduction in peripheral
oxygen saturation (SPO2) [1]. In current clinical practice,
the standard technique for monitoring the RR (particularly
outside the emergency units) is by manual count through
observation of the rib cage for one minute. This method
requires direct observation and may influence the patient’s
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respiration rhythm. Furthermore, the observer can have diffi-
culties in the detection of distinct breaths [2]. Current auto-
matic RR measurement requires either an airflow detection
method such as nasal air flow monitoring, end tidal fCO2
volume (ETCO2) using a capnograph, or a measurement
of movement, e.g. trans-thoracic impedance or inductance
plethysmography. These methods are obtrusive and time
consuming to setup for a general ward patient usage. Other
techniques have been proposed for RR monitoring, including
acoustic measurement of respiratory sound and extraction of
RR from photoplethysmography (PPG) [3].
Monitoring of the RR from PPG has previously been
studied through analysis of peripheral PPG. Leonard et al.
[4] and Clifton et al. [5] have described the derivation of
RR from finger PPG. Shelley et al. [6] have found that the
respiratory component is significantly larger in the regions of
the head (the ear and forehead) compared to the component
derived from the finger. This indicates that the measuring
site has a significant importance for the magnitude of the
respiratory component in the PPG signal. Furthermore, it
may also indicate that the smaller the distance to the chest,
the less attenuation of the respiratory component by the
vasculature. This is supported by Nilsson et al. [7] who
found that the respiratory and cardiac induced variations in
the PPG were different at different measuring sites (finger,
forearm, wrist, forehead, and shoulder). The application
of pulse oximetry using PPG at the sternum has recently
been demonstrated [8]. However, the extraction of the RR
from sternal PPG has not been investigated. It is therefore
interesting to investigate whether the combined monitoring
of pulse oximetry and respiratory rate at the sternum may be
a clinically useful approach.
The sternal body location is expected to be robust for
acquiring PPG signals, because of the central body location.
Additionally, PPG signals from the sternum might have a
different composition with a stronger respiratory component
than peripherally sampled signals, due to local pressure
variations. During inhaling/exhaling the pressure variations
in the thoracic cavity change and affect the blood volume
in the internal thoracic arteries and the anterior perforating
branches of intercostal vessels. Hence, we hypothesize that
RR estimated from sternal PPGs are equal to RR estimated
from capnography. The aim of this study is therefore to
examine whether the sternal PPG produces a reliable estimate
of the RR compared to gold standard capnography.
Sternal
PPG sensor
Nasal
catheter
ECG electrodes
Finger
PPG sensor
Fig. 1. Schematic overview of the measurement setup. For each subject,
the sternal PPG sensor, lead-II ECG, finger PPG, and nasal (fCO2) were
acquired simultaneously. The test subject is positioned in a supine position
during the experiment.
II. METHODS & MATERIALS
A. Data acquisition
A group of 10 healthy volunteers (9 males, 1 female)
with mean age of 39.2±12.6 years and a mean Body Mass
Index of 24.5±3.2 kg/m2 were recruited for this preliminary
study. The Danish Law and the Helsinki Declaration does
not require a clinical protocol for this setup. The room
temperature was 20 − 22 ◦C. A custom build infrared light
(940 nm) reflective PPG sensor was positioned on the
skin over the sternum. A transmission PPG was obtained
using a standard finger probe (Datex-Ohmeda AS/3, GE
Healthcare, USA) and lead-II electrocardiogram (ECG) was
also acquired and used as a cardiac reference signal. As a
reference signal to the RR derived from sternal PPG, the
inspiratory and expiratory fraction of carbon dioxide (fCO2)
was acquired via a nasal catheter. The reference signals
and the sternal PPG signal were collected simultaneously
and digitized with a sampling rate of 1000 Hz (Powerlab
8/35, 16 bit ADC, ADInstruments, USA) and stored on a
laptop computer using Lab Chart 7 Pro (Lab Chart Version
7.3.7, ADInstruments, USA) data acquisition software. Fig.
1 outlines the experimental setup. For each subject being in
a supine position data were collected in two stages:
1) Spontaneous respiration: The subjects were instructed
to relax and breathe with natural respiratory rate for
10 min.
2) Paced respiration: The subjects were instructed to
breathe in time with a visual scale. The pace was set
to 6, 17, 24, 12, and 27 breaths/min for 3 min. each.
The subjects were instructed not to make any unnecessarily
body movements to avoid motion artifacts.
B. Data analysis
In order to quantify the respiratory and cardiac contents of
the sternal PPG and compare them with the reference signals
we used three methods: (1) Power spectrum analysis, (2)
Magnitude squared coherence analysis, and (3) time-domain
RR estimation. All three methods have been applied on data
acquired during the first stage of the experiments. However,
only the last method has been used for the second stage of
the experiment. The analysis of the acquired signals was con-
ducted using MATLAB (MatLab R2012b, The MathWorks,
Inc., USA).
1) Power spectrum analysis: The power spectral density
(PSD via Welch’s averaged, modified periodogram- method,
50% overlap, 160-s Hamming window) for the sternal PPG
signal was calculated and the power (%) within the range of
0.1 to 0.45 Hz (6 to 27 breaths/min) was used as a measure
of the respiratory component. The same procedure was used
to estimate the cardiac content within the range of 0.5 to
2 Hz (30 to 120 beats/min) for the sternal PPG. The same
PSD for the reference signals has also been calculated for
comparison. 8 minutes recording periods were used in the
analysis.
2) Mangitude squared coherence analysis: The similarity
between the fCO2 reference signal and the sternal PPG
signal as well as between the ECG reference signal and the
sternal PPG signal is calculated using the magnitude squared
coherence analysis [7]. The magnitude squared coherence
Cxy(f) is given by (1)
Cxy(f) =
|Pxy(f)|2
Px(f)Py(f)
. (1)
The result is a normalized measure between 0 and 1 of
the correlation between the frequency content of two signals
x and y at the frequency f , where Pxy(f) is the cross-
spectral density between x and y, and Px(f) and Py(f) are
the power spectra densities of x and y respectively. Cxy(f)
was calculated at the frequency of the reference respiratory
rate and heart rate, respectively.
3) Extraction of the sternal PPG respiratory rate: The
sternal PPG signal was filtered using a zero-phase 3rd order
Butterworth band-pass filter with cut-off frequencies at 0.1-
0.5 Hz (6 to 30 breaths/min) [9]. These cut-off values are
chosen to suppress the cardiac-related variations and the
frequencies below the respiratory frequency in the PPG
signals. After the filtering process MATLAB’s peak detection
algorithm has been applied. The same procedure was applied
to the capnographic reference fCO2 signal. The RR was
estimated using 1-min, non-overlapping segments.
III. RESULTS
A typical example of a 1 min recording is shown in Fig.
2. It is clearly seen that spike like pulses is appearing in the
PPG signals and the variations are beat-by-beat synchronous
with the heartbeats in the ECG signal and the finger PPG
signal. At the same time the respiratory variations in the
sternal PPG signal can be identified clearly breath-by-breath,
corresponding to the respiration reference fCO2 signal.
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Fig. 2. Example of the acquired signals: a) PPG signal acquired from
the sternal PPG sensor. It is observed that the PPG signals include a high
frequency and a low frequency component, due to the cardiac and the
respiratory cycle, respectively. b) Nasal fCO2 signal, c) finger PPG signal,
and d) ECG signal.
During spontaneous respiration the median and (interquartile
range) of RR was estimated to 10.99 (3.68) breaths/min
and 11.41 (3.32) breaths/min from sternal PPG and the
reference signal respectively. The overall difference between
RR estimated from sternal PPG and the reference fCO2
signal during spontaneous respiration is summarized in a
Bland-Altman plot, Fig. 3. The average system bias is 0.21
breaths/min between the measurement methods. Fig. 4 shows
a typical result of the power spectral analysis for all three
acquired signals. The figure shows that the sternal PPG signal
contains both a respiratory and a cardiac component. The
power spectral content of the respiratory variations in the
sternal PPG is larger than the power spectral content of the
cardiac variations. The median and (interquartile range) of
the respiratory spectral power at the sternum is 78.8 (38) %,
while the pulse spectral power is 19 (18.4) %. The respiration
coherence is 0.97 (0.09) and the pulse coherence is 0.98
(0.01). The results for the paced respirations are summarized
in Table I. RRs derived from sternal PPG are significantly
correlated with reference RRs.
IV. DISCUSSION
The key findings of this preliminary study are that ster-
nal PPG shows very strong coherence with the respiratory
fCO2 reference signal and the ECG signal, respectively.
Furthermore, the power spectral analysis showed that the
sternal PPG contains larger power spectral content of the
respiratory variations than the cardiac variations. From the
sternal PPG signal we were able to extract the RR with
high accuracy, confirming the hypothesis of the study. The
respiratory rates were derived within a mean absolute error
of 0.04 breaths/min during spontaneous respiration. This is
a key result, which illustrates that the RR can be derived
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Fig. 3. Bland-Altman plot of RR derived from the sternal PPG signal
and the reference signal during spontaneous respiration. The dashed lines
represent the 95% confidence interval (lines of agreement). For each one-
min segment RR is calculated for each subject (n=80).
TABLE I
SUMMARY OF THE RESPIRATORY RATES DURING PACED RESPIRATION.
THE RESULTS ARE EXPRESSED IN MEDIAN (INTERQUARTILE RANGE).
Visual scale fCO2 Sternal PPG
RR RR RR
(breaths/min) (breaths/min) (breaths/min)
6 6.10 (0.14) 6.03 (0.15)
12 12 (0.14) 11.95 (0.12)
17 17.01 (0.55) 16.97 (0.12)
24 23.99 (0.15) 23.86 (0.24)
27 26.98 (0.01) 26.98 (0.13)
Correlation Coefficient 0.99
at the sternum with high accuracy within a clinical relevant
range (6-27 breaths/min). Additionally, the results showed
a high correlation (99%) between the capnography derived
RR and the PPG derived RR under both spontaneous res-
piration and paced respiration. The power spectral density
and magnitude squared coherence analysis are widely used
in the literature in order to quantify the respiratory content
in the PPG signal. In this study we used similar approach as
reported by L. Nilsson et al. (2007). These authors reported
that the best site for measuring the respiratory rate is at
the forearm. However, they did not investigate the PPG
at the sternum. In this preliminary study the sternal PPG
had a relatively larger respiratory component and a relative
smaller cardiac component when compared to the peripheral
PPG. Although, the respiratory component dominates the
sternal PPG signal, the pulse spectral power is 19 % of
the total spectral power. Furthermore, the magnitude squared
coherence analysis showed a strong similarity (0.98) between
the sternal PPG signal and the ECG reference signal.
The vascular properties of the skin differ between various
locations on the body. The tissue at the sternum is less
perfused when compared with the peripheral locations such
as the fingertip [8]. Nevertheless, acquiring the RR from
a) ECG b)  COf
2
c) Sternal PPG
Fig. 4. Power spectrum analysis of one of the recordings. a) The ECG signal, b) The respiratory reference signal, and c) The sternal PPG signal. Notice
that the respiratory component is also seen in the ECG signal.
sternal PPG has several advantages that make the sternum
an appropriate sensor position. First of all, a probe placed at
the sternum is less obtrusive than earlobe or finger probes.
Secondly, the sternum can be used to monitor other clinically
relevant parameter such as pulse wave variability [10] and
pulse oximetry [11]. Respiratory pressure variations in the
thoracic cavity affects the blood volume on the venous side
and on the arterial side. We propose that the center location at
the sternum and the anatomical structure of the thoracic cage
is the main contributor to a pronounced respiratory effect.
The perforating veins and arteries that surround the chest
bone affect the PPG signal at the sternum.
In addition to this mechanism we propose that the mechan-
ical tension over the sternum during inhalation/exhalation
causes the skin to stretch. This affects the underlying vas-
culature of the skin and due to the thin wall of the veins,
this mechanical effect is believed to be more prominent in
the veins than in the arteries and therefore contributes to the
respiratory component in the sternal PPG signal.
Pulse oximetry has recently been investigated by measur-
ing the PPG at the sternum [11]. It is reported that even
though the blood perfusion is low at the sternum the pulse
oximetry is still possible. Pulse oximetry is currently used
to detect hypoxemia and is used in many clinical settings as
in emergency care, during patient transportation within the
hospitals, etc. However, it does not detect hypo- or hyper-
capnoea which often precedes hypoxaemia [12]. Therefore
monitoring the arterial oxygen saturation, the heart rate in
combination with the respiratory rate at a single measuring
site using the same sensor could prove to be clinically useful.
V. CONCLUSION
This preliminary study showed that the sternum is
superior in regarding the estimation of the RR from PPG on
healthy subjects. Future experiments will be conducted on
patients with chronic obstructive pulmonary disease (COPD)
or asthma. These patients have different respiration patterns
and lower oxygen saturation in the blood. Additionally, how
well the RR can be extracted in more demanding conditions
like; during motion; in different body positions and in
long-term recordings will also be examined.
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Abstract 
Background: The respiratory rate (RR) is known to be an early indicator of exacerbations of 
Chronic Obstructive Pulmonary Disease (COPD). Currently, RR is most often monitored manually 
by the hospital staff and continuous evaluation of RR is seldom performed.  RR is a central vital 
sign and pivotal for catching early sign of severe decline in health. Accordingly, a growing interest 
in alternative, continuous techniques for estimating RR have been shown.  
Purpose:  The aim of this study was to assess the use of sternal PPG (photoplethysmography)for 
estimating the RR on patients with pathologic RR patterns such as COPD or asthma.  
Methods:  Sternal Photoplethysmography recording conducted from 30 patients suffering from 
obstructive airway disease, either COPD or severe asthma. The recording duration was between 10 
to 60 minutes. The patients were monitored through a nasal catheter obtaining the FCO2 
(capnography), from which the RR could be estimated. A custom build infrared PPG sensor was 
positioned on sternum. All the recording were divided into one minute segments (1250 segments) 
and annotated by a medical doctor.  
Results: The RR obtained from the patients ranged from 11 to 36 brpm (breaths per minute). The 
mean rate was 20 brpm with a standard deviation of 5 brpm. Pearson’s correlation coefficient 
between the two techniques showed a significant correlation (r = 0.93, p<0.001). The Blandt-
Altmann analysis showed an excellent agreement between the two measuring techniques giving a 
mean system bias of 0.6 brpm and the 95% limits of agreement to be -2.8 to 4 brpm. 
Conclusion: The results showed excellent agreement with capnography and may therefore be a 
future technique for RR estimation. Moreover, this may provide a useful clinical relevant 
improvement over manual or capnography estimated RR.   
Key words: COPD; asthma; photoplethysmography; respiration rate; sternum 
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Introduction 
Respiratory rate (RR) is a clinically important vital sign and is known to be an early 
indicator for detecting exacerbations and changes in the severity of Chronic Obstructive Pulmonary 
Disease (COPD) (1). According to the World Health Organization, COPD is currently the third 
leading cause of death globally. Exacerbation of COPD is not only one of the major causes of 
morbidity and mortality, but it also place a high economic burden on the healthcare system (2). In a 
small country like Denmark with around 6 million citizens, it is estimated that approximately 
23,000 acute COPD-related patients are admitted to the hospital every year and the readmission rate 
is as high as 24% (3). The mortality rate during admission is furthermore 8 %, which is in line with 
the mortality in acute myocardial infarction (2).  
It is generally recognized that one of the most important early warning signs 
indicating an exacerbation of COPD is a change in the respiration pattern of the patient. This 
change is among others characterized by an increased RR (1). In spite of this, recent studies have 
found that the RR, in particular, is often not recorded even in cases where the patient’s primary 
problem is a respiratory challenge (4). The lack of consistent routine RR monitoring may be a 
consequence of shortcomings in today’s measuring techniques. In current clinical practice, the 
standard method for monitoring the RR is by intermittent manual count of chest movement in one 
minute or by using the automatic capnography. The manual count is very time consuming and may 
even induce uncertainties by influencing the patient’s breathing rhythm. The capnography method 
is obtrusive and requires either a nasal CO2 detector or a face mask, both of which can be 
uncomfortable for the patient (5). Hence, the methods are therefore not ideal in the clinical setting. 
Other monitoring methods have been proposed. These methods include, among others, 
electrocardiography (ECG) derived respiration (6,7) and estimation of the RR from standard-pulse 
oximeters using photoplethysmography (PPG) (8–12) or chest impedance (5). Today, PPG is 
primarily performed peripherally and the most common measuring sites are the fingertip, earlobe, 
or the forehead (13). However, a number of other sites have also been investigated, e.g. the sternum 
(14) or the shoulder (15).  
The PPG signal is generated when the light is modulated by blood volume changes in 
the vessels. It is known that the respiration modulates the baseline ("DC") component of the PPG 
signal (16). This is illustrated in Figure 1. The respiratory induced variations in the intrathoracic 
pressure are transferred to the central veins in the circulation system. During inspiration, the chest 
wall expands and the intrathoracic pressure decreases and causes a decrease in the central venous 
pressure. This results in an increase in the venous return. This is observed as an increase in the 
 4 
baseline of the PPG signal (see Figure 1). During expiration the opposite occurs and the venous 
return will decrease. This is observed as a decrease in the PPG signal. Superposed on the DC 
component, there is a small intensity variation termed the AC component. This corresponds to 
blood volume changes due to the cardiac pulse. 
The application of PPG has previously been studied and is well documented (17–20). 
Some of the advantages include that the PPG derived RR can be used regardless of age, gender, 
anesthesia, and mode of ventilation (21, 22). However, as mentioned, the measuring sites have 
previously been confined to the extremities. It seems that the measuring site has a significant effect 
on the respiratory component of the PPG signal and it is interesting to further investigate the RR 
derived from PPG measured at the sternum. Recently, we have shown in a preliminary study that 
sternal measurements are advantageous for RR estimation (14). The PPG signals differ from the 
peripherally obtained PPG signals by showing extremely clear respiratory oscillations in healthy 
subjects. Therefore, the aim of this study is to assess the RR from a clinical relevant patient group 
with pathologic RR patterns using sternal PPG. 
 
Methods 
 
Study population 
The clinical study took place at two different departments; the department of pulmonary medicine 
and the medical admissions ward on Bispebjerg Hospital, Copenhagen University Hospital, 
Copenhagen, Denmark. The data was collected from 30 patients with obstructive airway disease, 
either COPD or asthma. One of the COPD patients was excluded due to missing data in the 
recording. The study was approved by the Danish regional ethical community (H-6-2014-013), the 
Danish Health and Medicines Authority (CIV-15-01-013029), and was monitored by the regional 
good clinical practice (GCP) unit. The patients provided written informed consent for study 
participation. The inclusion criteria required that the patients were diagnosed with COPD or asthma 
and were admitted to the hospital due to an exacerbation of their condition for at least 24 hours prior 
to their inclusion in the study. The patient demographics are listed in Table 1.  
Study materials and procedure 
The patients were monitored using a Datex-Ohmeda AS/3 Compact Patient Monitor, recording the 
fraction of carbon dioxide (FCO2) via nasal catheter, from which the RR can be calculated. A 
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custom build infrared PPG sensor was positioned on the skin over the sternum using adhesive tape. 
Both signals were collected simultaneously and digitized with a sampling rate of 1000 Hz 
(Powerlab 8/35, 16 bit ADC, ADInstruments, USA) and stored on a laptop computer using Lab 
Chart 8 Pro (Lab Chart Version 8.0.8, ADInstruments, USA) as data acquisition software. During 
the experiment the patients were at rest in a semi-supine position and, since it is known that motion 
artefacts impact the PPG signals negatively, the patients were instructed not to make any 
unnecessarily body movements during the measurements (23). However, physiological artifacts, 
e.g. coughing, are unavoidable. The recording duration was intended to be between 10 and 60 
minutes. However, the maximum recording length was 54 minutes, cf. Table 1.  
 
Data analysis 
The sternal PPG signal and the reference signal from the capnograph were filtered to suppress the 
cardiac related AC component and increase the respiratory related DC component (using a zero-
phase 3rd order Butterworth band-pass filter with cut-off frequencies at 0.1-0.7 Hz which 
corresponds to accentuation of the part of the signal that represents 6 - 42 brpm). After the filtering, 
both the sternal PPG and the capnographic signal were divided into one-minute non-overlapping 
segments. This yields a total of 1250 segments (half from the PPG and half from the capnographic 
signals). The 1250 segments were randomized and a medical doctor was asked to visually go 
through all 1250 segments and manually detect the RR in each one-minute segment. After the 
manual detection of the RR in each segment, the segments were paired to allow a direct comparison 
of the RRs obtained with simultaneous measurements from the two recording systems. The 
statistical package for social sciences (SPSS) ver. 23 was used to analyze the data. The Bland-
Altman assessment for agreement was used to compare the RRs estimated from the two methods. 
The 95 % limits of agreement were defined as mean bias ± 1.96 x standard deviation (SD) of the 
differences. The correlation between the two measurement techniques was calculated using 
Pearson’s correlation coefficient. A p-value less than 0.05 was considered statistically significant.  
 6 
Results 
 
Figure 2 illustrates three filtered segments from sternal PPG (black) and the corresponding flow 
signal from capnography (blue) at different RRs. The distribution of all the RRs derived from the 
capnographic signals and the sternal PPG signals is shown in figure 3. The RRs are ranged from 
11.3 to 35.5 brpm. The mean rate was 20.4 brpm with a standard deviation of 4.7 brpm. Figure 4 
contains the distribution of the differences between the sternal PPG derived RRs and the RRs 
derived from simultaneous measurements obtained with the capnographic signals. The mean bias 
between the rates was 0.6 brpm with a standard deviation of 1.7 brpm. The accuracy of the 
measurement defined as the root mean squared (Arms) difference between measured values of 
sternal PPG and the reference values from capnography was 1.9 brpm. This parameter is often used 
by manufactures in terms of accuracy and is often used as a key performance parameter when 
evaluating pulse oximetry (24).  A more detailed view of the differences is further provided in 
Figure 5. The figure contains a Bland-Altman plot of the data. The Bland-Altman analysis 
demonstrated a mean system bias of 0.6 brpm and the 95% limits of agreement to be -2.8 to 4 brpm. 
Additionally, Pearson’s correlation coefficient between the two techniques showed a significant 
correlation (r = 0.93, p<0.001). 
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Discussion 
 
The purpose of this study was to examine whether the RRs derived from sternal PPGs can be used 
for reliable monitoring of patients with obstructive airway disease like COPD or asthma. Besides 
the importance of monitoring the RR on these patients, it was also important to evaluate how well 
sternal PPG derived respiration rate could be correctly identified in a clinical setting over a broad 
range of RRs. 
The RR for a healthy adult at rest is between 9-16 brpm. Also it is known that COPD 
and asthma patients have higher RRs (1). This is reflected in the distribution plots provided in 
figure 3. Additionally, it is reflected in the figure that there are two main epochs in the distributions, 
one around 16 brpm and one around 24 brpm. By further inspection of the recorded data it was clear 
that the reason behind the two epochs is because the fact that the study took place at two different 
hospital wards having the majority of the patients with higher RR at the department of pulmonary 
medicine. One of the inclusion criteria of this study was that patients should be hospitalized for at 
least 24 hours prior to the measurement and when COPD or asthma patients are admitted to the 
medical admissions ward, they receive the needed treatment and some will be dismissed while other 
may need more medical attention. This means that we may have monitored a more stable group of 
COPD and asthma patients at the medical admissions ward than the patients at the pulmonary 
medicine. Usually when patients require more medical treatment they will be transferred to the 
pulmonary medicine ward. The majority of the segments (90%) with RRs above 28 brpm belong to 
the asthma patients. In conclusion, the patient population in this study seem to provide a realistic 
clinical basis for investigating the performance of sternal PPG obtained RRs. 
The standard procedure of measuring the respiration rate at the pulmonary ward and 
the medical admission ward at Bispebjerg Hospital in Denmark is by physical assessment either by 
direct observation of the chest movement or via breath sounds with a stethoscope. This procedure is 
done at least once a day. However, in some rare cases the traditional capnography is used for 
continuous monitoring of the patients. In this study we compared RRs derived from the sternum 
with capnography measurements. Excellent agreement was found between the two measurement 
methods. The documented accuracy of the used capnograph (Datex Ohmeda AS/3 Compact Patient 
Monitor) is ± 5 brpm and the result from the Blandt-Altmann analysis showed that the upper 95% 
limits of agreement was 4 brpm and the lower limit was -2.8 brpm. This finding is considered to be 
clinical acceptable and within the accuracy range of the used “gold standard” method. Furthermore, 
the standard deviation of differences and the root mean square of the differences (Arms) are 1.7 brpm 
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and 1.9, respectively, which indicates a very precise estimate by sternal PPG derived RR. These 
numbers can be compared to the performance of manual respiration counting as described in (25). 
Lim et al. (25) found that the repeatability coefficient for respiration rate monitoring made 
consecutively by the same observer is only 4.9 brpm and a repeatability coefficient as low as 5.7 
brpm for respiration rate monitored consecutively by a different observer, and finally a repeatability 
coefficient of 4.2 brpm when simultaneous observers were investigated. Based on this reporting and 
compared to the results of this study we can say that the respiration rate monitoring using PPG at 
the sternum is well within the currently clinically accepted tolerance. Importantly, the distribution 
of the differences seems to follow a normal distribution with a small bias as seen on figure 4. 
One of the limitations of this study is that the recording length for each patient is not 
equal. This means that one recording potentially may bias the results in a negative or positive 
direction. Furthermore, the different stages of COPD could be very useful to know in a future study 
as some patients contributed to a normal range of the RR and others to higher rates. If patients were 
screened using for example spirometry it would be possible to divide the COPD patients into 
subgroups during the analysis. The strength of this study is that the data covered a broad range of 
RR in a normal clinical setting on a relevant group of patients. The small group of severe asthma 
patients contributed to the high values of the respiration rates. This was very useful in our study. To 
our knowledge, no study has previously reported results regarding the possibility of deriving the RR 
from sternal PPG on COPD and asthma patients.  
Respiratory dependent oscillations are also seen in PPG signals from more peripheral 
located detectors, in example the finger and forearm as shown by Nilsson et al. (26). However, the 
authors reported that the strength of the respiration component in the PPG signal depended on the 
measuring site. The authors reported that the largest respiratory induced variations seem to be more 
prominent proximal to the chest (the largest component was found on the forearm). Furthermore, 
the largest respiratory induced variations in the PPG signal are evident at low respiratory rates and 
high tidal volumes. This is not completely in line with the results of this study: As seen in the 
Bland-Altman analysis there was excellent agreement in the whole range of respiration rates from 
11 to 35 brpm. We propose that the central location at the sternum and the anatomical structure of 
the thoracic cavity is the main contributor to this pronounced respiratory effect. Additionally, the 
respiratory variations affect both the blood volume in the venous side and on the arterial side, hence 
the pronounced respiratory component in the sternal PPG signal. 
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Sternum has recently been introduced as a novel measuring site for vital sign 
monitoring. Preliminary results from an hypoxia study conducted by Sola et al. (27) has 
demonstrated that even pulse oximetry measurement at the sternum is possible on a healthy group 
of subjects. Being able to measure the RR in combination with oxygen saturation level in the blood 
and the heart rate on a single measurement site using a small probe might lead to increased patient 
safety in terms of detecting earlier indication of developing respiratory exacerbations. The 
importance of continuous monitoring of the respiration rate in COPD patients has recently been 
reported by Yanez et al. (1).The authors found RR increases significantly few days before patients 
require hospital admission because of exacerbated COPD, this was the case for 70% of COPD 
patients (n=89). Interestingly, similar result was reported by Seemungal et al. (28), where COPD 
patients (n=101) reported an increased shortness of breathing during the days before formal 
diagnoses of exacerbated COPD is established. Early detection of worsening in the patient condition 
using sternal PPG may therefore possess the opportunity to increase early interventions.  
 
Conclusion 
 
In this clinical study we have demonstrated that the RR can be estimated from an unobtrusive 
sternal PPG probe placed on COPD and asthma patients. The results showed excellent agreement 
with capnography and may therefore be a future technique for respiration rate estimation. 
Moreover, this may provide a useful clinical relevant improvement over manual or capnography 
estimated respiratory rates.    
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Table 1. Patient demographics.   
 
 All COPD Asthma 
Gender (male/female) 11/18 9/15 1/4 
Age (mean±SD
a
), years 64.3±14.4 64.4±14.2 62.4±15 
BMI (mean±SD), m*Kg^-2 25.8±8.8 25.8±8.7 25.7±9.1 
Recording length, min
b
 21.5 (10 – 54) 21 (10 – 54) 24.2 (13 – 32) 
a Standard deviation 
b Duration lengths are presented as mean (minimum – maximum) 
 
 
Fig. 1. Sternal PPG segment showing the two PPG components. The AC component reflects the 
cardiac pulses. The DC component reflects the respiratory induced variations which 
modulate the baseline of the PPG signal. The grey area shows one respiration cycle including 
an inhalation and an exhalation.  
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Fig. 2. Filtered respiration signals from sternal PPG (solid) and the reference flow signal from 
capnography (dashed) respectively. These segments are six of the 1250 segments that the 
medical doctor annotated. 
 
 
 
                  (a)    (b) 
 
Fig 3. Distribution of all the RR of the patients included in this study. (a) The RR are calculated 
from the capnographic signal (b) and derived from sternal PPG. 
 
 
 
Fig 4. The distribution of all the differences between the sternal PPG derived respiratory rates and 
the respiratory rates estimated from the capnographic signal.  The solid curve shows a normal 
distribution curve of the differences. 
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Fig. 5. The Blandt-Altman plot of the data. The dashed lines are the lines of agreement 
(mean±1.96SD) and the solid line is the mean bias. The three square markers represent the mean 
and differences for signals shown in figure 2. 
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 
Abstract— Traditionally, measurements of the oxygen 
saturation (SpO2) has been confound to the extremities. In this 
study, we therefore investigated the possibility for reliable 
estimation of clinically relevant SpO2 levels from 
photoplethysmography (PPG) obtained on the sternum of 
patients with obstructive airway diseases. We initiated the 
study with a calibration of a prototype sternal PPG sensor. In 
accordance with the ISO 80601-2-61:2011 guidelines, the 
calibration was conducted as a controlled desaturation study. 
We obtained a calibration accuracy of 1.75% which is well 
within the clinically and commercially accepted range. We then 
compared the SpO2 levels simultaneously obtained from the 
sternal PPGs and a commercially available finger pulse 
oximeter on 28 admitted patients with either asthma or 
Chronic Obstructive Pulmonary Disease (COPD). The Pearson 
correlation between the SpO2 levels estimated from the two 
body locations was found to be 0.89 (p<0.05) and the mean 
system bias was only 0.052% with upper and lower limits of 
agreement of 2.5% and -2.4%, respectively. This finding is very 
promising for the future design of new sternum based patch 
technologies that might be able to provide continuous estimates 
of the SpO2 levels on critically or chronically ill patients.   
I. INTRODUCTION 
 
The oxygen saturation (SpO2) is known as a highly 
relevant vital sign that can be used to detect worsening in the 
condition of critically ill patients, e.g. patients suffering from 
Chronic Obstructive Pulmonary Disease (COPD) [1] [2]. 
According to the World Health Organization (WHO), COPD 
is the third leading cause of death globally. Furthermore, the 
readmission rate for this patient population is as high as 24% 
and the mortality during admissions is 8% [3]. These 
numbers indicate that it is highly relevant to be able to detect 
worsening in the condition of these patients in a timely 
manner and thereby be able to initiate treatment and prevent 
dangerous exacerbations in the patient’s condition. As 
mentioned, the SpO2 level is an important vital sign in this 
context. Unfortunately, continuous levels of SpO2 are not 
routinely monitored on this patient population today. It is 
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therefore desirable to design new methods for reliable 
continuous estimation of SpO2 levels. Traditionally, the SpO2 
levels have been found using wired pulse oximeters placed 
on, for instance, the fingertip or the earlobe [4]. Our group 
has previously shown that photoplethysmographic (PPG) 
signals recorded on the sternum are clinically useful for 
analysis of the respiratory rate [5]. This parameter is another 
very important vital sign that is especially relevant when 
considering the condition of COPD patients [6]. Accordingly, 
it is important to investigate whether PPG signals recorded 
on the sternum are also suitable for calculation of the SpO2 
levels. In combination with the currently emerging patch type 
electrocardiogram (ECG) recorders [7], the ability to add 
PPG analysis on the sternum might therefore open the 
possibility for a future vital sign patch that could assist in 
detecting any worsening in the condition of critically ill 
patients. The purpose of this study is therefore to investigate 
whether PPG recorded on the sternum is able to provide 
reliable and clinically relevant measures of SpO2 levels in 
patients suffering from obstructive airway diseases.   
A. The PPG Signal 
In relation to pulse oximetry, PPG is a method that 
estimates the relative variations in the blood volume by 
emitting light with different wavelengths into the tissue and 
detecting the reflected/transmitted light by a photo detector. It 
is generally accepted that the SpO2 values can be estimated 
from the optical ratio, R, between the normalized amplitude 
of the red ( = 660nm) and the infrared ( = 940nm) PPG 
signals, see Fig. 1 [8]. However, the exact mathematical 
relation between R and SpO2 needs to be established 
empirically with a controlled desaturation study. After this 
calibration, the recorded PPG signals can be used to estimate 
the SpO2 levels directly. A few other research groups have 
previously published results from successful calibrations of 
PPG sensors placed on the sternum [9] [10], but to our best 
knowledge, this is the first study that extends the 
investigation of sternal PPG to include an estimate of the 
performance on a clinically very important patient 
population.   
II. METHODS 
For this study, we used a custom build PPG sensor that 
can be attached to the skin over the sternum with an adhesive 
tape, see Fig. 2.  As mentioned, the first step was to calibrate 
the custom build prototype of a sternal PPG sensor. This was 
accomplished with a controlled desaturation study. The next 
step was to simultaneously measure SpO2 values from the 
prototype sternal PPG sensor and a commercially available 
finger PPG sensor on patients with obstructive airway 
disease. Finally, the last step was to compare the SpO2 values 
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Figure 1. Examples of red (red dotted line) and infrared (black solid line) 
PPG signals recorded with the custom build PPG sensor placed on the 
sternum with an oxygen saturation of 98% (a) and 71% (b), respectively. 
Both the respiratory component (slow baseline changes indicated with 
vertical dashed blue lines) and the cardiac component (high frequency 
fluctuations) are clearly observed in both examples. Finally, it is observed 
how both the heart rate (HR) and the depth of the breathing are increased 
during low oxygen saturation.  
 
obtained from the two systems. Each of these steps will be 
described in details in following section. The study was 
approved by the Danish Regional Ethical Community, the 
Danish Health and Medicines Authority, the Danish Data 
Protection Agency, and it was monitored by the regional 
Good Clinical Practice (GCP) unit. Furthermore, all subjects 
provided written informed consent to participate before they 
were enrolled in the study.   
A. Data Acquisition for Calibration of the PPG Sensor 
The protocol for the calibration was conducted in 
accordance with the recommendations stated in the ISO 
80601-2-61:2011 guidelines. We enrolled a total of 14 
healthy Caucasian volunteers. The demographics of the 
subjects are provided in Table I. During the desaturation 
study, the oxygen saturation in the blood was gradually 
reduced within the region of clinical interest (70% to 100%). 
The experimental setup is illustrated in Fig. 2. The calibration 
was based on invasive measures of the blood oxygen 
saturation in the radial artery (SaO2). Therefore, a medical 
doctor (MD) performed an Allen’s test on the hand before the 
subject was included. This test ensures that both the radial 
and the ulnar arteries are able to individually supply the hand 
with sufficient amount of blood during the experiment. If the 
Allen’s test was passed, the MD placed a catheter in the 
radial artery under local anesthesia. This catheter is used for 
collection of arterial blood samples during the experiment. 
The desaturation was controlled with a closed-loop breathing 
system: The subjects were breathing in a mask with a 
manually controlled mixture of oxygen and nitrogen air from 
a 50 L container (a Douglas bag). The regulation of the air 
mixture was conducted by the MD. The subjects were lying 
in a supine position and, to avoid the influence of motion 
artifacts, they were instructed to move as little as possible. 
The patients were monitored using the prototype PPG sensor 
placed on the sternum and a 3-lead ECG. These recordings 
are used for the calibration procedure. To ensure the subject 
safety during the experiment, they were furthermore 
monitored using a Datex-Ohmeda AS/3 Patient Monitor 
(finger pulse oximetry, invasive blood-pressure (BP), and 
fraction of CO2 in the breathing air). To ensure 
synchronization of all the modalities, all the equipment was 
connected to the same data acquisition device (Powerlab 
8/35, 16 bit ADC ADInstruments, USA) and acquired 
simultaneously.  
During the recordings, up to 25 blood samples of 2 ml 
each were taken from each test subject. The goal was to 
obtain a distribution of the SaO2 level from the blood samples 
in the range of 70% to 100%. The first five blood samples 
were taken when the subject was breathing outside the closed 
system (reference measurements). The experiment was 
stopped when 25 blood samples were obtained, when the 
subject reached an oxygen saturation of 70%, or when the 
MD decided to stop (whichever came first). During the 
experiment, we obtained a total of 324 blood samples from 
the 14 subjects. The blood samples were analyzed using a 
Radiometer blood gas analyzer (ABL 800 Flex, Radiometer 
Co.). Each time a blood sample was taken, a marker was 
placed in the data acquisition software. This ensures 
synchronization between the time instance for the blood 
samples and the recorded signals.  
B. Calibration of the Sternal PPG sensor 
The first step of the calibration is to estimate the optical 
ratio, R, between the normalized amplitude of the red and the 
infrared PPG signals. We estimated R as described below: 
1. Extract the simultaneously recorded ECG and PPGs 
in a 20 second window centered on the time marker 
for each of the blood samples (corresponding to the 
window size of the finger pulse oximeter). 
TABLE I. SUBJECT DEMOGRAPHICS FOR THE CALIBRATION STUDY. 
Gender (male/female) 9 / 5 
Age (years), mean ± SDa 30.3 ± 11 
BMIb (kg/m2), mean ± SDa 22.2 ± 3 
Recording lengthc (min)  24.9 (18.1 - 50.1) 
a SD is the standard deviation 
b BMI is the body mass index 
c The recording length is stated as mean (minimum – maximum) 
 
Figure 2. Illustration of the calibration setup and the recorded data 
modalities.  
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2.  Normalize the red and the infrared PPG signals 
according to (1), where x(t) is the original PPG and 
y(t) is the normalized PPG [8].   
3. Extract the heart rate (HR) as the frequency bin with 
the largest amplitude in the power spectral density of 
the ECG. Consider only frequencies from 0.5 Hz to 4 
Hz (corresponding to a HR of 30 to 240 beats per 
minutes).  
4. Design a Butterworth band-pass filter of order 4 [11]. 
The low cut-off frequency for each window 
(corresponding to one blood sample) was found by 
subtracting 0.2 Hz from the detected HR and the high 
cut-off frequency was found by adding 2 Hz to the 
detected HR for this specific window.  
5. Filter both the red and the infrared PPGs with the 
individually designed filter. The effect of the 
normalization and filtering is illustrated in Fig. 3.  
6. Calculate R as defined in (2), where yr(t) is the 
normalized red PPG signal and yir(t) is the 
normalized infrared PPG signal [8].  

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The last step is to mathematically link the calculated R 
values to the measured SaO2 reference values. This provides a 
formula for future estimation of the oxygen saturation based 
on the PPG signals directly. In line with [8], we decided to 
use a simple linear regression defined in (3), where a and b 
are the regression coefficients. To ensure a high 
generalization performance of our calibration curve and to 
gain knowledge about the performance of the regression on 
new subjects, we used a leave-one-out scheme to fit the 
calibration curve. This implies that all blood samples from 
one subject were left out, while the calibration was conducted 
on all the blood samples from the remaining 13 subjects. This 
procedure was repeated with all 14 subjects as the test 
subject. For each of the 14 iterations, the values of a and b 
were found and the performance of the obtained calibration 
curve was evaluated as the root mean squared error (RMSE) 
between the measured SaO2 reference values and the levels 
estimated based on the calibration curve for the test subject. 
The final calibration curve was fitted as an average of the 
regression coefficients obtained in the 14 iterations.  
 baROSp     2  
C. Data Acquisition for the Comparison Study 
As mentioned, the purpose of this study was to investigate 
whether clinical relevant and reliable measures of the oxygen 
saturation can be obtained from PPG signals recorded on the 
sternum of relevant patients suffering from obstructive 
airway diseases. We therefore included a total of 30 patients 
with either COPD or asthma in this part of the study. All 
enrolled patients were admitted to the Department of 
Pulmonary Medicine or the Medical Admission Ward at 
Bispebjerg Hospital, Denmark. They were admitted for at 
least 24 hours prior to their inclusion due to a worsening in 
their condition. Two of the patients were excluded due to 
missing data in the recording. The demographics of the 
remaining 28 patients are provided in Table II. During the 
recording, the patients were monitored with the same 
commercial Patient Monitor as in the calibration part of the 
study. Furthermore, the prototype of the sternal PPG sensor 
was attached to the sternum using adhesive tape. This allows 
for a comparison between the SpO2 measures obtained from 
the commercially available finger pulse oximeter and the 
SpO2 levels estimated from the sternal PPG sensor. As in the 
calibration study, all signals were recorded with the same 
acquisition device. The patients were at rest in a semi-supine 
position. They were furthermore instructed not to make any 
unnecessary movements since this is known to cause motion 
artifacts in the recorded PPG signals. 
D.  Performance of the Sternal PPG Signals 
To estimate the performance of the sternal PPG signals on 
the patient population, we divided the recorded sternal PPGs 
and the ECGs into non-overlapping windows of 20 seconds 
(corresponding to the finger oximeter and the windows 
applied during the calibration). Then we repeated step 2 – 6 
in the calibration procedure for each of the non-overlapping 
windows. The obtained R values were then used to estimate 
the SpO2 values from (3) with the calibrated regression 
coefficients. This provides a time course of the estimated 
SpO2 values. A representative example of this time course is 
illustrated in Fig. 4 together with the SpO2 values 
simultaneously obtained from the finger pulse oximeter. The 
SpO2 values obtained from the two systems were then 
compared to estimate the performance of the sternal PPG 
signals on clinically relevant patients.   
III. RESULTS 
A. Calibration of the Sternal PPG Sensor 
The relation between R estimated from the sternal PPG 
signals and the measured SaO2 reference values are provided 
in Fig. 5(a) together with the obtained calibration curve. For 
validation of the calibration, the final calibration curve was 
applied to estimate the SpO2 values based on the calculated R 
value for all 324 blood samples. In accordance with the ISO 
80601-2-61:2011 guidelines, the accuracy of the sternal PPG 
sensor was then estimated according to (4), where n indicates 
 
 
Figure 3. Illustration of the effect of normalization and filtering. For 
comparison, the raw unprocessed signals are provided in Fig. 1. It is 
observed how the relation between the amplitude of the red (dotted red line) 
and the infrared PPG (solid black line) signals shift for different oxygen 
saturation levels. 
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the number of blood samples (n = 324). The accuracy was 
found to be Arms = 1.75%.  
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The Blandt-Altman plot of the comparison between the 
measured SaO2 reference values and the estimated SpO2 
values are provided in Fig. 5(b).  The mean system bias is  
-0.21% and the limits of agreements are 3.5% and -3.9% 
respectively. This shows slightly overestimated sternal 
derived SpO2. 
B. Performance of the Sternal PPG Signals 
The Pearson correlation between SpO2 measured on the 
finger and the SpO2 estimated from the sternal PPGs was 
found to be 0.89 (p<0.05). The Blandt-Altman plot of the 
comparison between the two methods is provided in Fig. 6.   
IV. DISCUSSION 
The first step was to calibrate the sternal PPG sensor 
through a controlled desaturation study. The results showed 
that there is an excellent agreement between the estimated 
SpO2 values and the measured SaO2 reference values in the 
clinical region of interest (70% to 100%). The accuracy of 
the sternal PPG system was found to be Arms = 1.75%. This 
accuracy is acceptable according to the ISO 80601-2-61:2011 
guidelines that allows Arms values of up to 4%. Commercially 
available pulse oximeters such as Masimo R25-L and 
NellCore Oximax N-65 reports accuracies of 1.79% and 
1.3%, respectively. Furthermore, another recent desaturation 
study conducted with a sternal PPG sensor has obtained an 
accuracy of 1.7% [9]. The calibration thus indicates an 
accuracy that is well within both the state of the art 
performance and the clinically acceptable range. We thus 
consider the calibration to be successful and we therefore 
find it reasonable to apply the estimated calibration curve to 
 
Figure 4. Time course of the SpO2 measured on the finger (blue dashed line) 
and estimated from the sternal PPGs (red solid line) for a COPD patient. 
The rapid increase in SpO2 observed from both systems is caused by the 
initiation of oxygen therapy. 
 
 
 
Figure 5. (a) Relation between the calculated R values and the measured 
SaO2 reference values (red dots) and the final calibration curve (blue line). 
The final calibration coefficients were a = -25.89 and b = 116.48. The 
average RMSE for the 14 calibration iterations was 1.73%. (b) The Blandt-
Altman plot of the comparison between the measured SaO2 reference values 
and the estimated SpO2 values. The middle solid line represents the mean 
system bias, whereas the upper and lower dashed lines represent the limits 
of agreements ±1.96 standard deviations (SD).  
 
 
 
Figure 6. The Blandt-Altman plot of the comparison between the two 
measurement systems. Each dot corresponds to the difference between the 
obtained SpO2 in one of the 20 second analysis windows. The study 
included a total of 1784 non-overlapping 20 second analysis windows.  
 
TABLE II. PATIENT DEMOGRAPHICS FOR THE COMPARISON STUDY. 
Gender (male/female) 10 / 18 
Age (years), mean ± SD 64.25 ±14.65 
BMI (kg/m2), mean ± SD 25.99 ± 8.87 
Recording length (min)  21 ( 10 - 54) 
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investigate the clinical performance of the sternal PPG 
signals on the patient population.  
As observed from Fig. 6 and the statistically significant 
correlation, there was a very high agreement between the 
results obtained from the commercially available Patient 
Monitor and the sternal PPGs. Furthermore, the Patient 
Monitor has a standard deviation in the estimation of SpO2 of 
±2% points in the range of 80% to 100%. Taking the 
individual accuracy of the two systems into account, we thus 
consider the agreement to be excellent. This shows that PPGs 
recorded on the sternum are reliable for estimation of SpO2 
levels in admitted COPD and asthma patients. Furthermore, it 
is observed from Fig. 4, that the sternal PPG sensor actually 
has a shorter response time for detection of changes in the 
SpO2 levels when oxygen therapy is initiated. However, the 
instantaneous deviations in the estimated SpO2 levels are 
observed to be slightly higher for the sternal PPGs. However, 
these minor fluctuations are within a very small range that is 
not considered to be critical for clinical applications. The 
high performance is expected to be caused by several factors. 
First of all, the signal quality was found to be excellent on the 
sternum and it was furthermore observed that the signal 
quality increased during episodes of hypoxia. This might be 
caused by an increase in the blood perfusion at the sternum. 
Furthermore, the temperature was observed to be higher on 
the sternum compared to the traditional finger or earlobe 
locations and the sensor might therefore obtain a better 
interface between the skin and tissue due to increased 
sweating and additional thermal insulation. These factors 
might contribute the high signal quality levels. Furthermore, 
the algorithm design contains several factors that are 
expected to increase the overall performance of the system, 
e.g. the window specific filter that was designed to maximize 
the attenuation of both movement artifacts and the influence 
of the respiratory component.  
One of the major limitations in this study is that both the 
healthy volunteers and the patients were instructed to move 
as little as possible. In future studies, it could be highly 
relevant to investigate the ability to conduct and analyze 
long-term PPG recordings on the sternum. In this context, it 
is, of course, necessary to investigate the performance of the 
system in the presence of different amounts of artifacts. 
However, several studies have demonstrated a high 
performance of adaptive noise cancellation using active 
sensors such as accelerometers [12]. This possibility would 
be very interesting to investigate in a future study. 
Furthermore, many episodes of physiological artifacts, e.g. 
coughing, are present in the recordings obtained from the 
patient population. The designed method is thus evaluated in 
the presence of physiological artifacts. Another limitation is 
that only four of the admitted patients did not receive oxygen 
therapy during the comparison. This implies that 89% of all 
the data points from the patient recordings represent SpO2 
levels of > 90%. It is expected that the uncertainty of the 
estimated SpO2 levels increases for both recording systems 
with decreased SpO2 levels. It might therefore be interesting 
to expand the comparison to include lower SpO2 levels as 
well. However, patients admitted with obstructive airway 
diseases are not normally allowed to reach SpO2 levels below 
90% while in the hospital bed. We thus find the evaluated 
range of SpO2 levels adequate for estimating the in-hospital 
performance of the sternal PPGs in this patient population.  
To our best knowledge, this is the first study addressing 
the possibility for reliable estimation of clinically relevant 
SpO2 levels from sternal PPGs on patients with obstructive 
airway diseases. We have thus demonstrated that SpO2 levels 
can be estimated from a prototype of a sternal PPG sensor 
placed on the sternum of COPD and asthma patients. The 
results show an excellent agreement with the gold standard 
(SaO2) and the accuracy is well within the range of 
commercially available SpO2 systems. This indicates that 
sternal PPG recordings might be incorporated into a vital sign 
patch together with e.g. ECG, accelerometer recordings, and 
estimation of the respiration rate. Such a patch may be able to 
assist in a timely detection of worsening of the condition of 
critical or chronically ill patients and improve the 
possibilities of treatment for this important patient 
population.   
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 
Abstract— Calculation of long-term quasi-continuous oxygen 
saturation (SpO2) levels is highly relevant for critically ill 
patients. The purpose of this study is therefore to conduct a 
preliminary investigation of the clinical reliability of long-term 
photoplethysmography (PPG) recordings obtained from the 
sternum of patients admitted to the hospital with obstructive 
lung diseases. Due to the lack of a gold standard reference that 
is suitable for long-term monitoring without interfering with 
the patient’s activity level, we extracted reliable segments based 
on knowledge from the basic pulse oximeter theory as well as 
knowledge about the inherent physiological regulation of the 
SpO2 levels. We included 15 admitted patients who were 
monitored with a prototype of a sternal PPG sensor for 
approximately 20 hours. On average, we found that clinically 
reliable SpO2 levels could be calculated for 58% of the 
recording time. Furthermore, the average longest period of 
time with unreliable data was only 23.6 minutes. This indicates 
a high potential for quasi-continuous calculation of SpO2 levels 
from sternal PPGs in many different clinical applications in the 
future.  
I. INTRODUCTION 
Outside the intensive care unit, the oxygen saturation 
(SpO2) level is often only monitored manually a few times per 
day. For critically ill patients, e.g. patients with Chronic 
Obstructive Pulmonary Disease (COPD), this might not be 
enough to ensure timely detection of a potential worsening in 
the patient’s condition [1][2]. Recently, the possibility for 
calculation of SpO2 levels from photoplethysmography (PPG) 
signals obtained from the sternum has been investigated [3]. 
Our group has furthermore previously shown that clinically 
relevant SpO2 levels can be obtained from short-term sternal 
PPGs recorded in a controlled environment on the sternum of 
admitted patients with COPD or asthma [4]. These findings 
show that sternal PPGs are highly applicable for reliable 
calculation of clinically relevant SpO2 levels in controlled 
conditions with a minimum influence of artifacts. However, 
in real-life applications, the recorded PPGs will be influenced 
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by varying amounts of unavoidable artifacts. This includes 
for instance artifacts from motions, changes in the amounts of 
ambient light, and changes in the contact between the skin 
and the sensor. When the PPG signals are affected by these 
artifacts, the calculation of the SpO2 levels might be 
unreliable. From a clinical point-of-view, it is acceptable to 
estimate the SpO2 levels in quasi-continuous periods with 
sufficient signal quality, e.g. provide a reliable calculation of 
the SpO2 level six times per hour or provide a reliable SpO2 
trend curve. This implies that periods of poor data quality are 
clinically acceptable as long as they alternate with periods of 
data that permits reliable calculation of the SpO2 levels. Due 
to the current lack of unobtrusive SpO2 measurement devices 
suitable for long-term monitoring, without impairment of 
normal activity levels, we utilize knowledge about the 
inherent physiological regulation of the SpO2 levels to 
investigate the reliability of the recorded PPGs. To our best 
knowledge, the long-term quasi-continuous reliability of SpO2 
levels calculated from sternal PPGs has never been 
investigated in chronically ill patients before. The purpose of 
this study is thus to investigate this possibility using long-
term sternal PPGs obtained from patients with obstructive 
lung diseases.   
II. METHODS 
An overview of the analysis is provided in Fig. 1. The 
recorded signals are divided into non-overlapping windows 
of 20 seconds and the SpO2 level is calculated in each of these 
windows. The window length is chosen to represent enough 
physiological information to provide a reliable calculation of 
the changes in the SpO2 levels over time. We then 
investigated the reliability of each segment and excluded 
unreliable segments. This is described in details later.  
A. Data Acquisition 
We enrolled a total of 15 patients with obstructive lung 
diseases (two asthma patients and 13 COPD patients). The 
patient demographics are provided in Table I. All 15 patients 
were admitted to the Department of Pulmonary Medicine at 
Bispebjerg University Hospital, Denmark. The patients were 
admitted due to a worsening in their conditions for at least 24 
hours prior to their inclusion in the study. Most of the 
patients received oxygen therapy. It is expected that these 
patients cause a relatively high amount of physiological 
artifacts, e.g. due to coughing, clearing of their throats, and 
their higher amount of muscle activation during respiration. 
The patients were furthermore instructed to follow their daily 
routines during the hospitalization (except showering). This 
ensures that the investigation is conducted on a clinically 
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highly relevant patient population with a realistic amount of 
artifacts. The patients were monitored using a custom build 
prototype of a PPG sensor. The PPG sensor simultaneously 
records a red ( = 660nm) PPG signal, an infrared ( = 
940nm) PPG signal, and a bipolar ECG signal. The PPG 
sensor was attached to the sternum of the patients using an 
adhesive electrode, see Fig. 2. The SpO2 level was also 
measured using a conventional finger pulse oximeter (Nellcor 
OxiMax N-65) in the beginning of each recording. This is 
used as a reference for comparison with the SpO2 levels 
obtained from the sternal PPGs in the beginning of the 
recording. The study was approved by the Danish Regional 
Ethical Community, the Danish Health and Medicines 
Authority, the Danish Data Protection Agency, and it was 
monitored by the regional Good Clinical Practice (GCP) unit. 
Furthermore, all patients provided informed written consent 
to participate before they were enrolled in the study.   
B. Calculation of the SpO2 Levels 
The SpO2 level was calculated as SpO2 = -25.89·R + 
116.48, where R represents the relation between the 
amplitudes of the normalized and filtered red and infrared 
PPG signals and, in accordance with the ISO 80601-2-5-
61:2011 guidelines, the calibration coefficients were found 
from a desaturation study recently conducted by our group 
[4]. A detailed description of the normalization and filtering 
is also provided in [4]. An example of the obtained time 
course of the SpO2 levels is provided in Fig. 3(a).   
C. Reliability of the Calculated SpO2 Levels 
We applied two different criteria to check the reliability 
of every one-minute segment of the recorded data (see Fig. 
1). The first check is related to the basic assumptions for 
calculation of the SpO2 level based on the red and the infrared 
PPG signals. Since the SpO2 level is calculated based on the 
relation between the amplitudes of the two signals, it is 
theoretically reasonable that a certain mathematical 
correlation is required between the two signals [5]. The first 
criteria was therefore that the one-minute segment was 
deemed unreliable if the Pearson correlation coefficient 
between the red and the infrared PPG signal in any of the 
three 20-second windows was below 0.75 [6]. The second 
part of the reliability check is related to knowledge about the 
inherent physiological regulation of the SpO2 levels. The SpO2 
change observed within one minute is physiologically 
expected to vary very little [7]. Several research groups have 
investigated the response time to changes in SpO2 levels 
during low endurance walk in COPD patients and they 
generally found a decrease in the SpO2 level around 3% per 
minute [7][8][9]. We therefore deemed the one-minute 
segment unreliable if the absolute difference between the 
maximum and minimum SpO2 values obtained in the one-
minute segment exceeded 3%. The reliability check was 
conducted as a sliding window with an overlap of two 20-
second windows. This implies that each 20-second window is 
included in three different runs of the reliability check. If it is 
deemed unreliable in at least one of the three checks, the 20-
second segment is considered unreliable. The performance of 
the reliability check is illustrated in Fig. 3(b).  
D. Estimation of Long-Term Accuracy 
As observed from Fig. 3(b), the included segments have a 
certain variation around a baseline SpO2 level. To estimate 
this variation, we calculated an estimated reference SpO2 
trend curve. This curve is calculated with an average filter 
with 30 points (corresponding to 10 minutes). All unreliable 
segments were excluded for calculation of this reference 
trend curve. An example of the trend curve is provided in 
Fig. 3(c). We then defined the long-term accuracy of the SpO2 
calculation as the Root Mean Squared (RMS) error between 
this reference curve and the SpO2 values that were deemed 
reliable.    
III. RESULTS 
The RMS error between the SpO2 values calculated from 
the sternal PPGs in the beginning of the recording and the 
SpO2 values obtained from the conventional finger pulse 
oximeter was only 2.3%. Fig. 4 contains a few examples of 
the time course of the calculated SpO2 values. It is observed 
from both Fig. 3 and Fig. 4 that several short periods of data 
are excluded. An overview of the lengths of all excluded 
TABLE I. DEMOGRAPHICS OF THE PATIENT POPULATION. 
Gender (male/female) 3/12 
Age (years), mean ± SDa 67.4 ± 19 
BMIb (kg/m2), mean ± SDa 25 ± 4.5 
Recording lengthc (hours)  18-20 
a SD is the standard deviation 
b BMI is the body mass index 
c The recording length is stated as minimum – maximum 
Figure 1. Schematic overview of the analysis. The reliability is checked 
based on the SpO2 levels calculated from three consecutive 20-second 
windows (corresponding to a one minute data segment). If the input data 
from the one-minute segment is deemed unreliable, all three corresponding 
20-second windows are deemed unreliable and they are excluded from 
further analysis (illustrated by zeros in the reliability vector).  
 
 
 
Figure 2. (a) Illustration of the chest of a patient before application of the 
prototype PPG sensor. (b) Illustration of the prototype PPG sensor attached 
to the sternum of the patient using an adhesive electrode. The ECG 
recording sites are embedded in the adhesive electrode.  
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successive windows from all 15 patients is provided in Fig. 5. 
On average, the longest period of unreliable data from the 15 
patients was only 23.6 minutes. Overall, the average 
percentage of reliable PPG segments from the 15 patients 
was 58%. Finally, the average RMS error between the SpO2 
values calculated directly from the sternal PPGs and the 
estimated average reference curves was only 2.5%.  
IV. DISCUSSION 
This study is a preliminary investigation of the possibility 
for long-term quasi-continuous calculation of SpO2 levels 
based on sternal PPGs. We have previously shown the 
potential for calculation of clinically relevant and reliable 
SpO2 levels based on sternal PPGs obtained in controlled 
 
 
Figure 3. (a) Example of the time course of all calculated SpO2 values for two hours during the night for one patient. (b) Illustration of the reliable segments 
(blue marks) and the unreliable segments (red marks). (c) Illustration of the time course of all the extracted reliable segments (blue marks) together with the 
estimated average reference curve (green line). This curve is applied to calculate the long-term accuracy of the reliable SpO2 values. (d) Time course of the 
raw red PPG signal. (e) Time course of the raw infrared PPG signal. It is observed how segments with high amounts of artefacts in the PPG signals are 
considered unreliable and therefore excluded from the SpO2 analysis.  
 
 
Figure 4. Three different examples of the time course of the calculated SpO2 segments that were deemed reliable (blue marks) and the estimated average 
reference curve (green line). (a) Illustration of a full 20-hour recording. It is observed how the SpO2 level temporarily decreases several times during the day. 
This might be caused by removal of the oxygen therapy, e.g. if the patient left the bed. (b) Illustration of the SpO2 level during the transmission between day 
and night. It is observed that the calculated SpO2 levels vary more during the day compared to the night. Furthermore, several segments are deemed 
unreliable right before bedtime (around 22:00). This might be caused by artifacts in the PPGs when the patient was getting ready for the night. (c) Example 
of slow variations in the SpO2 levels during the day.  
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conditions [4]. In this preliminary long-term study, it was 
important to restrict the patient’s daily activities as little as 
possible. This mimics a realistic impression of the 
possibilities for future quasi-continuous calculation of SpO2 
levels in the presence of artifacts arising from normal in-
hospital activities. It was therefore not feasible to compare 
the calculated SpO2 values with either the gold standard 
(arterial blood samples) or the conventional pulse oximeters 
(wired finger probes) throughout the recording length. 
Instead, we compared the SpO2 values obtained from the 
sternal PPGs with a conventional finger pulse oximeter in the 
beginning of the recordings. This comparison was applied to 
establish a baseline accuracy of the sternal PPGs. Based on 
our previous findings [4] and the very low RMS error 
between the two methods in the beginning of the recordings, 
we assume that the SpO2 levels calculated from the long-term 
sternal PPGs are reliable in segments of sufficient data 
quality. For the rest of the recording time, we therefore 
investigated the reliability based directly on knowledge about 
the inherent physiological regulation of the SpO2 levels and 
the basic theory of pulse oximetry. It is observed from Fig. 3 
how the reliability check correctly removes many of the 
outliers. These outliers are expected to be caused by poor 
data quality. It should be mentioned that our limit of a 
maximum SpO2 difference of 3% in one minute is quite strict. 
This implies that the actual amount of reliable data segments 
might have been even higher. We selected the stricter limit 
because it is worse to include an unreliable segment and 
hereby provide the doctor with an erroneous SpO2 calculation 
than it is to exclude a segment that could have provided 
reliable calculation of the SpO2 level.     
On average, we found the calculated SpO2 values to be 
reliable in 58% of the recording time. More importantly, we 
generally found that segments of reliable SpO2 values could 
be extracted throughout the recording length. This indicates 
that when the SpO2 calculation temporarily becomes 
unreliable due to artifacts, it becomes reliable again after the 
artifact event. This is observed from Fig. 4. Furthermore, it is 
observed from Fig. 5 that almost all excluded time periods 
are less than ten minutes. Looking at the SpO2 levels in one 
hour intervals, it is therefore indicated that it would be 
possible to measure the SpO2 level at least six times per hour. 
This is very promising for future quasi-continuous 
calculation of SpO2 values based on sternal PPGs.  
In the future, it might be possible to design new 
algorithms for automatic detection of data segments that 
would provide a reliable SpO2 measure. This would allow for 
a real-time quasi-continuous setup for long-term monitoring 
of SpO2 values in chronically ill patients. The low RMS error 
between the included SpO2 values and the estimated average 
reference curves furthermore indicates a high long-term 
accuracy of the calculated SpO2 values. This indicates that we 
have obtained a high attenuation of artifacts in the originally 
calculated SpO2 values. In the future, it will be possible to 
increase the uptime even further, e.g. by optimizing the 
sensor design, implementing adaptive noise cancellation from 
additional recording modalities, or implementing more 
advanced algorithms for calculation of the SpO2 values.  
In this preliminary study, we have thus demonstrated the 
ability to calculate clinically relevant and reliable SpO2 values 
in long-term sternal PPG recordings obtained from patients 
suffering from obstructive lung diseases. This finding is very 
promising for future implementation of SpO2 measures in a 
sternum based vital sign patch. In the future, such a patch 
might assist in early detection of worsening in the condition 
of these patients and hereby ensure timely treatment of the 
patients.  
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Figure 5. Illustration of the distribution of the lengths of unreliable 
(excluded) time segments for each patient. The red vertical lines indicate 
the median for each subject, the blue boxes indicate the interquartile ranges, 
and the red marks indicate outliers. The green vertical line indicates a 
threshold of 10 minutes (corresponding to obtaining an average of at least 
six reliable SpO2 measures every hour).   
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